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Abstract 
Wolfram Syndrome (WS), is a neurodegenerative disorder defined historically by the 
combination of diabetes insipidus, diabetes mellitus, optic atrophy and sensorineural 
deafness (DIDMOAD). The majority of patients with WS harbour recessive mutations within 
the WFS1 gene (OMIM 606201), which encodes the wolframin protein. Wolframin is 
implicated in a number of critical cellular pathways, in particular the ER stress response and 
calcium homeostasis. Mitochondrial dysfunction is suspected to play a key role in the 
pathology of the disease. This link is highlighted by mutations in the CISD2 (OMIM 611507) 
gene, which also result in WS through a deleterious effect on mitochondrial calcium flux and 
disturbed ER-mitochondrial interactions. Wolframin is also suspected to have a role in the 
development of the brain and neuronal tissue and is associated with numerous neurological 
and psychiatric disorders.  
The aim of this study was to characterise novel zebrafish models (wfs1a & wfs1b) of WS to 
further our understanding of the role of wolframin in WS, particularly in regulating 
mitochondrial function and neuronal development.  This model could also be used to screen 
for therapeutic compounds.  
The characterisation of this zebrafish model involved observing histological, behavioural and 
biochemical changes in the knockout zebrafish and determining if the model was 
comparable to the pathological features reported in patients with WS. We have shown that 
this zebrafish model of WS shares defects in the ability to cope with ER stress and 
importantly, it shares similar phenotypes to the human, in particular optic atrophy. 
Mitochondrial dysfunction was also observed in the model with changes seen in trafficking, 
respiration and changes in expression of Complex I of the mitochondrial electron transport 
chain. 
This zebrafish model provides a powerful tool to observe neuronal development and 
mitochondrial function in a live animal model, providing new insights on the mechanisms 
driving neuronal degeneration in WS.  
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Chapter 1: Introduction 
1.1 Endoplasmic Reticulum 
The endoplasmic reticulum (ER) is the largest eukaryotic organelle which forms an 
intracellular membrane system (Halperin et al., 2014). The ER is most known for its role in 
protein synthesis and folding. However, it is a complex organelle critical in other cellular 
pathways including: protein transport, lipid and steroid synthesis, carbohydrate metabolism 
and calcium storage (Schwarz and Blower, 2016).  
1.1.1 Structure & Function 
The ER is split into two domains the nuclear envelope (NE) and the peripheral ER: which is 
further divided into a number of distinct domains responsible for numerous functions within 
the same continuous membranes (English and Voeltz, 2013; Westrate et al., 2015). 
The NE is made of two flat ER membrane bilayers (the inner nuclear membrane (INM) and 
outer nuclear membrane (ONM) is responsible for trafficking of macromolecules into the 
nucleus alongside its role of anchoring for both chromatin and the cytoskeleton(Hetzer et 
al., 2005). The peripheral ER is formed from the ONM with two dominant morphologies: the 
peripheral ER cisternae and ER tubules. ER cisternae tend to lie closer to the NE with the ER 
taking a more tubule shape closer to the plasma membranes (Puhka et al., 2007).  
The two distinct morphologies are separated into the rough (cisternae) and smooth (tubule) 
ER (Figure 1.1). The rough is named so as it tends to be studded with ribosomes for protein 
translation leading to the hypothesis that the cisternae where responsible for protein 
production/modification (Westrate et al., 2015). The cisternae do have a higher number of 
ribosomes and a larger volume (for protein folding) compared to the tubular ER supporting 
the hypothesis (Puhka et al., 2007; West et al., 2011; English and Voeltz, 2013). However, 
ribosomes are also found on the tubular ER, in lower concentrations, suggesting a much 
more complicated picture. The tubular network is better designed for lipid synthesis and has 
abundant membrane contact sites for ER interactions with other organelles such as the 
plasma membrane and mitochondria. These contact sites are integral for ER function of 
lipid/steroid synthesis and Calcium ion homeostasis (Phillips and Voeltz, 2016). 
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Figure 1.1 Electron Micrographs of Rough vs Smooth ER. Image adapted from (Schwarz and 
Blower, 2016) 
1.1.2 Calcium Ion Homeostasis 
Calcium ions act within the cell as an important secondary messenger that is linked to 
numerous cellular functions including: metabolism, gene transcription and apoptosis 
(Berridge et al., 2003). Due to the large number of critical processes affected by Ca2+, the cell 
needs to keep a tight control on Ca2+ homeostasis. This approximately 100 nM  in the cytosol 
and under normal circumstances is tightly controlled by intracellular compartments and by 
Ca2+ ion channels found on the plasma membrane (Bollimuntha et al., 2017). Other 
concentrations of Ca2+ include: 100–500 µM in the ER (Bagur and Hajnoczky, 2017), 0.1 to 
1.0 mM in mitochondria (Bollimuntha et al., 2017) and approximately 1mM in the 
extracellular milieu (Bagur and Hajnoczky, 2017).  
Ca2+ ions enter the cell down the electrochemical gradients through plasma membrane 
channels that include the voltage operating calcium channel (VOC) - found in excitable cells, 
N-methyl-D-aspartate receptors (NMDA), transient receptor potential channels (TRPC) and 
store operated Ca2+ channels (SOCE), these channels respond to numerous stimuli to 
increase Ca2+ levels in the cell. In order to maintain control, Ca2+ ions are moved out of the 
cell using the Na+/Ca2+ exchanger of the plasma membrane (NCX) and the plasma membrane 
Ca2+ ATPase (PMCA). The NCX, also found in the mitochondrial membrane, uses the 
electrochemical gradient of sodium to transport Ca2+ out of the cell; while PMCAs require 
energy in the form of ATP for transport (Berridge et al., 2003; Sharma and O'Halloran, 2014; 
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Krebs et al., 2015). Ca2+ is also tightly controlled by the intracellular compartments and 
mainly stored in the ER. Ca2+ is pumped into the ER by the sarco ER Ca2+ ATPase (SERCA) an 
ATP dependant reaction and is released mainly through the Inositol trisphosphate receptor 
(IP3R) and the ryanodine receptor (RYR) (Berridge et al., 2003; Krebs et al., 2015). The other 
major intracellular stores are the mitochondria, where the Ca2+ levels are increased through 
the mitochondrial calcium uniporter (MCU) and reduced through the NCX. Ca2+ at extreme 
concentrations can cause the opening of the mitochondrial permeability transition pore 
(MTPT) which will release Ca2+ to the cytosol (Lemasters et al., 1998).  
 
Figure 1.2 Regulation of cytoplasmic Ca2+. Schematic describing the main pathways for the 
regulation of cytosolic Ca2+ modified from (Krebs et al., 2015)  
The MCU and the NCX have higher capacities for Ca2+ transport making them important in 
the regulation of high dynamic ranges of Ca2+ concentrations. This makes the mitochondria 
an important regulator in cytosolic Ca2+ levels at high levels. It has been observed that the 
mitochondrial uptake is much higher at concentrations over 300nM of cytosolic Ca2+ (Collins 
et al., 2001). The PMCA and SERCA pumps have a much higher affinity but lower capacity for 
Ca2+ making them important in the tight regulation of basal levels and coping with small 
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increases. The SOCE acts as the high capacity pump for refilling the endoplasmic reticulum. 
When low Ca2+ levels are detected in the ER by stromal interacting molecule (STIM) proteins: 
the STIM protein will interact with ORAI (a SOCE) causing Ca2+ to enter the ER through the 
plasma membrane (Roos et al., 2005; Prins et al., 2011) . This process is also negatively 
regulated by the protein SARAF in order to prevent dangerously high levels of Ca2+ (Palty et 
al., 2012) . Alongside these sensors of Ca2+ levels are a whole host of other sensors and 
buffers that bind calcium in order to regulate free Ca2+.  One such sensor is BiP; also known 
as GRP78 or HSPA5, which alongside its role in buffering Ca2+ acts to help post translationally 
modify proteins, a key function of the ER. 
1.1.3 Unfolded Protein Response/ER Stress Response 
The ER is a key organelle in the post translational modification of proteins. Approximately 
one-third of all cellular proteins will be translocated to the ER lumen in which they will 
undergo post-translational modifications (Kaufman, 1999). Post translational modifications 
include formation of disulfide bonds, folding, glycosylation, proteolytic cleavages and 
oligomerization. The lumen of the ER is an oxidised environment that contains numerous 
chaperones in order to help facilitate proper folding of proteins (Kaufman, 1999). If proteins 
are misfolded they are targeted by the ubiquitin pathway for degradation (Claessen et al., 
2012). Changes in ER homeostasis can lead to the accumulation of unfolded proteins. The 
unfolded protein response (UPR) also known as the ER stress response is a mechanism to 
correct ER function or push the cell towards apoptosis if corrections cannot be made. There 
are three pathways that will be activated during ER stress: Inositol-requiring enzyme 1 
(IRE1), Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) and Activating 
transcription factor 6 ATF6, all three are regulated by BiP also known as GRP78 (Figure 1.3) 
(Bertolotti et al., 2000; Shen et al., 2002). The activation of the three pathways is caused by 
the dissociation of BiP from IRE1, PERK and ATF6, caused by an increase in misfolded 
proteins in the ER (Bertolotti et al., 2000). IRE1 and PERK, when released will form oligomers 
in the ER membrane which activate a number of downstream signalling pathways to 
alleviate ER stress. ATF6 is slightly different in the fact that BiP blocks a Golgi localisation 
signal and when BiP dissociates ATF6 localises to the Golgi were it is cleaved and becomes 
active.   
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Figure 1.3 The Unfolded Protein Response. The three pathways of the UPR and the main 
downstream effects of each pathway.  
IRE1 has two homologues IRE1α/β. After oligomerization IRE1α cleaves X-box binding 
protein 1 (XBP1) RNA which produces an active form of XBP (XBPu). IRE1β cleaves the 28S 
ribosome RNA which will lead to a reduction of translation (Iwawaki et al., 2001). XBP is a 
transactivator which causes the upregulation of a number of genes reducing protein 
production and reversing ER stress (Bravo et al., 2013). IRE1α also upregulates the c-Jun N-
terminal kinases (JNK) which is involved in both cell survival and apoptotic pathways (Liu and 
Lin, 2005). 
As with IRE1, when BiP dissociates with PERK it forms oligomers to produce their 
downstream signalling effects. PERK activation causes the phosphorylation and activation of 
eIF2α. This in turn activates ATF4. In combination these two factors reduce protein 
expression in cell undergoing ER stress (Harding et al., 2000). ATF4 also upregulates CCAAT-
enhancer-binding protein homologous protein (CHOP) expression, CHOP is a pro-apoptotic 
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factor which will eventually lead to apoptosis if homeostasis is not restored (Fawcett et al., 
1999). PERK activation also activates Nuclear factor (erythroid-derived 2)-like 2 transcription 
factor (Nrf2) which has an opposite role in cell survival (Cullinan et al., 2003). 
ATF6, like IRE1, has two isoforms ATF6α and ATF6β. Both are transported to the Golgi after 
dissociation by vesicles by the COPII protein (Schindler and Schekman, 2009). In the Golgi 
ATF6 is cleaved by Sphingosine-1-phosphate (S1P) and Sphingosine-2-phosphate (S2P) 
proteases (Shen and Prywes, 2004). Both isoforms go on to produce opposite effects. ATF6α 
when cleaved localises to the nucleus where it upregulates numerous proteins involved in 
regulating the ER stress response such as BiP (Thuerauf et al., 2004). The ATF6β subunit 
appears to have a role in the regulation of the strength of the ATF6α response (Thuerauf et 
al., 2004).  
The ER removes unfolded proteins through two main pathways. The ER-associated protein 
degradation (ERAD) and autophagy.  ERAD involves the retrotranslocation of misfolded 
proteins to the cytoplasm for ubiquitination by E3 ligase followed by degradation by the 
proteasome (Ruggiano et al., 2014). The IRE1-JNK pathway is activated in response to ER 
stress and is responsible for the upregulation of autophagy (Ogata et al., 2006). Autophagy is 
a more general degradation pathway and uses endolysosomal degradation to remove 
misfolded proteins, pathogens or dysfunctional organelles such as mitochondria.  
1.1.4 Mitochondria Associated Membrane (MAM) 
The ER and mitochondria interact at specialised locations named MAMs (Franke and 
Kartenbeck, 1971; Vance, 1990). These areas are where the two membranes of the two 
organelles are in close proximity (10–25 nm) but do not fuse (Csordas et al., 2006). This 
domain is important for the two organelles and is involved in processes such as lipid 
biosynthesis, mitochondrial division, Ca2+ signalling and the regulation of dynamics of 
organelles (Rowland and Voeltz, 2012).  
1.2 Mitochondria 
The mitochondria are organelles that evolved by endosymbiosis of an alphaproteobacterium 
into a precursor eukaryotic cell. This addition of mitochondria has allowed eukaryotes to 
develop much more complex genomes with 200,000-fold more genes being expressed (Lane 
and Martin, 2010).This is due to the heavy selection pressure to remove extra DNA from 
prokaryotes  due to the energy expenditure (Lane and Martin, 2010). The 
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alphaproteobacterium have been simplified with a large transfer of the mitochondrial DNA 
(mtDNA) across to the eukaryotic genome, it is thought that a large number of these genes 
have been replaced and that modern eukaryotes share few common genes with the 
alphaproteobacterium but most eukaryotic mitochondria contain their own genome 
(Huynen et al., 2013; Karnkowska et al., 2016). These modifications were thought to have 
occurred largely before eukaryotic radiation suggesting their importance in the increasing 
complexity of eukaryotic organisms (Huynen et al., 2013). The mitochondria primary 
function is to produce ATP through oxidative phosphorylation (OXPHOS). The mitochondria 
also have a number of other roles including ROS signalling, metabolism, lipid synthesis, Ca2+ 
homeostasis, apoptosis and the production of iron sulphur clusters alongside other functions 
(Schmidt et al., 2010). 
1.2.1 Structure 
As mitochondria have evolved from bacteria they maintain their separate double membrane 
structure with an outer (OMM) and inner membrane (IMM) separated by the inter 
membrane space (IMS). The outer membrane is contains many pore forming proteins which 
makes the OMM permeable to molecules smaller than 5kDa (Dukanovic and Rapaport, 
2011). 30 different proteins were described as being localised to the OMM in yeast, 
predominantly involved in pore formation, protein import and mitochondrial dynamics 
(Schmitt et al., 2006; Zahedi et al., 2006). The IMM is impermeable to most of the small ions 
which allows for an electrochemical gradient to be produced which is utilised in OXPHOS. 
The IMM is folded into cristae. The IMM contains a large number of proteins responsible for 
the majority of important processes of the mitochondria: OXPHOS, protein import, 
morphology, translation, iron–sulphur cluster biogenesis, and protein degradation (Zahedi et 
al., 2006). The IMM encircles the mitochondrial matrix where a number of important 
functions are carried out and the mitochondrial DNA is maintained. 
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Figure 1.4 Structure of Mitochondria. Electron microscope image of a mitochondrion 
alongside a cartoon to better discriminate between structures. EM image taken from (Wu et 
al., 2017) 
1.2.2 mtDNA 
mtDNA can vary significantly between eukaryotes with genomes found coding for 1 gene up 
to 100 (Karnkowska et al., 2016; Lavrov and Pett, 2016). However, the number of proteins 
found in mitochondria are larger than the number expressed on the mtDNA (mitochondria in 
saccharomyces contain ~1000 proteins and mammals ~1500). The majority of mitochondrial 
genes are contained in the nucleus and the proteins transported to the mitochondria 
through protein import (Reinders et al., 2006; Meisinger et al., 2008).  
In humans mtDNA is a circular, double-stranded DNA molecule approximately 16569 bp in 
length (Andrews et al., 1999). The strands can be distinguished by the guanine rich heavy 
strand and the cytosine rich light strand. The genes are efficiently organised with no introns, 
one regulatory region and intergenetic sequences can overlap or separated by a few base 
pairs (Taanman, 1999). mtDNA codes for 37 genes: 2 genes encode the mitochondrial 
ribosomal subunits (a 16s and a 12s subunit); 24 genes encode tRNA molecules and the 
remaining 13 OXPHOS subunits (Chinnery and Hudson, 2013).  
Mitochondria generally contain several copies of mtDNA (Taanman, 1999). The majority of 
the sequences will be identical but populations of mtDNA can be mixed referred to as 
heteroplasmy. A number of factors including oxidative damage and inefficient mtDNA repair 
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a number can contain mtDNA mutations(Chinnery and Hudson, 2013). Aging humans have 
increased levels of somatic mtDNA mutations suspected to be linked with respiratory chain 
dysfunction in ageing (Larsson, 2010). Inheritance is thought to be maternal. However, a 
number of cases of biparental inheritance have been discovered (Luo et al., 2018).  
1.2.3 Oxidative Phosphorylation 
OXPHOS is the process in which mitochondria convert ADP to ATP. This process involves the 
five respiratory complexes (Complex I-V) as well as two electron shuttles, ubiquinone and 
cytochrome c. These complexes are embedded into the IMM as illustrated in Figure 1.5. 
Complexes I, III and IV transport H+ ions from the matrix into the IMS and create an 
electrochemical gradient, this process is known as the electron transport chain (ETC). This 
gradient is utilised by complex V to convert ADP to ATP. 
 
Figure 1.5 Mitochondrial OXPHOS. Schematic of electron transport and H+ ion transport 
through the mitochondrial OXPHS complexes.  
1.2.4 Mitochondrial Complexes 
The initial H+ ion transport is powered by electron transfer from the entry points at complex 
I and II.  
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Complex I (NADH:ubiquinone oxidoreductase) contains 45 subunits 14 of these are highly 
conserved core subunits and 31 supernumerary subunits (Hirst, 2013; Zhu et al., 2016). The 
core subunits form two key domains in complex I. The seven hydrophobic core subunits 
encoded by the mtDNA are involved in the transfer of the H+ ions from the matrix to the 
IMS. The seven hydrophilic core subunits produce a redox domain for interacting with NADH 
(Vinothkumar et al., 2014). The NADH interacts with a Flavin Mononucleotide which 
transfers the electrons along seven iron-sulfur clusters to be transferred to ubiquinone 
(Hunte et al., 2010). Two H+ ions are transferred across the membrane for every one 
electron. This represents around 40% of the H+ ions moved across the membrane (Hunte et 
al., 2010). Complex I also produces the majority of reactive oxygen species (ROS) from the 
ETC (Liu et al., 2002; Hirst et al., 2008). ROS are involved in a number of cellular signalling 
pathways but an over production can lead to damage of proteins and cell death so under 
physiological conditions these levels are tightly controlled (Zorov et al., 2014). ROS can be 
produced at the NADH binding site but also at the ubiquinone binding site which acts as the 
electron shuttle between complex I and III. 
Ubiquinone also known as Coenzyme Q is a fully substituted benzoquinone ring with a long 
polyisoprenyl tail which allows the molecule to be positioned in the midplane of the lipid 
bilayer with the head in the hydrophilic regions (Samori et al., 1992). This allows Ubiquinone 
to accept electrons from complex I and II and transfer them to complex III.   
Complex II (succinate dehydrogenase) is the only complex with no subunits produced from 
the mtDNA. The complex contains four subunits, a flavin-adenine dinucleotide (FAD); iron 
sulfur clusters and heme (Sun et al., 2005). Complex II utilises succinate as a substrate which 
it converts to fumerate, this is an integral part of the tricarboxylic acid (TCA) cycle of aerobic 
respiration. Succinate transfers electrons to the FAD and like complex I, the electrons pass 
up the iron sulfur clusters and are transferred to ubiquinone. Unlike complex I this unit has 
no transmembrane domain to transfer H+ ions to the IMS. ROS can also be produced by this 
complex at the ubiquinone binding site although under physiological conditions this effect is 
negligible. Complex II does also contribute to ROS production through reverse electron 
transfer, when high levels of succinate can be detected complex II through ubiquinone can 
transfer electrons back down the chain to complex I to produce ROS (Bezawork-Geleta et al., 
2017). 
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Complex III (cytochrome c reductase) contains 11 subunits (Schagger et al., 1986). Three of 
these subunits are catalytically active, the first cytochrome b (mtDNA encoded) contains two 
b-type hemes and this subunit interacts with the ubiquinone. The second Rieske iron-sulfur 
protein contains an iron sulfur cluster that removes electrons from ubiquinone and transfers 
one to the third active subunit Cytocrome c1. This transfers electrons to cytochrome c the 
seconded electron shuttle(Sousa et al., 2018).  
Cytochrome c is a 13 kDa globular and soluble protein which is predominantly found in the 
IMS. This shuttles the electrons from complex III to IV. Cytochrome c has other functions 
such as a prominent role in apoptosis when released from the mitochondria as well as less 
lethal roles such as platelet formation and monocyte differentiation (Ow et al., 2008).   
Complex IV (Cytochrome c oxidase) is the final proton pump in the ETC. It is composed of 14 
different subunits three of which are encoded by mtDNA. Complex IV at its centre contains 
four redox-active metal cofactors, one of these factors CuA accepts electrons from 
cytochrome c which are transferred to an active site where they are converted to H2O 
through an intermediary step where a hydroxide ligand is protonated to create H2O. This 
reaction uses eight protons with four transferred across the IMM by complex IV and four 
converted to H2O(Sousa et al., 2018). 
This transfer of H+ ions creates the electrochemical proton motive force which drives ATP 
production by complex V. Complex V (F1Fo ATP synthase) acts as a membrane embedded 
motor powered by H+ ion movement from the IMS to the matrix (Noji et al., 1997). Complex 
V is split into two regions F0 which is embedded in the IMM which acts as the rotor and the 
F1 region which binds the ADP (Abrahams et al., 1994). The rotors movement powered by 
the H+ ion movement causes conformational changes to complex V force ADP + Pi to ATP 
(Sousa et al., 2018).  
Complexes although initially thought to be independent have been observed existing as 
supercomplexes (Schagger and Pfeiffer, 2000). The supercomplexes found in in mammals 
are: complexes I1III2 and I1III2IV while complex V can exist in dimeric forms (Minauro-
Sanmiguel et al., 2005; Davies et al., 2018). Although the function of respiratory 
supercomplexes is not fully understood it is suspected supercomplexes play a role in 
stability, ROS production and most importantly substrate channelling which creates more 
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efficient respiration (Vempati et al., 2009; Lapuente-Brun et al., 2013; Maranzana et al., 
2013). 
1.2.5 Mitochondrial Dynamics 
The mitochondria are highly dynamic organelles which undergo changes in fission and fusion 
and have the ability to move throughout the cell. The process of fusion increases the ATP 
production allows the sharing of metabolites and can prevent mitophagy (Chen et al., 2005; 
Molina et al., 2009; Gomes et al., 2011). This process is mainly controlled (in mammals) by 
three proteins: Mfn1, Mfn2 and OPA1.  
Mfn1 and Mfn2 are GTPase proteins which can be found in the OMM these tether two 
mitochondria together, when GTP binds it induces a conformational change and the two 
mitochondrial membranes are brought together and fuse (Tilokani et al., 2018). OPA1 
controls IMM fusion. OPA1 is cleaved into a short and long form (S and L-OPA) by alternative 
cleavage sites found on OPA1. Only L-OPA is required for fusion by interacting with 
cardiolipin on the opposing membrane bringing the two together (Ban et al., 2017). While S-
OPA is thought to be possibly involved in fission (Head et al., 2009; Tondera et al., 2009).   
Mitochondrial fission is important in cell division, for dividing mitochondria between 
daughter cells and allowing mitochondria to undergo mitophagy - the process by which 
mitochondria are degraded by lysosomes (Farmer et al., 2018). The ER is also involved in this 
process and fission occurs at points where ER tubules contacted mitochondria this reduces 
the mitochondrial width at this point to 150nm (Friedman et al., 2011). This is possibly 
caused by the increase of Ca2+ uptake at the ER contact point (Chakrabarti et al., 2018). The 
Drp1 protein then recruited to these constricted sites. Drp1 is a GTPase protein which is 
localised to the cytosol but can be recruited to mitochondria and peroxisomes when 
undergoing fission (Tilokani et al., 2018). This constricts the mitochondria further at the cut 
points and is eventually cleaved by Dynamin 2 (Lee et al., 2016). 
In yeast mitochondria move along the actin cytoskeleton while in metazoan cells 
mitochondria are transported on microtubules powered by kinesin and dynein motors 
(Wang and Schwarz, 2009). This is to ensure mitochondria are distributed correctly 
throughout a cell, which can be for a number of reasons including: cell division, Ca2+ 
buffering, signalling or localised ATP production (Jayashankar and Rafelski, 2014). 
Mitochondria transport was initially thought to be important only for larger cells such as 
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neurons but recent evidence suggest knocking out important transport proteins in smaller 
cells has significant effects on mitochondrial morphology and cell function (Schuler et al., 
2017). Mitochondrial transport is control by different sets of motors depending on direction; 
towards the positive end of microtubules (anterograde) the kinesin-1 family controls 
movement. In the opposite direction (retrograde) dynein/dynactin maintain control (Yu and 
Pekkurnaz, 2018). These proteins bind to adaptor proteins Miro (a Rho GTPase) and Milton 
(TRAK1/2) which are localised to the mitochondria (Stowers et al., 2002; Fransson et al., 
2006).  
 
Figure 1.6 Mitochondrial Transport Along Microtubules. Mitochondria can be transported 
in then anterograde direction by kinesin motors and dynein motors the retrograde direction. 
This involves binding to the Miro Milton complex on the mitochondria which can be 
inhibited by Ca2+.  
This complex has a key role in the regulation of mitochondrial transport, as it binds the 
respective motors the majority of signalling pathways controlling trafficking will target this 
complex (Yu and Pekkurnaz, 2018). ROS can also modify motility by activating p38α which 
again targets the Miro Milton complex to prevent movement (Debattisti et al., 2017). 
Metabolite availability is another factor that can control trafficking in high glucose levels 
Miro is glycosylated preventing any further movement ensuring the mitochondria are in the 
correct location for glucose utilisation (Pekkurnaz et al., 2014). Cytosolic Ca2+ is also a 
regulator of this complex, it can bind to Miro modifying its shape and releasing it from motor 
proteins (Wang and Schwarz, 2009). This allows mitochondria to be in the correct location to 
act as a buffer for cytosolic Ca2+  
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1.2.6 Calcium Flux 
As described in 1.1.2 Calcium Ion Homeostasis the strict control of Ca2+ is necessary for cell 
survival and the mitochondria play an important role in this regulation. The mitochondria 
can buffer Ca2+ bound to phosphate as Ca3(PO4)2 . This is important in the control of cytosolic 
Ca2+ but a number of mitochondrial processes also depend on Ca2+ including steps in the TCA 
cycle (Pathak and Trebak, 2018). As the OMM is permeable to molecules smaller than 5kDa 
Ca2+ flows through these VDAC pores into the IMS. Ca2+ can enter the matrix of mitochondria 
through the mitochondrial calcium uniporter (MCU). This has a low affinity but high 
specificity for Ca2+ so requires a high localised Ca2+ concentration for entry into cell (Jiang et 
al., 2009). This is achieved mainly through collaboration with the ER which can release Ca2+ 
localised to the mitochondria at MAMs demonstrated in Figure 1.7.  
 
Figure 1.7 Calcium Flux from the ER to Mitochondria. Calcium flows from the ER through 
the IP3R to the mitochondria. A connection is made to the VDAC pore of the mitochondria 
by GRP75 and Ca2+ flows through to the matrix through the calcium specific MCU.  
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1.2.7 Mitochondrial Disease 
As demonstrated a large number of important biological processes are affected by 
mitochondrial function. Due to mitochondrial importance in energy production as well as 
other mechanisms, dysfunction can be particularly damaging. This is especially the case in 
high energy tissues such as the CNS, the heart, muscles and eyes. (Chinnery and Hudson, 
2013). Patients with mtDNA mutations or nuclear mutations effecting mitochondria can 
display a variety of phenotypes with limited treatment options.  
1.3 The Retina and Optic Nerve 
The retina has a number of high energy cells that may be susceptible to mitochondrial 
dysfunction. The retina is largely conserved through vertebrates containing similar cell types 
(described in Figure 1.8). Light enters the eye and interacts with the photoreceptors (the 
rods and cones) which transmits signals through the retina to the retinal ganglions cells 
(RGCs) which signal through to the brain along the optic nerve.  
 
Figure 1.8 Retinal Structure. Cells found within the retinal and basic organisation. 
1.3.1 Retinal Structure 
The rods are the more sensitive photoreceptors that are important for low light vision as 
these can detect even a single photon (Sampath and Rieke, 2004). The cones are much less 
sensitive but have a faster signalling response, they are also more sensitive to colour so are 
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useful for bright colour vision (Hoon et al., 2014). The cone cells can also be specific for 
different wavelengths of light. This can vary between species while humans have three short 
(λ~415–430nm (blue)), middle (λ~530–537nm (green)) or long (λ~555–565nm (red)) (Mustafi 
et al., 2009). Zebrafish have an extra UV cone while mice only contain short and medium 
cones (Applebury et al., 2000; Li et al., 2009). Rods and cones signal to bipolar and horizontal 
cells by the release of glutamate. The release of this neurotransmitter is controlled by the 
depolarization of the cell. Photons activate rhodopsin in the photoreceptors this activates G-
protein signalling which hyperpolarizes the plasma membrane reducing glutamate signalling 
(Mustafi et al., 2009).  
This signal sent is received by horizontal or bipolar cells. Horizontal cells mediate feedback 
inhibition to photoreceptors and are able to feedforward inhibition to bipolar cells 
(Diamond, 2017). Bipolar cells can exist as ON or OFF bipolar cells which react in opposite 
manners to glutamate. In OFF cells glutamate opens a cation channel which depolarises the 
cell while ON cells hyperpolarise (Mustafi et al., 2009). Rod bipolar cells are always ON while 
cones can be either. This signals to RGCs either directly or indirectly through amacrine cells. 
The amacrine cells can synapse and stimulate with RGCs, other bipolar cells or form 
inhibitory signals with other amacrine cells (Diamond, 2017).  
The RGCs will send the signal to the brain there are around 30 different types of ganglion 
cells with multiple functions relating to different visual cues (Sanes and Masland, 2015). The 
axons of the RGCs connect the eye to the brain along the optic nerve.  
1.3.2 Optic Nerve Anatomy 
Approximately 1 million RGC axons form the optic nerve in humans which carry visual cues 
from the RGCs which synapse with neurons in the lateral geniculate nucleus (Yu et al., 2013). 
From here signals are sent to the visual cortex which processes the signals from the visual 
cues. These axons, in mammals, begin unmyelinated from the RGC cell bodies and become 
myelinated after lamina cribrosa (Yu et al., 2013). Myelination of axons insulates the nerve 
allowing for enhanced speed of nerve impulse conduction and decreases the energy 
expenditure needed for electrical impulses (Hartline, 2008). Due to the high energy 
expenditure of these RGCs they become affected by disorders of energy production. 
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1.4 Wolfram Syndrome 
Wolfram syndrome (WS) was first described in 1938 by Wolfram and Wagener (Wolfram DJ, 
1938), who described symptoms of juvenile diabetes and optic atrophy. Since the initial 
discovery of WS, the symptom spectrum has expanded and now includes diabetes insipidus, 
diabetes mellitus, optic atrophy and sensorineural deafness (also defined as DIDMOAD). 
Approximately 30% of patients will present with the full DIDMOAD phenotype (66.26% when 
considering patients with 4 or clinical features) and as it is a progressive disease a large 
number of disorders can develop over a patient’s life span including: ataxia, peripheral 
neuropathy, urinary tract dysfunction and psychiatric illnesses alongside numerous other 
conditions shown in Table 1.1 (de Heredia et al., 2013; Urano, 2016)  
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Table 1.1 Symptoms Associated with Wolfram Syndrome Adapted from Urano 2016 
 
Diabetes mellitus is commonly the first symptom with 98.2% of patients developing this on 
average in the first 10 years of life. Then 82.14% of patients will develop optic atrophy 
Major Symptoms Common Symptoms 
Diabetes Mellitus Fatigue 
Optic Nerve Atrophy Hypersomnolence 
Diabetes Insipidus Apnea 
Sensorineural Deafness Dysphagia 
Ataxia Headaches 
Urinary Tract Dysfunction Reduced sense of smell 
 Reduced ability to taste 
 Anxiety 
 Panic attacks 
 Depression 
 Mood swings 
 Temperature regulation dysfunction 
 Dizziness 
 Constipation 
 Diarrhea 
 Hypergonadism 
 Hyponatremia 
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around 11. 48.21% develop hearing loss; 37.76% Diabetes insipidus; 19.39% Urinary tract; 
and 17.09% normally after the development of the first two symptoms (Barrett et al., 1995; 
de Heredia et al., 2013). The range of symptoms varies in patients but the majority will have 
both diabetes mellitus and optic atrophy.  
An autopsy of a DIDMOAD patient revealed a loss of pancreatic β-islet cells contributing to 
diabetes mellitus (Hilson et al., 2009). Loss of RGCs and neurons in the retina, neuronal loss 
in the optic nerve tract and lateral geniculate nucleus contribute to the loss of vision in 
patients (Hilson et al., 2009). In the ear hair cells in the basal turn of both cochleae were lost 
as well as the organ of Corti. In the brain neuronal loss was recorded in a number of areas 
including the thalamus olivopontocerebellar system (Hilson et al., 2009). 
Neurodegeneration is a key feature of WS where patients die at a median age of 30 due to 
respiratory failure with brain stem atrophy (Barrett et al., 1995). Changes in brain volume 
and myelination have been been described in patients highlighting the role of 
neurodegeneration in WS (Hershey et al., 2012; Lugar et al., 2016).  
WS is a rare disease with an incidence of 1:770 000 and a carrier prevalence of 1:354, in the 
UK (Barrett et al., 1995). The prevalence in children was found to be 1 in 500 000 and the 
prevalence is variable worldwide. Other estimates include 1 in 68 000 in Lebanon, 1 in 
100,000 in the USA and 1 in 710,000 in Japan (Kinsley et al., 1995; Medlej et al., 2004; 
Matsunaga et al., 2014)  
1.4.1 Wolfram Syndrome 1 
1.4.2 The WFS1 Gene 
The majority of patients with WS harbour recessive mutations within the WFS1 gene, which 
encodes for the Wolframin protein. Although initially suspected to be a mtDNA mutation it 
was observed through linkage analysis to be autosomal and that the gene is located on 
chromosome 4 (Inoue et al., 1998; Strom et al., 1998).  
There is no single mutational hotspot within the WFS1 gene although 178 different 
mutations have been reported they are distributed nonuniformly along the protein: a higher 
concentration can be found in transmembrane domains, the last the last 100 amino acids 
and between amino acids 94–237. However, it has been described that mutations in the last 
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few amino acids provided a full DIDMOAD phenotype suggesting important functional 
domains throughout the protein (Sam et al., 2001). 
Although WFS1 mutations are generally recessive, dominant mutations have been observed 
and have been linked with Wolfram like syndrome where patients tend to develop visual and 
hearing impairment (Fukuoka et al., 2007; Hogewind et al., 2010; Rendtorff et al., 2011; 
Berry et al., 2013).  
1.4.3 Wolframin 
The Wolframin protein localises in the endoplasmic reticulum (Takeda et al., 2001), in a 
proteomic profiling of the MAMs in mouse brains  wolframin was detected suggesting it may 
be important in ER mitochondrial connections (Poston et al., 2013). Wolframin contains  9 
transmembrane domains with the c-terminus in the endoplasmic reticulum lumen and the n-
terminus in the cytosol, a schematic can be seen in Figure 1.9 (Hofmann et al., 2003). 
 
Figure 1.9 Structure and Localisation of Wolframin. Adapted from Hofmann et al 2003. 
The protein is 890 amino acids in length corresponding to around 100 kDa; higher weight 
complex in the ER of around 400 kDa have been described in the membrane which are 
suspected to be a homo-oligomeric complex (Hofmann et al., 2003). The protein is post 
translationally modified by N-glycosylation. This is required for protein to be stably 
expressed and Hofmann. et al suggest the glycosylation is important in the proteins stability 
or  required for stability or proper synthesis of the protein (Hofmann et al., 2003). The 
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human tissue atlas describes wolframin expression to be ubiquitous by RNA expression but 
did not show expression in all tissues when looking on a protein level (Uhlen et al., 2010). 
This was also observed histologically were alongside expression in multiple adult tissues an 
almost ubiquitous expression in human foetal organs and tissues was observed (De Falco et 
al., 2012). In the adult tissue expression appears to be variable depending on tissue types 
with the highest levels of expression of the protein found in the tissues responsible for some 
of the phenotypes of WS e.g. brain and pancreas, RGCs (Schmidt-Kastner et al., 2009). The 
protein is thought to have multiple functions in important cellular mechanisms including 
regulation of the ER UPR, calcium ion homeostasis and pro-insulin modification among 
others.  
1.5 Functions of Wolframin 
1.5.1 Proinsulin Modification 
Diabetes mellitus is the most common phenotype seen in WS. In patients with WS a loss of 
Insulin-producing β-cells is seen with no autoimmune process as seen in traditional type 1 
diabetes suggesting a genetically encoded β-cell loss (Karasik et al., 1989). The mechanism 
behind this has been suggested to be due to two main causes: apoptosis of islet cells and 
impaired insulin secretion. This was observed in a knockout mouse model were increased 
apoptosis and β-cell loss at 24 weeks with an increase in ER stress response markers BiP and 
CHOP has been described. However, prior to this at 12 weeks the mice had an impaired 
glucose-stimulated insulin secretion (Riggs et al., 2005). This suggested that there may be a 
secretory defect alongside the apoptosis. This was confirmed by wolframin localizing to 
secretory granules and determines granule acidification in mouse pancreatic β-cells. Further 
work confirmed that wolframin had a role in stabilising Vacuolar-type H+-ATPase V1A subunit 
in neuroblastoma cells leading to a failure in acidification of secretory granules (Gharanei et 
al., 2013). It was suggested this could be having an effect on the insulin secretory granules 
acidification which is necessary for converting proinsulin to its active form (Hatanaka et al., 
2011). Increased apoptosis due to ER stress is the key factor in the development of diabetes 
mellitus (Riggs et al., 2005; Gharanei et al., 2013).  
1.5.2 Unfolded Protein Response 
Wolframin expression has been shown to be regulated by the upstream regulators of the 
UPR IRE1, PERK and ATF6β (Yamaguchi et al., 2004; Odisho et al., 2015). The protein 
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contains a highly similar sequence to the to the ER stress response element (ERSE) and its 
protective role in islet cells suggested the protein had a downstream regulatory role in the 
UPR (Kakiuchi et al., 2006). It was later shown that Wolframin was negatively regulating 
ATF6α in islet cells through ubiquitination and proteasome-mediated degradation of the 
protein. This was by two mechanisms the stabilisation of the E3 ubiquitin ligase HRD1 and 
the trafficking of ATF6α to the proteasome (Fonseca et al., 2010). This suggested that due to 
the lack of regulation of ATF6 was leading to chronic activation of ATF6α signalling; pushing 
the cells towards apoptosis through the CHOP pathway. However, it is also possible that 
dysregulation of Ca2+ ions may be one of the factors leading to apoptosis. 
1.5.3 Calcium Homeostasis 
It was suggested that due to mild similarities to the TRP-caspasin channel family that ion 
homeostasis could be a function of wolframin (Osman et al., 2003). This was tested in 
Xenopus oocytes which showed wolframin is associated with ion channel activity in the ER 
membrane suggesting wolframin acted like a TRPV channel and its expression altered 
cytosolic calcium levels (Osman et al., 2003). However, they were not able to show directly 
that wolframin acted as a Ca2+ channel and suggested it could be possible that it was 
regulating ER calcium channel activity. This was added to in HEK293 cells showing regulation 
of the filling of the ER by store-operated Ca2+ entry and interestingly showed that the 
changes seen in cytoplasmic Ca2+ levels were not due to changes in mitochondrial Ca2+ 
uptake (Takei et al., 2006). Co-immunoprecipitation experiments in Cos-7 cell lines showed 
an interaction with wolframin and SERCA. It was shown that wolframin was negatively 
regulating SERCA expression by targeting SERCA for degradation by the proteasome in a 
similar manor to ATF6 (Zatyka et al., 2015). It was also hypothesised that regulating SERCA 
expression was in order to compensate for ER calcium depletion in conditions of ER stress 
(Zatyka et al., 2015).  
It was suggested however, that SERCA may not been the key component in the regulation of 
cytosolic Ca2+. It has been suggested that changes in ER stress leads to inositol 1,4,5-
trisphosphate receptor (IP3R) dysfunction which in turn is affecting the cytosolic Ca
2+ levels. 
(Cagalinec et al., 2016). It was hypothesised that the Ca2+ changes could be altering 
mitochondrial function.  
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1.5.4 Calpain Activation 
Calpain hyperactivation has been implicated as a possible cause for neurodegeneration in 
WFS1 knockout mice (Lu et al., 2014). Calpain is a calcium dependant protease localised to 
the cytosol. As an increase in cytosolic Ca2+ leads to the hyperactivation of Calpain in 
knockout mouse brains which leads to cleavage of the myelin basic protein (MBP) (Lu et al., 
2014). This may explain the loss of myelination in patients with WS (Lugar et al., 2016). 
1.5.5 Cell cycle 
WFS1 is also involved in cell cycle regulation. In WFS1 knockout β-cells BrdU incorporation 
was decreased suggesting a reduction in cell cycle progression and division. Alongside this 
p21 a cell cycle regulating protein was upregulated (Yamada et al., 2006). Cell cycle 
disruption was also found in WFS1 depleted neuroblastoma cells. However, p21 expression 
was downregulated (Gharanei et al., 2013). Cell cycle regulation and p21 expression could be 
partially rescued by overexpressing BiP suggesting an increase in ER stress is slowing cell 
cycle progression (Gharanei et al., 2013). 
1.5.6 Evidence for Mitochondrial Dysfunction 
Initially WS was considered a mitochondrial disease as it was thought the phenotypes were 
consistent with an ATP supply defects (Bu and Rotter, 1993; Vora and Lilleyman, 1993). The 
evidence was also added to by the discovery of multiple mtDNA deletions and 
polymorphisms (Pilz et al., 1994; Barrientos et al., 1996). When looked at on a larger scale at 
the changes in the mtDNA they found no evidence supporting a role for mtDNA in Wolfram 
syndrome (Barrett et al., 1995; Barrett et al., 2000). No abnormal mitochondrial respiratory 
function was detected in 5 patients muscle biopsies (Barrett et al., 2000). This added with 
the evidence of endoplasmic reticulum localisation and a role in ER stress response made it 
appear as though mitochondrial dysfunction was not a primary cause of WS. This idea was 
disputed when the WFS1 gene was knocked down in HEK cells and this caused the activation 
of genes related to mitochondrial dysfunction again bringing into question the role 
mitochondria play in WS (Koks et al., 2013). More evidence for mitochondrial dysfunction 
was seen in mitochondrial trafficking in knockdown cultured rat/mouse neurons, which was 
argued could be caused by disturbed cytosolic Ca2+ homeostasis (Cagalinec et al., 2016). 
Wolframin was observed by proteomic profiling to be found in the mitochondrial associated 
membrane (Poston et al., 2013). This could be causing changes in the Ca2+ dynamics 
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between the two organelles and is a possible link between WS and Wolfram syndrome type 
2 caused by mutations in different gene (CISD2).  
1.6 Wolfram Syndrome Type 2 
A second gene was identified in 16 Jordanian consanguineous families (El-Shanti et al., 
2000). The patients presented similar symptoms to WS with optic atrophy, diabetes mellitus 
and high-frequency sensorineural hearing loss. This gene CISD2, also known as Miner1. The 
encoded protein is localised to the endoplasmic reticulum but has no direct interaction with 
wolframin (Amr et al., 2007). The protein is known to have a role in Fe-S management, redox 
reactions, Ca2+ homeostasis, Calpain regulation and has a role in the regulation of ER–
mitochondrial contacts (Conlan et al., 2009; Lu et al., 2014; Rouzier et al., 2017a). A 
knockout mouse model of CISD2 has been created which showed mitochondrial dysfunction 
and a premature aging phenotype (Chen et al., 2009). These obvious mitochondrial 
connections with no interaction with WFS1 may suggest similar downstream pathways are 
effecting in these two diseases with similar phenotypes.  
1.7 Treatment 
No treatment is currently available to prevent or reverse the effects of WS (Urano, 2016). 
Two candidates suspected to be able to improve the symptoms of WS are: sodium valproate 
and dantrolene. Sodium valproate is expected to increase p21 expression which is reduced 
in WFS1 knockdown cells (Gharanei et al., 2013).  Dantrolene a target of the ryanodine 
receptor suppresses leakage of calcium from the ER to cytosol to prevent Calpain 
hyperactivation (Lu et al., 2014) . As WS has multiple diverse phenotypes and possibly 
multiple pathways that may be responsible for symptoms, multiple drugs may have to be 
prescribed to counteract WFS1 depletion. Animal models are important in discovering more 
about the disease as well as trialling drug treatments. 
1.8 Animal Models of Wolfram Syndrome 
WS has been modelled in several animal models. Mouse, rat and drosophila models have 
been created of WFS1 knockouts (Ishihara et al., 2004; Plaas et al., 2017; Sakakibara et al., 
2018). The gene identity and its similarities to the human gene are described in Table 1.2  
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Table 1.2 Gene identity of WFS1 with orthologues of published animal models of WS. Data 
acquired from ensembl. 
 
1.8.1 Mouse 
The mouse model of WS was the first animal model, and multiple models have been 
developed. The majority of work focussed on the development of diabetes and ER stress. 
The original knockout mouse developed glucose intolerance while demonstrating a 
progressive β-cell loss (Ishihara et al., 2004). An islet cell specific knockout also 
demonstrated glucose intolerance and insulin deficiency with a loss of beta cell mass. 
Expression of BiP was also increased and changes to the ER and decreased secretory 
granules where observed using electron microscopy (Riggs et al., 2005). The Wfs1 knockout 
mice however do not develop a severe diabetic phenotype as humans. The Wfs1 KO mice 
have normal non-fasted blood glucose levels and is suggested they were clearing blood 
glucose through the urine to maintain normal glucose levels (Terasmaa et al., 2011). 
Additional investigation into other symptoms of WS have been assessed.  
The expression of Wfs1 in the CNS has been described and expression was observed in areas 
associated with emotional behaviour, energy homeostasis, and hearing (Luuk et al., 2008). 
Magnetic resonance imaging (MRI) of the brain of knockout mice demonstrated a reduction 
of the optic nerve and brain stem volumes (Cagalinec et al., 2016). Visual function was 
characterised which demonstrated some visual dysfunction with changes to visual evoked 
potentials, but showed no substantial RGC loss or any significant changes in visual acuity 
(Bonnet Wersinger et al., 2014). Although the mouse model shows a number of similarities 
with humans it appears to be a milder model of WS. 
1.8.1 Rat 
A knockout rat model of WS has also been described with a deletion of exon 5 in Wfs1 (Plaas 
et al., 2017). The rat model develops diabetes mellitus with a loss of insulin secretion which 
leads to: glycosuria, hyperglycaemia and beta cell loss which correspond slightly better than 
Species Orthologue Target % identity 
Fruitfly (Drosophila 
melanogaster) wfs1  (FBgn0039003) 22.86% 
Mouse (Mus musculus) 
Wfs1  
(ENSMUSG00000039474) 86.97% 
Rat (Rattus norvegicus) Wfs1  (ENSRNOG00000005108) 86.29% 
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the mouse model to WS. Alongside this the rat develops a reduction in medullary volume 
suggesting neurodegeneration as seen in WS patients. The rats also develop optic nerve 
volume reduction as do the mice. The rats also develop cataracts, showed signs of retinal 
gliosis and disturbed myelin structure in the optic nerve (Plaas et al., 2017). However, there 
are no observations made on RGCs or RNFL which are affected in patients with WS (Hoekel 
et al., 2014).  
An invertebrate to study WS (drosophila) has also been developed to look at neurological 
dysfunction (Sakakibara et al., 2018). 
1.8.3 Fly 
The drosophila knockdown model of the WFS1 orthologue was CNS specific.  This was 
produced by creating wfs1 RNAi expressing flies expressed under a pan-neuronal elav-GAL4 
driver. Two mutant lines were also created one causing a C-terminally truncated version of 
the wfs1 protein, and another showing a 60% reduction in mRNA expression. The flies 
demonstrated behavioural deficits, neurodegeneration and had reduced lifespans.  
However, in the fly ER stress was not induced and no mitochondrial dysfunction was 
observed which is contrary to what was reported in the culture rat and mouse neurons 
(Cagalinec et al., 2016; Sakakibara et al., 2018). It is suggested that wfs1 in the fly is 
responsible for a protective role against various stressors associated with aging (Sakakibara 
et al., 2018).  
1.8.4 Zebrafish 
A zebrafish morpholino model was also created during a multi gene knockdown assessment 
of diabetes causing genes in zebrafish. This model demonstrated a reduction in pancreatic β-
islet cells (O'Hare et al., 2016). As this model was not the main focus of this paper the fish 
was not fully characterised. 
1.7 Zebrafish 
Zebrafish development  
The zebrafish have been studied for a number of years, though work in the 80’s creating 
genetically modified zebrafish lead to the rise in popularity of the model(Streisinger et al., 
1981). 
27 
 
In 1995 Kimmel et al. described the accurate staging of the zebrafish embryonic 
development (Kimmel et al., 1995). The first 45 minutes of development the embryo will 
remain at the one cell stage, from then division and development occurs rapidly with a larval 
zebrafish developed by 72hours post fertilisation (hpf), as demonstrated in Figure 1.10.  
After this point development slows and a zebrafish do not become sexually mature until 
approximately 3-4 months. In the wild a zebrafish would typically live for a year although in 
captivity the mean lifespan 42 months but can live to 66 months (Gerhard et al., 2002).  
 
Figure 1.10 Time points of embryonic development of the zebrafish. Adapted from (Kimmel 
et al., 1995) 
 
Zebrafish have become a popular model for a number of reasons: they develop externally, 
rapidly, are transparent at early stages, the large volume of offspring from one mating and 
the relative ease of genetic manipulation (Bradford et al., 2017).The zebrafish genome was 
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also fully sequenced beginning which allowed for more accurate genetic  modification (Howe 
et al., 2013). 
1.7.1 Genetics 
Whole genome sequencing revealed that the majority of human genes implicated in disease 
will have a zebrafish orthologue (82%) (Howe et al., 2013). The most recent genome 
reference assembly GRCz11 states there are over 25,000 zebrafish genes (Zerbino et al., 
2018). This however includes a number of duplications as the zebrafish genome underwent 
duplication approximately 340 million years ago (Meyer and Schartl, 1999), which has 
resulted in multiple genes that may require knockout to model diseases in zebrafish.  
Genetic manipulation has allowed for the modelling of a number of diseases in zebrafish 
either transiently by morpholino to knockdown RNA expression or by mutations to knockout 
genes.  
1.7.2 Zebrafish as a model of retinal disease 
The zebrafish has been used to develop multiple models of retinal dysfunction. Models have 
been developed of: glaucoma, diabetic retinopathy, retinal ciliopathies, retinitis pigmentosa 
alongside many other retinal diseases (Link and Collery, 2015; Richardson et al., 2017). Part 
of the popularity of using the zebrafish model is the eye is fairly well conserved through 
vertebrates, reducing some of the drawbacks normally seen using a simpler animal model.  
The retina of zebrafish is anatomically and functionally similar to humans and due to the 
rapid zebrafish development of zebrafish the eye resembles adult morphology by 72hpf 
(Richardson et al., 2017). Although similar there are a number of differences between the 
two sets of eyes. The zebrafish retinal thickness is 180μm thick while the human retina 
measures approximately at 289μm, the zebrafish contains no macular and has 
tetrachromatic vision compared to humans trichromatic  (Chhetri et al., 2014b).  Although 
the retinal thickness is smaller in zebrafish as the eye itself is smaller this represents a larger 
proportion of the eye in the zebrafish. The optic nerve also has a number of changes. The 
first is that the fibres of the optic nerve are fully myelinated in zebrafish while in humans 
myelination of fibres begins after the optic tectum. As seen in Figure 1.11 the structure of 
the retina contains all the same layers in humans and zebrafish.  
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Figure 1.2 Comparison of Human and Zebrafish Retinal Sections. Figure replicated from 
Richardson et al, 2017.  
This allows for both histological and functional assessments of the zebrafish eye. Zebrafish 
behaviour is an important marker in a number of disease models. Eye function can be tested 
in multiple methods:  Optokinetic response, optomotor response and escape response can 
all be measured behaviourally and electrophysiologicaly electroretinogram can be 
performed (Fleisch and Neuhauss, 2006; Chrispell et al., 2015). This allows for the 
combination of histological and functional data to provide a robust model for retinal disease.  
1.7.3 Zebrafish as a model of mitochondrial disease 
A number of optic neuropathies can be caused by mitochondrial dysfunction. Two examples 
with zebrafish models have been developed are: OPA1 and OPA3. These are two nuclear 
encoded mitochondrial proteins, located in the IMM. The OPA1 model was a transient 
knockdown using antisense morpholinos. This model demonstrated fragmented 
mitochondria and reduced respiratory function suggesting that OPA1 is also involved in the 
fusion of mitochondria in zebrafish (Rahn et al., 2013). As morpholinos are only effective in 
the first few days of development extensive retinal testing was not carried out but no RGC 
loss or ON thinning was seen in the first 48 hours. 
The OPA3 knockout was genomic which allowed the fish to be studied for a longer time 
period. The knockouts demonstrated optic nerve deficits at 12months, ataxia and movement 
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disorder (Pei et al., 2010). Although normal OXPHOS function was shown under physiological 
conditions the fish proved more sensitive to inhibitors of OXPHOS (Pei et al., 2010). 
Although no primary mtDNA mutants have been produced knockouts of DNA polymerase 
gamma which in involved in the proofreading during mtDNA replication leading to mtDNA 
mutations and depletion (Rahn et al., 2015). The benefit over a mouse model of this disease 
is survival to 4 weeks rather than death during embryonic development in the mouse (Rahn 
et al., 2015).  
These models demonstrate a number of conserved factors of mitochondrial function in the 
zebrafish. This highlights a number of benefits from zebrafish models that cannot easily be 
replicated in other models. The transparency allows live imaging which can provide in vivo 
data difficult to achieve in larger animals; whole larval fish can be examined by oxygen 
consumption measurement to look at overall OXPHOS function external development allows 
for the observation of mutations that prove fatal in the early stages of development. Large 
numbers of offspring also make them an attractive drug screening model.  
The study of WS in a zebrafish model can allow a more in depth look at mitochondrial 
function and also provide a model of OA for future therapeutic screening. 
1.7.4 wfs1a/b 
Two zebrafish orthologues exist and are named wfs1a and wfs1b, the two genes are 
compared in Table 1.3. The wfs1a gene located on chromosome 1 shares a 55% cDNA 
identity with coverage of 89% of the human cDNA. The Gene Order Conservation (GOC) 
score is 50 which suggest two of the surrounding 4 genes are conserved from the human. 
The wfs1b gene located on chromosome 14 has a slightly higher cDNA identity (57%) but a 
much higher coverage, 97% of the human cDNA is covered in the wfs1b gene. The GOC score 
is lower with only 1 of the surrounding genes being conserved.  
Table 1.3 cDNA Alignment of Human and Zebrafish. Data acquired from ensembl. 
Species Gene ID % identity (cDNA) % coverage GOC score 
Human (Homo 
sapiens) 
WFS1 
(ENSG00000109501) 
   Zebrafish 
(Danio rerio) 
wfs1a  
(ENSDARG00000062341) 55% 89% 50 
Zebrafish 
(Danio rerio) 
wfs1b  
(ENSDARG00000074617) 57% 97% 25 
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On a protein level a similar pattern emerges with similar percentage identities but a 7% 
higher coverage seen in wfs1b, demonstrated in Table 1.4.  
Table 1.4 Peptide Alignment of Human and Zebrafish. Data acquired from ensembl. 
Species Peptide ID 
Peptide 
length % identity (Protein) % coverage 
Human 
(Homo 
sapiens) ENSP00000226760 890 aa 
  Zebrafish 
(Danio rerio) 
wfs1a 
ENSDARP00000084458 814 aa 52% 90% 
Zebrafish 
(Danio rerio) 
wfs1b 
ENSDARP00000124957 895 aa 53% 97% 
 
Uniprot predicts that each zebrafish proteins are located to the ER and have 8 
transmembrane domains which would be one fewer than the human protein (The UniProt, 
2017).  
A large scale screen of in situ hybridisations has been carried out on a large number of genes 
in zebrafish; this study involved the expression of the wfs1a and wfs1b (Thisse, 2004). This 
study detected no expression until the segmentation phase of development at 
approximately 19hpf. This detection was said to be predominantly in the myotomes. The 
wfs1b expression was detected from the 1-cell stage detected in the whole organism, with 
increased expression in the notochord (Thisse, 2004). The notochord is important in the 
development of the nervous system and somites (Eisen, 1996). 
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Figure 1.3 Insitu Hybridisation of wfs1a and wfs1b RNA expression. Figure adapted from 
Thisse, 2004.  
This project involved the characterisation of two zebrafish models of Wolfram syndrome 
(wfs1a and wfs1b). Animal models are important in helping develop our understanding of 
the disease while also creating opportunities to test therapeutic compounds. 
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1.8 Project Aims 
WS is a multisystem, complex disorder for which there are currently no treatments. A mouse 
model of WS has been studied for a number of years, a number of insights into the disease 
have been predominantly focused on the development of diabetes mellitus (Ishihara et al., 
2004). A rat and drosophila model of WS have recently been developed. The rat model 
describes diabetes, optic atrophy, hearing loss which represents a closer model to WS than 
in mice (Plaas et al., 2017). The drosophila model was developed to model 
neurodegeneration but many differences in protein function were observed when compared 
to the mouse/human (Sakakibara et al., 2018). A zebrafish model would be able to bridge 
the gap of using a simpler model while maintaining a closer gene identity to humans. 
A zebrafish model of the disease creates unique opportunities to study WS. Using a number 
of whole system and live imaging techniques it is possible to determine changes during the 
development of WS that is not possible in other models which could provide insights into 
both neuronal development and mitochondrial dysfunction in an in vivo system.  
The overall aim of this project was to characterise a zebrafish model of WS. A transient 
morpholino model and a genomic knockout model were both examined and the suitability of 
the two models assessed. Characterisation of the zebrafish involved observation of some of 
the molecular mechanisms and disease phenotypes seen in patients of WS and determining 
if the zebrafish knockouts accurately modelled this.  
The secondary aims of this project were to observe neurodevelopment and mitochondrial 
function. The development of the brain and neurons in WS are impeded. Zebrafish 
development allows for this to be monitored in the first few days giving a unique insight into 
the development of this condition. Mitochondrial dysfunction has been implicated in this 
process and the role of further mitochondrial dysfunction in WS will be investigated within 
this thesis. 
  
34 
 
Chapter 2: Material and Methods 
2.1 Zebrafish care 
Wildtype zebrafish (Danio rerio) (AB) were used alongside further genetically modified fish 
lines described in Table 2.1. 
Table 2.1 Transgenic fish lines 
Lines Function 
slc24a5 (Golden) Loss of pigment making them translucent 
Islet 1 Gfp Express GFP in the cranial motor neurons 
Sa10021 (wfs1a) Nonsense mutation in wfs1a  
Sa16422 (wfs1b) Nonsense mutation in wfs1b 
 
Genetically modified strains sa10021 (wfs1a), sa16422 (wfs1b) were purchased from the 
European Zebrafish Resource Center (EZRC) as heterozygotes and crossed to create a stable 
line of homozygote mutants. 
Zebrafish were maintained in fresh water at 28.5 °C and maintained to home office 
standards. Euthanasia was performed by overdose of euthanized in 4mg/ml tricaine 
methanesulfonate (tricane) 1:1 ratio with fresh system water. 
2.2 Zebrafish breeding/embryo harvesting 
The evening prior to embryo collection one male and one female zebrafish were placed into 
breeding tanks separated by a mesh grid with another mesh grid below to separate the fish 
from the eggs. This was also performed with larger tanks with multiple male and females for 
a higher success rate of fertilisation.   
On the day of the collection the fish were combined in fresh system water to mate. The eggs 
were strained, rinsed and stored in E3 medium (5 mM NaCl, 0.17 mM KCl, 10 mM HEPES, 
0.33 mM MgSO4, 0.33 mM CaCl2 0.00002% methylene blue). 
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2.3 Zebrafish Heat shock 
50 embryos were transferred into a 1.5ml Eppendorf with 1ml E3 medium. The Eppendorf 
was placed in a heat block set to 37⁰C for 1 hour. After the hour zebrafish were either 
harvested or placed back in a petri dish containing E3 medium at 28.5⁰C to develop.    
2.4 Zebrafish Imaging 
Imaging was carried out using bright field microscopy. Images were taken on a Leica MZ16F 
stereomicroscope with a Leica DFC420 C camera attachment on the Leica Application Suite 
V3 program. Zebrafish measurements were performed in ImageJ, a micrometer image at 
each magnification was used to set a scale. Measurements of length used straight lines from 
the head to tail. Measurements of otoliths and cerebellums were drawn round using the 
“freehand” tool. 
2.5 Fin clip 
Zebrafish were anesthetised in 1:25 (tricane:system water). The anesthetised fish were 
removed from water and a small amount of the tail fin removed using a scalpel. The fish 
were then placed in fresh system water in separate tanks to recover. Genomic DNA was 
extracted from fin clips using the hotshot extraction method described in Section 2.8 DNA 
extraction. 
2.6 Microinjection 
Zebrafish embryo injections were performed using glass needles made from Bo-glass 
capillaries with filament (Hilgenberg, Hilgenberg, Germany) using a model P-97 
Flaming/Brown Micropipette Puller (Sutter Instrument Co. Novato, USA) with the settings as 
follows: P=500, Heat=800, Pull=150, Velocity = 100 and Time= 150.  
Needles containing 2.5μl of required solution were held in a micromanipulator attached to a 
FemtoJet™ Microinjector (Eppendorf, Stevenage, UK) and viewed down a Leica MZ9.5 
Stereomicroscope. The needle was broken at the tip and calibrated using a micrometer to 
obtain a 2nl droplet by changing pressure and time setting on the microinjector (80-100(kPa) 
0.1-0.6 seconds). 
Embryos were taken at the 1-4 cell stage and manipulated into a single file line against a 
glass slide in a petri dish. The embryos were turned so the cell was in line with the slide edge 
36 
 
and any dead or small embryos were removed. Embryos were injected through the yolk and 
as close as possible to the cell without puncturing. 
2.6.1 Morpholino Preparation 
Morpholinos were obtained from Gene Tools, LLC and arrived as 300 nmols of lyophilized 
powder; these were diluted to a 2mM stock in ddH2O. The morpholinos used are listed in 
Table 2.2. 
Table 2.2 Morpholino utilised  
Morpholino Morpholino Oligonucleotide Sequence Exon 
Target 
wfs1a Splice Blocking 5’-TGCAGACCCTAAAGTGAAAGAATGA-3’ 8 
wfs1b Splice Blocking 5’-CCAATCTGCCCAACAAGACAAATGT-3’ 3 
wfs1b Translation Blocking 5’-ACGTGTCCATTTTTAAGCCTGAGCT-3’ 2 
P53 5’-GCGCCATTGCTTTGCAAGAATTG-3’ 1 
 
Prior to injection morpholino stocks were heated to 65⁰C for 10 minutes to avoid 
precipitation, diluted to the desired concentration in Deneau solution (58 mM NaCl, 0.7 mM 
KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)
2, and 5.0 mM HEPES [pH 7.6]) with 0.05% phenol red 
dye. 
2.6.2 CRISPR Preparation 
The CRISPR solution contained: 1μl 10x Cas9 buffer, 2μl Cas9 protein (2uM), 3000ng RNA, 
1.5μl 2M KCl, 1μl 0.5% phenol red and the reaction made up to 10μl with RNase free H2O. 
This was heated to 37⁰C for 5 minutes prior to injection.  
2.7 RNA extraction 
RNA was extracted using a combined method of TRIzol (ThermoFisher, Waltham, USA) and 
RNeasy kit (Qiagen, Manchester, UK). Prior to RNA extraction all surface areas and 
equipment were cleaned with 70% ethanol then RNaseZap (ThermoFisher). ~50mg of tissue 
was homogenised in 500 µl TRIzol and incubated at room temperature for 5 minutes. 1:5 
ratio of chloroform to TRIzol added and mixed before centrifugation at 12000g for 15 
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minutes. The aqueous phase is removed and added to 70% ethanol at a 1:1 ratio. This is then 
added to an RNeasy spin column and followed the manufacturer’s instructions. Sample 
concentrations and purity were measured on a NanoDrop 2000 (ThermoFisher) and purified 
RNA was stored at -80⁰C. 
2.8 DNA extraction 
Genomic DNA was extracted using the Hotshot method. Tissue was placed in an appropriate 
volume of 50mM NaOH (50μl single embryo/100μl fin clips/500μl tissue) in eppendorfs and 
heated to 95⁰C at a speed of 1500rpm on a Labnet AccuTherm (Labnet, Edison, USA) for 15 
minutes. After cooling to 4⁰C 1/10th volume of 1 M Tris-HCl pH8 was added to neutralise the 
solution. The solution was centrifuged at 16000g and the supernatant stored at -20⁰C 
(Meeker et al., 2007). 
2.9 cDNA Synthesis 
cDNA synthesis was performed using the Applied Biosystems: High-Capacity cDNA Reverse 
Transcription Kit using the following reaction: 2μl 10x RT Buffer, 0.8μl dNTPs (100mM), 10x 
2μl RT Random Primers, 1μl MultiScribe Reverse Transcriptase and 4.2μl Nuclease Free H2O. 
This was added to 10μl of 1000ng RNA in RNase free water and the reaction carried out on a 
thermocycler to the following programme. 
Table 2.3 cDNA reaction thermocycler steps 
Step 1 2 3 4 
Temperature (⁰C) 25 37 85 4 
Time (minuted) 10 120 5 ∞ 
  
2.10 PCR GoTaq® Hot Start Polymerase  
The GoTaq PCR method was used on morpholino experiments.  
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Table 2.4 Zebrafish morpholino primers 
Primer Sequence 
wfs1a_splice-F 5’-GCAAATGAAGAGGAGGGGATA-3 
wfs1a_splice-R 5’-CGATGGTGAGATTGGAGATG-3’ 
wfs1b_splice-F 5’-CTCCTTCAGCCATGACTCCG-3’ 
wfs1b_splice-R 5’-CCTCTCTGTTCTCCGCTGTG-3’ 
 
10μl 5X Green Go Taq Flexi Buffer(Promega, Portsmouth, UK), 8μl MgCl2 (25mM), 5μl dNTPs 
(10mM each, (Rovalab, Teltow, Germany)), 1μl Forward Primer (10μM), 1μl Reverse Primer 
(10μM),  5μl betaine (5M, Merck Darmstadt, Germany), 0.25μl GoTaq® Hot Start Polymerase 
(5u/µl) (Promega) and 17.75μl ddH2O.  
Table 2.5 GoTaq® Hot Start polymerase reaction thermocycler steps 
Step 1 2 3 4 5 6 
Temperature (⁰C) 95 95 variable 75 75 4 
Time 2 minutes 30s 30s 30s 5minutes ∞ 
Cycles  x30  
 
Mytaq polymerase (Bioline, London, UK) was used for all other PCR reactions 
2.11 PCR MyTaq DNA Polymerase  
5x MyTaq Reaction Buffer 5 l, Primers 10M each 0.5 l MyTaq DNA Polymerase 1 l 18µl 
(Bioline) water (ddH2O) up to 25 l. 
Table 2.6 MyTaq DNA polymerase reaction thermocycler steps 
Step 1 2 3 4 5 6 
Temperature (⁰C) 95 95 variab
le 
75 75 4 
Time 2 minutes 15s 15s 30s 5 minutes ∞ 
Cycles  x30  
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2.12 Gel Electrophoresis 
Depending on the size of the designed fragment, 1-2% (w/v) agarose (Bioline) gels were 
made in 100mls of 1x TAE buffer (EDTA · Na2 · 2H2O, Acetic Acid glacial and Tris (AppliChem, 
Maryland Heights, USA)). 10μl Gel red (Merck) or 5μl SafeView (NBS Biologicals, Huntingdon, 
UK) was added to the mix and the gel poured into a casting tray. The gel was inserted into a 
FHU10 submarine gel tank (ThermoFisher) covered in 1x TAE, 19μl of PCR product with 
loading dye(Blue/Orange Loading Dye, 6X (Promega)) was added to the wells and 5μl Bioline 
hyperladder IV or I and electrophoresed at 80V. 
Gels were imaged using a GelDoc-IT Imaging system (UVP, Upland, USA)   
2.13 Gel extraction 
Gels were viewed on a GelVue UV Transilluminator (SYNGENE, Cambridge, UK) with bands of 
interest cut out with a scalpel and purified using a QIAquick Gel Extraction Kit to 
manufacturer’s instructions.   
2.14 qPCR 
qPCRs used the BioRad: iTaq™ Universal SYBR® Green Supermix (BioRad, Hercules, USA). 
Reactions were set up containing: 9ul water, 2.5ul primer mix (500nM), 12.5 SYBR Green 
Supermix (2x) and 1μl cDNA. Correct cDNA concentrations were optimised by serial dilution 
of stock cDNA with appropriate primers (heat shock primers taken from: (Vacaru et al., 
2014)).  
Reactions were run a CFX96 Touch Real Time detection system (BioRad). With a reaction as 
follows: 3 minute 95⁰C, a cycle of 40x 10 seconds 95⁰C and 1 minute 58⁰C and a melt curve 
which ran from 65⁰C to 90⁰C at 0.5⁰C increments. Data analysis was performed in CFX 
Manager software (version3.0) 
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Table 2.7 qPCR primers  
Primer Sequence 
xbp1s-F  5’-TGTTGCGAGACAAGACGA-3’ 
xbp1s-R  5’-CCTGCACCTGCTGCGGACT-3’ 
xbp1t-F  5’-GAGGAGCCCACAAAGTCCTC-3’ 
xbp1t-R  5’-CGAAGTGCTTTTTCCTCTGG-3’ 
atf4-F  5’-TTAGCGATTGCTCCGATAGC-3’ 
atf4-R  5’-GCTGCGGTTTTATTCTGCTC-3’ 
atf6-F  5’-CTGTGGTGAAACCTCCACCT-3’ 
atf6-R  5’-CATGGTGACCACAGGAGATG-3’ 
bip-F  5’-AAGAGGCCGAAGAGAAGGAC-3’ 
bip-R  5’-AGCAGCAGAGCCTCGAAATA-3’ 
ddit3-F  5’-AAGGAAAGTGCAGGAGCTGA-3’ 
ddit3-R  5’-TCACGCTCTCCACAAGAAGA-3’ 
dnajc3-F  5’-TCCCATGGATCCTGAGAGTC-3’ 
dnajc3-R  5’-CTCCTGTGTGTGAGGGGTCT-3’ 
edem1-F  5’-ATCCAAAGAAGATCGCATGG-3’ 
edem1-R  5’-TCTCTCCCTGAAACGCTGAT-3’ 
wfs1a-qF        5’-TGTGCCCTGTGTGCTCTAC-3’ 
wfs1a-qR     5’-GGCAACACAAGTACGGATCA-3’ 
wfs1b-qF  5’-CGCCCCGAATCTAAGCTTTT-3’ 
wfs1b-qR  5’-GCGGAAGTGTGTGTTTGTCT-3’ 
wfs1b-q2F  5’-CCAAACAATACGCTGAGGGT-3’ 
wfs1b-q2R  5’-GCCCAGTCAATCAACACCTC-3’ 
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Table 2.8 qPCR housekeeping primers 
Primer Sequence 
s18-F 5’-AAGAAGATCAGGGCTCACCG-3’ 
s18-R 5’-GCGACGACCAGTTGTTTTGG-3’ 
b2m-F 5’-AAACGGCCACAATGAGAGCA-3’  
b2m-R 5’-AGCAGATCAGGGTGTTTGGT-3’  
ef1α-F 5’-CTGGAGGCCAGCTCAAACAT-3’ 
ef1α-F 5’-ATCAAGAAGAGTAGTACCGCTAGCATT-3’ 
β-actin-F 5’-CGAGCTGTCTTCCCATCCA-3’ 
β-actin-R 5’-TCACCAACGTAGCTGTCTTTCTG-3’ 
 
2.15 Zebrafish mtDNA Levels 
A modified protocol from Bestman et al., 2015 was performed to measure mtDNA in 
zebrafish larvae. gDNA and mtDNA was extracted from individual zebrafish at 48hpf by the 
hot shot method described in Section 2.8 DNA extraction. Primers were used from the 
described protocol (Table 2.9) and the qPCR protocol (Section 2.14) was performed. ΔCq was 
calculated by subtracting nd1 value from ef1α value to give a ratio of genomic to mtDNA 
(Bestman et al., 2015). 
Table 2.9 mtDNA primers 
Primer Sequence 
ef1a F 5’-AAGCCGCTGAGGTAAGCGTTCAAC-3’ 
ef1a R 5’-TTGAGCCGAGAAACGCGTGCTG-3’ 
nd1 F 5’-GGGCACCCATACCCATGCCCTAT-3’ 
nd1 R 5’-TGCGCTACAGCTCGTAAGGC-3’ 
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2.16 Guide RNA (gRNA) synthesis 
gRNAs were designed for CRISPR cas 9 genome editing. Crisprscan 
(http://www.crisprscan.org/) was used to design oligos. gRNAs were picked due to high 
scores on the CRISPRscan predictive sgRNA-scoring algorithm (>70), that targeted the correct 
exons described in Table 2.10. 
 
Table 2.10 gRNA oligos 
Oligos Sequence 
wfs1b-70F:  5’-TTACCTGAGACTAGCCGAGC-3’  
wfs1b-70R:  5’-TGCAAGCACAGAGAAAGAGA-3’ 
wfs1b-83F:  5’-GCTTGAATCTCAGCTGTCGG-3’ 
wfs1b-83R:  5’-ACAATCACTGACATGGGACTG-3’ 
wfs1b-78F:  5’-TCATGAGGGTTTTAGGGCGA-3’ 
wfs1b-78R:  5’-GTATTGGGCTGGAGAGAGGG-3’ 
Universal bottom-
strand Ultramer 
5’AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTA
TTTTAACTTGCTATTTCTAGCTCTAAAAC-3’ 
 
The oligos for gRNA are then combined with the universal bottom-strand ultramer in the 
following reaction: 5x MyTaq Reaction Buffer 5 l, Top strand oligo (100M) 2 l, universal 
bottom-strand ultramer (100M) 2 l, MyTaq DNA Polymerase 0.2 l Water (ddH2O) up to 
25 l. The reaction was placed in a thermocycler on the following programme: 
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Table 2.11  gRNA template reaction thermocycler steps 
Temperature 
(°C) 
Time 
95 05:00 
89 00:15 
83 00:15 
77 00:15 
71 00:15 
65 00:15 
59 00:15 
53 00:15 
50 10:00 
72 10:00 
4 ∞ 
 
The reactions were purified using a Qiagen PCR purification kit to manufacturer’s 
instructions. The purified product was used as template DNA for a MEGAshortscript™ T7 Kit 
reaction with 8 reactions for each oligo mixture. 
2 μl T7 10X Reaction Buffer, 2 μl T7 ATP Solution (75 mM), 2 μl T7 CTP Solution (75 mM), 2 μl 
T7 GTP Solution (75 mM), 2 μl T7 UTP Solution (75 mM), 8 μl Template DNA, 2 μl T7 Enzyme 
Mix. The reaction was incubated at 37°C overnight. 1 μl of TURBO DNase was added and 
incubated for a further 15 minutes. 
Reactions were pooled and RNase free water added to a volume of 800 μL. This was pipetted 
on to a Mirvana spin column from the mirVana miRNA Isolation Kit (ThermoFisher) and 
washed as per manufacturer’s instructions.  
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RNA was eluted in 30 μl RNase free water aliquoted and stored at -80⁰C.  
2.17 Sequencing 
Primers used for sequencing reactions: 
Table 2.12 Sequencing Primers 
Primer Sequence 
wfs1bseq-f 5’-AGCCATACCTCTACTTTCTCCT-3’ 
wfs1bseq-R 5’-AGATGCACACTGTTACGATCA-3’ 
wfs1aseq-f 5’-ACCCCAATCAGACACACCTT-3’  
wfs1aseq-R 5’-ATCGAGTCCAGAGTCGCAGT-3’ 
wfs1a_splice_seq-F  5’-GCGATGTAGCCAGATTTGATAAG-3’ 
wfs1a_splice_seq-R 5’-AGCTTTTATGTCCAGGGCTCT-3’ 
wfs1b_splice_seq-F 5’-GGACAATCAGCGTTTCCTCC-3’ 
wfs1b_splice_seq-R 5’-ACAGCAGTAACAGCATTCACC-3’ 
 
2.18.1 Exo I/Fast AP DNA purification 
PCR reactions were purified by Exo I/Fast AP DNA purification. 5μl of PCR reaction were 
added to Exonuclease I (Exo I) 0.5 µl (10 U) and 1µl FastAP Thermosensitive Alkaline 
Phosphatase (1U). The samples were placed on a thermocycler for the following reaction 
(Table 2.13) 
Table 2.13 Exo I/Fast AP reaction thermocycler steps 
Step 1 2 3 4 
Temperature (⁰C) 25 37 85 4 
Time (minutes) 10 120 5 ∞ 
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2.18.2 BigDye terminator cycle sequencing reaction 
5μl of purified PCR product was added to 15μl big dye (Applied Biosystems, Foster City, USA) 
master mix containing 1μl big dye, 2μl 5x Big Terminator Sequencing buffer, 1μl of either the 
forward or reverse primer and 11μl H20. 
Table 2.14 BigDye reaction thermocycler steps 
 1 2 3 4 5 
Temperature (⁰C) 96 96 50 60 4 
Time 1 minute 10s 5s 4 minutes ∞ 
Cycles  X25  
 
2.18.3 Ethanol Precipitation 
Prior to sequencing the big dye reaction had to be cleaned by ethanol precipitation. 2μl 3M 
sodium Acetate (Merck), 2μl 125mM EDTA (Merck) and 70μl 100% ethanol were added to 
each big dye reaction, mixed and incubated for 15 minutes at room temperature. The 
reactions were centrifuged at 2000g for 30 minutes then the supernatant removed, 70µl 
70% ethanol added and the samples were centrifuged for 15 minutes at 1650g. The 
supernatant was removed and the samples left to air dry in the dark for 15 minutes. 
2.18.4 Sanger Sequencing 
Samples were resuspended in 10µl Hi-Di (Applied Biosystems) and sequenced using a 
capillary electrophoresis on a 3130XL Genetic Analyser (Applied Biosystems). The analysis 
was performed using SeqScape V2.6. 
2.18.5 Commercial Sequencing 
A proportion of sequencing was also sent to GATC and Eurofins Genomics (Germany) for 
sequencing. 250ng of purified PCR products and 5 µM primers were sent to per reaction for 
the GATC lightrun. The Eurofins PlateSeq Service was also used 150ng of unpurified PCR 
product and 30pmol of primer per reaction sent separately. 
2.19 Western Blot 
2.19.1 Protein lysates extraction 
Zebrafish <48hpf were homogenised using a p200 pipette tip while older larvae and adult 
tissue were homogenised using a tissue ruptor.  Tissue was homogenised in RIPA buffer with 
cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail (Roche, Basel, Switzerland) and left 
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to incubate on ice for 10 minutes. The samples were centrifuged at 13000g for 10 minutes at 
4⁰C, the protein concentration determined by Bradford assay, aliquoted and stored at -80⁰C. 
2.19.2 Bradford assay 
Protein standards were made using BSA (bovine serum albumin) and sterile water at the 
following concentrations (mg/ml) 0, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5. 10 μl of standard were 
added to a 96 well plate in triplicate alongside protein at a 1:10 dilution to ddH2O. 
190 μl of 1 part Bradford Dye Reagent Concentrate with 4 parts ddH2O was added to each 
well and incubated in the dark for 10 minutes. 
Absorbance at 610nm was measured on a Magelan Tecan F50 plate scanner (Tecan, 
Männedorf, Switzerland) 
2.19.3 Antibodies 
Table 2.15 Antibodies for Western blots 
Antibody Company Dilution Species Company 
Identifier  
Anti-NDUF9A abcam 1:1000 
1:500 
Mouse ab14713 
Anti-MTCO1 abcam 1:1000 Mouse ab14705 
Anti-SDHA abcam 1:1000 Mouse ab14715 
Anti-HSPA5 abnova 1:1000 Mouse PAB2462 
Anti-VDAC abcam 1:1000 Rabbit ab15895 
 
2.19.4 SDS Page Gel and Transfer 
Zebrafish lysates of 50μg were made up in NuPAGE LDS Sample Buffer and NuPAGE Sample 
Reducing Agent (ThermoFisher). Pre cast NuPAGE 4-12% Bis-Tris Protein Gels (ThermoFisher) 
were loaded with the samples alongside a SeeBluePlus2 marker (ThermoFisher) in an XCell 
SureLock electrophoresis system (ThermoFisher). NuPAGE MES buffer was added to the upper 
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chamber with 500μl NuPAGE Antioxidant solution.  To the lower chamber unaltered MES 
buffer was added and the gels run at 150V until the desired endpoint had been reached. 
Transfer to PVDF membranes was by dry transfer performed using i Blot 2 PVDF mini Stacks 
(ThermoFisher) on an iBlot 2 system. This was performed to manufactures’ instructions using 
the “P0” programme (20 V for 1 minute, 23 V for 4 minutes and 25 V for 2 minutes). 
Membranes were incubated in 5 % (w/v) milk in Tris buffer saline (Santa Cruz, Dallas, USA) 
with 1 % (v/v) Tween 20 (TBST; (Bio-Rad)). These were blocked for 1 hour at room 
temperature with gentle agitation. Then an appropriate antibody was added in a 5% milk 
TBST solution and incubated at 4 degrees overnight (Section 3.12.3). The membranes were 
washed 3 times for 10 minutes in TBST then either anti-rabbit or anti-mouse polyclonal HRP 
conjugated antibody (Agilent, Santa Clara, USA) was added in 5% milk TBST at a dilution of 
1:2500, for 1 hour.  The membrane was washed a further 5 times in TBST prior to imaging.  
2.19.5 Chemiluminescent Detection  
Biorad Clarity ECL (BioRad) was used to detect the HRP signal using an Amersham Imager 
600. Clarity Western Peroxide Reagent and Clarity Western Luminol/Enhancer Reagent were 
added to the membrane at a 1:1 ratio. Excess ECL reagent was removed and the membrane 
imaged on an auto setting on the Amersham Imager 600. If no signal was detected 
incremental settings were used for a longer exposure.  
2.19.6 Coomassie 
The SDS gel from the transfer was coomassie stained to determine equal protein loading of 
the samples. Coomassie staining solution (0.1% Coomassie Brilliant Blue G-250 Dye 
(ThermoFisher), Methanol (50% (v/v)) Glacial acetic acid (10% (v/v)) ddH20 (40% (v/v))) was 
added to the gel for 30 minutes until the gel was stained blue. Background Coomassie stain 
was removed from the gel by Coomassie destain solution (Methanol (50% (v/v)) Glacial 
acetic acid (10% (v/v)) H20 (40% (v/v))) for 1 hour with two changes of destain solution. Gels 
were washed overnight in ddH20 before imaging.  
2.20 Mitochondria Isolation 
Mitochondria isolation from zebrafish was modified from Jha P et al, 2016. Zebrafish were 
lysed in isolation buffer (IB) (6.846% of sucrose (w/v), 0.121% Tris (w/v), 1% 0.1 M EGTA/Tris 
(v/v). Adjusted to pH 7.4 with 1 M HEPES in ddH20) with cOmplete™, Mini, EDTA-free 
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Protease Inhibitor Cocktail (Roche). Homogenate was centrifuged at 600g for 10 minutes (all 
centrifugation steps at 4⁰C). This process was repeated; the supernatant was removed and 
centrifuged at 7,000g for 10 min. The pellet contained isolated mitochondria and was 
resuspended in IB to determine concentration by Bradford assay. 
50μg aliquots of mitochondria were pelleted at 7000g the supernatant discarded and 
aliquots used immediately or stored at -80⁰C. 
2.21 Digitonin Solubilisation of Isolated Mitochondria  
A concentration of 8 g/g digitonin to mitochondrial proteins was added to 50 μg protein, 5 μl 
of NativePAGE sample buffer (4×) (ThermoFisher) and made up to 20μl with ddH20. The 
solution was incubated on ice for 20 minutes then centrifuged at 20000g for 10 minutes. The 
supernatant was taken and added to 2μl coomassie G-250 sample additive (ThermoFisher).  
2.22 Native Page Gel  
Samples were loaded on 3-12% NativePAGE Bis-Tris Gels with a NativeMark™ Unstained 
Protein Standard (ThermoFisher).The gels were electrophoresed for the first 30 minutes at 
150V with dark blue cathode buffer (1X Native page running buffer 1X Dark Blue Cathode 
buffer (ThermoFisher) to the upper chamber of an XCell SureLock electrophoresis system 
and 1X Native page running buffer in the bottom. After 30 minutess the dark blue cathode 
buffer was replace by light blue buffer (1X Native page running buffer 0.1X Dark Blue 
Cathode buffer) 
The remaining steps of the protocol followed the Western Blot protocol from the Page Gel 
and Transfer although “P0” was altered with 2 additional minutes at 25V for the transfer 
using the iBlot 2. The membrane had to be destained in Coomassie destain with three 10 
minutes washes before blocking. 
2.23. Whole Mount Staining of Zebrafish Larvae 
2.23.1 Staining 
Embryos were euthanised in a 1:1 dilution of tricane:system water. To preserve the tissue 
embryos were fixed overnight at 4⁰C in 4% paraformaldehyde (PFA). The PFA removed and 
the embryos were rinsed with PBS for 5 minutes the ddH20 for 5 minutes. The embryos were 
then permeabilised in acetone at -20⁰C for 7 minutes. The acetone was removed and 
embryos washed in ddH20. 
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Embryos were transferred to a 6 well plate and washed in 1XPBSTween20 (0.1%) (PBST). The 
PBST was replaced with 2ml 5% Horse serum (in PBST) to block for an hour with gentle 
agitation. Primary antibodies were diluted to concentrations listed in Table 2.16 in 5% Horse 
serum and incubated with zebrafish embryos overnight at 4⁰C with gentle agitation. The 
embryos were washed in PBST four times for 20 minutes. Secondary antibodies were 
prepared in 5% horse serum and incubated with the fish for 2 hours at room temperature. 
The embryos were then washed twice more in PBST for 20 minutes and then washed again 
overnight. The embryos were then mounted on permafrost slides or confocal dishes and 
taken for confocal microscopy. 
2.23.2 Antibodies 
Table 2.16 Antibodies for whole mount staining 
Antibody Company Concentration Species Company 
Identifier  
SV2 The Developmental Studies 
Hybridoma Bank 
1:1000 Mouse  
Alexa Fluor™ 546 
Phalloidin 
ThermoFisher 1:1000 Mouse A22283 
Goat anti-mouse – 
Alexa 488 
ThermoFisher 1:1000 Goat A-11029 
Alpha-Bungarotoxin – 
Alexa 594 
ThermoFisher 1:500 Mouse B13423 
 
2.23.3 Acquisition by Confocal Microscopy 
Zebrafish were mounted on glass Superfrost Plus™ slides in Vectorshield fluorescent 
mounting medium. Glass coverslips were raised by placing electrical tape around the outside 
of slides and placed over the zebrafish. This was sealed with nail varnish to prevent drying. A 
Nikon A1R confocal (invert) was used for imaging Z-stacks were acquired using a high speed 
piezo Z stage.  
Analysis was carried out in ImageJ. 
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2.24 Seahorse XF Mito Stress Test 
Oxygen consumption rate of 48hpf embryos (OCR) was measured using the Seahorse XFe96 
Extracellular Flux Analyzer (Agilent). 48hpf embryos were anesthetised in a 1:25 tricane E3 
solution and single embryos still within the chorion added to a single well on a Seahorse 
XFe96 Spheroid Microplate, in 150μl E3 tricane. Modifying the seahorse stress test 3 Basal 
reading were recorded, Oligomycin (final conc 25μM) with 5 recording cycles, FCCP (final 
conc 4μM) 3 recordings and Rotenone + Antimycin A (final concentration 25μM) were all 
added. Calculations for parameters (Non-mitochondrial respiration, Basal respiration, 
Maximal respiration, Proton leak, ATP-prodiction and Spare respiratory capacity) were made 
from the Seahorse XF Cell Mito Stress Test Kit User Guide (Agilent). 
2.25 Live Trafficking of Mitochondria in a 48hpf Zebrafish 
2.25.1 Plasmid Preparation 
neuroD:GFP and neuroD:mito-RFP (a gift from Tamily A. Weismann) plasmids were used 
(Marra et al., 2015). The plasmids were transformed into JM109 E. coli. (Promega).  
2.25.2 Transformation 
Plasmids were added to 25μl of JM109 competent cells, mixed and incubated on ice for 30 
minutes. The mixture was then heat shocked at 42⁰C for 45 seconds in a water bath, then 
returned to ice for 2 minutes. 475μl Luria-Bertani (LB) broth was added to the mixture and 
incubated at 37⁰C for 1 hour shaking at 225rpm in a C5 shaking incubator (New Brunswick, 
Enfield, USA). 200μl of the reaction was spread on an LB agar plate containing 100 µg/ml 
ampicillin, allowed to dry and incubated upside down at 37⁰C overnight. 100 µg/ml 
ampicillin LB broth was then inoculated with a single colony and incubated at 37⁰C overnight 
shaking to allow for plasmid replication. 
2.25.3 Plasmid Purification 
Plasmids were purified following the Qiagen mini prep protocol. Plasmids were eluted in 
30μl elution buffer and plasmid concentration check by 2000 UV-Vis spectrophotometer 
(ThermoFisher) and quality and size assessed by agarose gel electrophoresis.   
2.25.4 Zebrafish Preparation 
Zebrafish were co injected with both neuroD:GFP (3 pg) and neuroD:mito-RFP (5 pg) 
plasmids at the 1 cell stage to visualise both the lateral line and the mitochondria. The fish 
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were allowed to develop to 48hpf in E3 medium and screened for good GFP transfection 
rates using a Leica MZ16F fluorescent stereomicroscope and these fish picked for confocal 
microscopy. 
2.25.5 Acquisition by Confocal Microscopy 
Zebrafish were embedded in 1% low melt agarose (Merck) on Thermo Scientific™ Nunc™ 
Glass Bottom Dishes (ThermoFisher) and covered with E3 medium. Images were acquired at 
60x magnification using 1.40 NA oil objective and a 5 minute time lapse of both GFP and RFP 
at 5 second intervals.  
2.25.6 Kymograph Analysis 
Images were analysed in ImageJ using kymographs using the following plugin 
(https://www.embl.de//eamnet/html/body_kymograph.html). A segmented line was used 
to highlight the neuron, the channels were split and the RFP image used from this point 
onwards. The width of the line was altered to encompass the whole neuron (line width 9). 
The kymograph plugin was used to create a kymograph. Straight lines were drawn using the 
line tool tracking mitochondria (Figure 2.1).  
 
Figure 2.1 Representative Kymographs with mitochondrial movement marked with yellow 
lines. 
The lines values were calculated using tsp050706. These values were converted from pixels 
to μm and from frames to seconds. Velocity, percentage movement and changes in direction 
can be extrapolated from these data.   
2.26 OKR 
The zebrafish were anesthetised and fixed between two sponges using needles to keep them 
in place. The sponge was fixed to the bottom of a clear plastic drum. System water was 
added and the fish left to relieve the effects of anaesthesia. This was placed inside a variable 
speed rotating drum with a black and white grating. When the fish had sufficiently recovered 
the grating was rotated at 8rpm for 30 seconds clockwise and 30 seconds anti-clockwise. 
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This was repeated at 16 rpm and the videos recorded using a Nikon camera attached to a 
stereomicroscope. The eye movements were counted manually.  
2.27 OCT 
OCT images were captured using the Bioptigen Envisu R2200 SDOIS (Bioptigen, Inc., 
Morrisville, USA). The zebrafish were anesthetised in a 1:20 ticane to system water ratio and 
placed on the imager in a grooved plasticine wedge placed and submerged 1mm 
underwater, or placed in a rubber hold. For SD-OCT cross-sectional B-scans 1000 A-scans per 
B-scan with 100 total scans. Images were created using the Diver software (Bioptigen,Inc.) 
(Toms et al., 2017). 
2.28 Histology 
2.28.1 Fixation 
Zebrafish were fixed in 4% paraformaldehyde (PFA). Zebrafish up to 5 days were fixed whole 
overnight at 4⁰C while adult zebrafish were decapitated to allow better perfusion into the 
head and fixed for 1 week at 4⁰C. 
2.28.2 Decalcification 
Decalcification was required on adult fish to allow for whole head sections. The PFA was 
removed and the head washed twice in PBS. 0.5M EDTA was added to each head and 
incubated at room temperature for 10 days. 
2.28.3 Tissue Processing 
Fish heads were removed from EDTA washed twice in ddH2O and placed in M512 – 
Macrosette (Simport, Beloeil, Canada) the cassettes were then placed in a Microm STP 120 
tissue processor. The program is described in Table 2.17 
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Table 2.17 Microm STP 120 tissue processor programme 
Time Reagent 
7 hours 70% ethanol 
1 hour 70% ethanol 
45 minutes 90% ethanol 
45 minutes  90% ethanol 
45 minutes 90% ethanol 
45 minutes 100% ethanol 
45 minutes 100% ethanol 
30 minutes 100% ethanol 
30 minutes Xylene 
30 minutes Xylene 
1 hour Paraffin 
1 hour Paraffin 
 
2.28.4 Paraffin Wax Embedding and Sectioning 
Zebrafish heads were embedded in disposable plastic moulds (Simport). These were 
orientated in a face down position and molten paraffin wax added to the base moulds. M512 
– Macrosette were placed on top and used as a base for the paraffin blocks. Blocks were 
rested on ice for 5 minutes prior to sectioning. Fish heads were sectioned at 4 μm using a 
Leica RM 2135 microtome (Leica Biosystems). When the optic nerve was located multiple 
tissue sections were collected on Superfrost Plus™ slides and incubated at 37⁰C to melt onto 
slides.  
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3.28.5 H&E Stain 
Sections were deparaffinised in two changes of Histoclear (NationalDiagnostics, Atlanta, 
USA) for 5 minutes. Rehydration of tissues occurred through two changes of 100% ethanol, 
90% ethanol 70% ethanol and then H20 for 5 minutes each. Tissue stained in Mayers 
Haemalum (ThermoFisher) for 1 minute and washed in running tap water until blue. Tissue 
was then counterstained in 1% aqueous eosin solution (ThermoFisher) and washed to 
remove excess eosin. Tissue was dehydrated through the ethanol gradient and cleared in 
Histoclear (1 minute in each). Slides were mounted with DPX mounting medium (Merck) and 
glass coverslips. 
2.29 Retinal Cell Counts 
Images were acquired by light microscopy using an Axio Imager Z1 fluorescence microscope 
(Zeiss, Oberkochen, Germany) using a 20x objective. The images were analysed on ImageJ. 
Six 100μm2 sections, three on each side of the optic nerve were selected spaced along the 
retina as displayed in Figure 2.2, RGCs were counted from these sections to give an average 
RGC number. Three tissue sections were examined from an area displaying the optic nerve 
of each zebrafish and averaged. 
 
Figure 4.2 Representative Retinal sections and 100μm2 section of retina.  
2.30 Optic Nerve measurements 
At the optic head measurements of the optic nerve were taken across from the retinal 
pigment epithelial cells. 
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2.31 Electron Microscopy 
Electron microscopy was performed by the Newcastle University Electron Microscopy 
Research Services. 
2.32 Zebrafish Twitch Response 
Zebrafish were grown in E3 medium up to 24 hpf, 15 zebrafish from each condition were 
recorded for 1 min per dish using a Leica stereomicroscope with a Chameleon digital camera 
(CMLN-13s2M). The 15 fish movements were counted and averaged. 
2.33 Zebrafish Touch Response Assay 
Zebrafish were grown in E3 medium up to 48hpf. Fish were dechorionated at least 1 hour 
prior to testing.  Single zebrafish were placed in fresh E3 medium on an illuminated stage 
and the back of the head touched using a fine pipette tip to see the response to tactile 
stimulation. Videos were recorded using a Canon legria hfr76 camera at 25 frames per 
second suspended 7cm above the zebrafish using a clamp, a ruler was recorded for scale.  
Analysis was performed in ImageJ as described in O’Connor et al. 2018. Videos imported 
using the Movie FFMPEG plugin. The images were converted to 8bit and thresholding was 
performed to acquire a black and white image which could be converted to binary and 
analysed using the Trackmate plugin. Thresholding performed in Trackmate to assure only 
fish movements tracked. Values for distance travelled and average speed could be extracted 
from data (O'Connor et al., 2018). 
2.34 Adult Movement 
Adult zebrafish were placed in pairing tank with enough water to move in horizontal 
directions but not vertically. The fish were allowed 3 minutes to become acclimatised to the 
tank and recorded for 1 minute. Videos were recorded using a Canon legria hfr76 camera at 
25 frames per second suspended above the zebrafish using a clamp, a ruler was recorded for 
scale. 
Videos were analysed the same as in the “Zebrafish Touch Response Assay”.  
3.35 Blood Glucose 
Blood Glucose was measured using a modified protocol from Eames et al., 2010 (Eames et 
al., 2010) OneTouch Ultra blood glucose monitor and OneTouch Ultra test strips (Lifescan, 
Milpitas, USA). Zebrafish were separated overnight in breeding tanks to prevent feeding. 
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Zebrafish were euthanized in tricane then decapitated. The decapitation cut through the 
heart and blood could be taken from here onto the OneTouch Ultra test strips. The blood 
glucose in mmol/L was recorded (Eames et al., 2010). 
3.36 Mitochondrial Ca2+ uptake 
Mitochondria were isolated but instead of resuspending in IB, they were washed then 
resuspended in KCl buffer (125 mM KCl, 2 mM K2HPO4, 1 mM MgCl2, 5 mM glutamate, 5 
mM glutamate and 20 mM HEPES (pH 7)). Protein concentration was determined by 
Bradford assay and 50μg protein added to 1ml KCL buffer and centrifuged at 10600g for 10 
minutes. The pellet was resuspended in 180 µl of KCL medium containing 1 μM of the 
cytosolic calcium probe OregonGreen 5N. This was transferred into a black 96-well plate 
with flat and transparent bottom measurements were taken on a Varioskan LUX platereader 
(ThermoFisher) every 2 seconds at excitation at 485 nm and emission at 510 nm. After 30 
seconds 20 µl of KCL buffer supplemented with 200 µM CaCl2 was added and fluorescence 
measured for a further 4 minutes 30 seconds (Prudent et al., 2013). 
3.37 Acetylcholine Esterase Assay 
The Acetylcholine esterase assay was modified from Teixido et al., 2013.  Zebrafish tissue 
and pooled embryos were homogenized in 0.5 ml ice-cold sodium phosphate buffer (0.1 M, 
pH 7.4, and 0.1% v/v Triton X-100). Homogenates were centrifuged for 15 minutes at 4⁰C at 
10000g. After quantification through BCA assay 10μg of protein had 0.3mM DNTB and 
0.45mM AChE added and the spectrophotometric reading at 405nm read for 10 minutes on 
a Varioskan LUX platereader (ThermoFisher) (Teixido et al., 2013). 
 
 
 
 
 
  
57 
 
Chapter 3: A Morphant Model of Wolfram Syndrome  
3.1 Introduction  
Morpholinos were developed in 1998 by Dr James Summerton’s group and have been used 
as a tool to transiently knockdown expression of mRNA in zebrafish since 2000 (Partridge et 
al., 1996; Nasevicius and Ekker, 2000). Morpholinos are normally comprised of 25 bases that 
work by complimentary base pair binding to RNA through an RNase-H–independent 
mechanism (Summerton, 1999). Due to a phosphorodiamidate backbone the neutrally 
charged oligo has a very high affinity for RNA (Bill et al., 2009). By binding to mRNA they are 
predominantly designed to effect translation in two ways: splice blocking and translation 
blocking as seen in Figure 3.1. 
 
Figure 3.1 Morpholino Function. The principle of splice blocking and translation blocking 
morpholinos and action on RNA transcripts. 
A splice blocking morpholino is designed to target splice sites and will prevent splicing 
machinery from functioning, leaving intronic mRNA, this defective transcript is degraded 
resulting in a knockdown in expression of the selected protein. Translation blocking 
morpholinos work by steric hindrance of the translation machinery by binding at 
transcription start points. This also results in lower protein expression. This highlights that a 
morpholino model is not a true knockout, but rather a knockdown of protein expression.     
A number of issues have been known to occur when using morpholinos in zebrafish. This 
includes a number of off target effects that can be caused by the off target activation of p53 
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pathways (Robu et al., 2007). In response to this discovery a number of guidelines (Eisen and 
Smith, 2008) were published in which a number of controls were established to ensure non-
specific effects were mediated. However, even with these guidelines it was described that a 
number of morpholino experiments did not match up when equivalent CRISPR knockouts 
were made (Kok et al., 2015) and morpholino knockdowns tend to be more severe in 
phenotype then their CRISPR counterparts. New guidelines have been produced (Stainier et 
al., 2017) that suggest genetic knockouts should be used as a control for any morpholino 
experiment and if complete knockout is lethal, rescue experiments should be attempted to 
ensure the phenotype is corrected by co-injection with mRNA. Rossi et al. suggest that the 
more subtle effects of the CRISPR knockouts may be due to compensatory mechanisms after 
deleterious mutations (Rossi et al., 2015). They observed that when morpholino was injected 
into genetic knockouts they were less sensitive than the wild-type knockdowns. This 
suggested that morpholino off target effects were not the main cause of differences seen 
but another mechanism. Alongside this they showed that knocking down vegfaa showed an 
upregulation of vegfab in the knockout but not the morphant. This shows that compensatory 
mechanisms are being upregulated in knockouts suggesting phenotypes seen in morphants 
may be a truer representation of protein function compared to knockouts (Morcos et al., 
2015).  
The WFS1 orthologues wfs1a and wfs1b were knocked down by morpholinos in zebrafish. 
This was performed in order to ascertain the feasibility of using genetic knockouts as a 
model of WS.    
3.2 Characterisation of Abnormal Phenotypes  
In order to create a consistent marking scheme for phenotyping, a number of specific 
phenotypic markers were assessed for severity. The markers were: the eye, the otoliths (ear) 
and the brain, these were chosen as they are similar tissues that are affected in WS in 
patients, the tails also showed a large number of changes so were also included in the 
phenotyping. Using a combination of marks an overall phenotypic score was created to 
assess the effectiveness of the morpholino models: 0-2 points mild, 3-5 moderate and 6+ 
severe. Examples of each category of phenotype can be seen in Figure 3.2. 
The markers were visually assessed at 72hpf for mild/moderate/severe phenotypes.  For the 
zebrafish tails (Figure 3.2A) slight curvature was classed as mild, while severe tails were 
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severely curved and much smaller in size. For eyes (Figure 3.2B), mild eyes had a size 
reduction while moderates started to develop structural abnormalities with severe eyes 
being substantially smaller or even lacked eyes. The zebrafish heads/brains (Figure 3.2C) 
appeared to develop oedema and substantially different cranial features at the severe end 
of the scale. The zebrafish ear, which is comparable to a human inner ear, contains two 
otoliths at 72hpf that are moved to sit on the macular in the zebrafish ear. In the morphants 
these appeared displaced either moving towards each other (mild) or fused or missing 
(severe).  
 
Figure 3.2 Phenotyping of wfs1 Morpholino Zebrafish. A-Examples of tails in each category, 
B- Examples of eyes in each category, C- Examples of head/brain abnormalities in each 
category and D- Examples of Otoliths in each category. A point system was designed with: 1 
point was given for a mild phenotype, 2 for moderate and 3 for severe. These were used to 
separate zebrafish into gross phenotypic groups 0-2 points mild, 3-5 moderate and 6+ 
severe. 
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3.3 Optimisation  
Morpholino concentrations had to be optimised to find the best concentration for use in 
future experiments. Three morpholinos were tested a wfs1a and wfs1b splice blocking 
morpholino, a wfs1b translation blocking morpholino was also used.  
 
Figure 3.3 wfs1a and wfs1b gene and location of morpholinos. The orange blocks represent 
splice blocking morpholinos and the green translation blocking. The wfs1a splice blocking 
morpholino interrupts splicing between exon 8 and 9 and the wfs1b morpholino between 
exon 3 and 4.   
For wfs1a three concentrations were used 0.2mM, 0.4mM and 0.8mM. Clutches of 50 
zebrafish embryos were injected with 3 the three concentrations of wfs1a splice blocking 
morpholino. At 72hpf the phenotypes were scored and sorted into gross morphological 
phenotypes as described in Figure 3.1., dead fish were also recorded. 
The wfs1a morpholino at low concentrations did not provide any significant differences to 
uninjected zebrafish. At higher concentrations (0.8mM) the morpholino appeared to be toxic 
resulting in a higher percentage of fish dying (40%), this was not significant although 
injections at this concentration were not repeated. It was decided to continue using 0.4mM 
of the morpholino as it had a total of 11% of fish with a phenotype (mild, moderate and 
severe). 
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Figure 3.4 wfs1a Splice Blocking Morpholino Optimisation. A: Percentage of zebrafish with 
mild phenotypes. B: Percentage of zebrafish with moderate phenotypes C: Percentage of 
zebrafish with severe phenotypes. D: Percentage of zebrafish with no phenotypes. E: 
Percentage of fish with that were normal compared to effected/dead. 
The percentage of fish in each group was calculated alongside number of deaths and plotted 
on a grouped column graph +SEM using Graphpad Prism (mean only for F). Uninjected 
control n=4, 0.2mM n=4, 0.4mM n=4, 0.8mM n=1. A-E: Two-way ANOVA was performed and 
no significant differences were seen when compared to the control using Bonferroni 
multiple comparisons: p>0.05. 
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For the wfs1b splice blocking morpholino (Figure 3.5) four concentrations were used: 
0.2mM, 0.4mM, 0.5mM and 0.6mM. Clutches of 50 zebrafish embryos were injected with 
the 4 concentrations of wfs1b splice blocking morpholino. The phenotypes were scored and 
sorted into gross morphological phenotypes as described in Figure 3.2. 0.5mM and 0.6mM  
of morpholino resulted in a significantly higher proportion of dead zebrafish (80% p<0.001) 
while 0.2mM and 0.4mM provided significantly different numbers of mild phenotypes 
compared to the control (0.2mM p>0.05 and 0.4mM p>0.001). 0.4mM also had a higher 
proportion of severe phenotypes 4% compared to 0.1% for controls. 
It was decided to continue with 0.4mM of morpholino as the optimum concentration due to 
the higher percentage of mild phenotypes while not increasing the death rate Figure 3.5 A 
and D.  
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Figure 3.5 wfs1b Splice Blocking Morpholino Optimisation. A: Percentage of zebrafish with 
mild phenotypes. B: Percentage of zebrafish with moderate phenotypes C: Percentage of 
zebrafish with severe phenotypes. D: Percentage of zebrafish with no phenotypes. E: 
Percentage of fish that were normal compared to affected/dead.  
The percentage of fish in each group was calculated alongside number of deaths and plotted 
on a grouped column graph +SEM using Graphpad Prism (mean only for F). 0.2mM n=4 
0.4mM n=6 0.5mM n=3, 0.6mM n=3 uninjected control n=6. A-E: Two way ANOVA was 
performed and significant differences were seen when compared to the control using 
Bonferroni multiple comparisons and noted on the graph p<0.05 = *, p<0.005 = ***.and 
p<0.001 = **** 
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As a control for the wfs1b splice blocking morpholino a wfs1b translation blocking 
morpholino was purchased. This was injected at 6 different concentrations: 0.2mM, 0.4mM, 
0.5mM, 0.6mM, 1mM and 1.4mM. The zebrafish were injected and scored using the 
previously categorised system. 
The results had no consistently significant changes in mild, moderate and severe 
phenotypes. Suggesting the translation blocking morpholino was unsuccessful; this could not 
be confirmed by western blot as there is currently no zebrafish specific wfs1 antibody 
available. Although an increased number of mild phenotypes could be seen this was not 
significant and did not seem to change with increasing doses, as off target effects could not 
be ruled out the experiments were continued with splice blocking morpholinos only. 
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Figure 3.6 wfs1b Translation Blocking Morpholino Optimisation. A: Percentage of zebrafish 
with mild phenotypes. B: Percentage of zebrafish with moderate phenotypes C: Percentage 
of zebrafish with severe phenotypes. D: Percentage of zebrafish with no phenotypes. E: 
Percentage of fish with that were normal compared to effected/dead.  
The percentage of fish in each group was calculated alongside number of deaths and plotted 
on a grouped column graph +SEM using Graphpad Prism (mean only for F). 0.2mM n=4 
0.4mM n=6 0.5mM n=3, 0.6mM n=3 uninjected control n=6. A-E: Two way ANOVA was 
performed and significant differences were seen when compared to the control using 
Bonferroni multiple comparisons and noted on the graph p<0.01 = ** and p<0.001 = ****. 
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The two splice blocking morpholinos were combined at their optimum concentrations 
(0.4mM) in order to determine if a double knockdown morphant was viable. The zebrafish 
were injected and scored using the previously categorised system. 
The combination of the two morpholinos only resulted in a significant increase in deaths 
compared to normal phenotypes in uninjected controls. In addition, a large change is 
observed in the reduction of mild phenotypes seen in wfs1b 0.4mM compared to the 
combined morphants (Figure 3.7A). This change suggests that the double knockdown is 
causing the zebrafish to die instead of these less severe phenotypes.  
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Figure 3.7 Phenotyping for combined injection of wfs1a and wfs1b morpholinos. A: 
Percentage of zebrafish with mild phenotypes. B: Percentage of zebrafish with moderate 
phenotypes C: Percentage of zebrafish with severe phenotypes. D: Percentage of zebrafish 
with no phenotypes. E: Percentage of fish with that were normal compared to 
effected/dead.  
Zebrafish embryos were co-injected with 0.4mM concentrations of either wfs1b or wfs1a or 
wfs1a+wfs1b splice blocking morpholinos into 1-4 cell zebrafish embryos. The percentage of 
fish in each group was calculated alongside number of deaths and plotted on a grouped 
column graph +SEM using Graphpad Prism (mean only for F). Replicates of 50 embryos were 
taken for each concentration.  Wfs1a 0.4mM n=4 wfs1b 0.4mM n=6, uninjected control n=6 
and Combined 0.4mMa+b n=3. A-E: Two way ANOVA was performed and compared to the 
control using Bonferroni multiple comparisons. Significant differences were seen and noted 
on the graph, p<0.001 = ****.  
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3.4 Confirmation of Splicing Defects  
To confirm that the splice blocking morpholinos were modifying the RNA transcripts RT-PCRs 
were performed on pooled embryos which displayed a phenotype.  
For wfs1a knockout fish there were very obvious changes in splicing. This can be seen in 
Figure 3.8 where there is no trace of a normal (~350bp) sized band seen in the uninjected 
control. The larger molecular weight product suggests a retained intronic sequence and the 
fact no 350bp fragment is seen in the morphants suggested very efficient splice blocking. 
These bands were extracted and subjected to a second round PCR in order to get enough 
material for sequencing. The larger molecular weight product was sequenced to reveal 
intronic DNA being retained in the wfs1a morphants. Intron 7-8 was shown to be completely 
retained and partial coverage of intron 6-7 was also detected. Band shifts in the wfs1b splice 
blocking morpholino (Figure 3.9) were less clear than the wfs1a counterpart. 
 
Figure 3.8 Confirmation of abnormal wfs1a splicing. A: PCRs were performed of cDNA from 
wfs1a splice blocking morpholino and uninjected control zebrafish. PCRs were performed 
using the wfs1a_splice primer set from Table 2.4.B: Second round PCRs of gel extracted 
product. The PCR products were extracted from the gel (Figure 4.5A) and subjected to a 
second round PCR 19µl of product was loaded (Figure 4.5B). To visualise products samples 
was loaded on a 1.5% agarose gel, alongside Hyperladder IV (Bioline) and electrophoresed at 
80V for 2 hours. Gels were visualised using UV imaging on a GelDoc-IT Imaging system (UVP) 
(A)  
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Multiple bands could be observed and bands in both 48hpf and 72hpf that differed from the 
control were extracted for further analysis.  
The bands extracted were: “48hpf High Band”, “48hpf expected”, “72hpf expected” and 
“72hpf Lower Band” noted in Figure 4.6A. The four bands with successful PCR reactions were 
marked with arrows in Figure 4.6A. Second round PCR reactions were extracted and 
sequenced the 48hpf High Band when sequenced included a 60bp intronic sequence.   
At 72hpf, a lower band was observed and sequencing only detected exon 2 indicating that 
exon 3 might be skipped. However, a large amount of the non-spliced product can be seen 
suggesting this morpholino was not as effective as the wfs1a morpholino. 
 
 
Figure 3.9 Confirmation of abnormal wfs1b splicing. A: PCRs were performed of RT-PCR 
products from wfs1b splice blocking morpholino and uninjected control zebrafish. PCRs were 
performed using the wfs1b_splice primer set from table 2.4.B: Second round PCRs of gel 
extracted product. The PCR products were extracted from the gel (Figure 4.5A) and subject 
to a second round PCR 19µl of product was loaded (Figure 4.6B). To visualise products 
samples was loaded on a 1.5% agarose gel alongside Hyperladder IV (Bioline) and 
electrophoresed at 80V for 2 hours. Gels were visualised using UV imaging on a GelDoc-IT 
Imaging system (UVP) 
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3.5 Controls  
3.5.1 p53 Morpholino co-injection  
Wfs1b zebrafish were co-injected with a p53 morpholino as a control for off target effects. 
Percentages of phenotypes accurately mirror the results of the wfs1b morpholino by itself. It 
can also be seen that the phenotypes are also similar between the two groups as seen in 
Figure 3.10b with eyes, heads and tails all having similar effects.     
 
 
Figure 3.10 Co-injection of p53 and wfs1b splice blocking morpholino. A: Percentage of 
zebrafish with mild, moderate, severe, dead and normal phenotypes when injected with 
wfs1b splice blocking morpholino and p53 morpholino, compared to wfs1b splice blocking 
alone. B: Representative images of p53+ wfs1b and wfs1b splice blocking morpholino by 
itself. The phenotypes were sorted into gross morphological phenotypes as shown in Figure 
4.2. The percentage of fish in each group was calculated alongside number of deaths and 
plotted on a grouped column graph +SEM using Graphpad Prism (mean only for F). 
Replicates of 50 embryos were taken for each concentration.  p53 wfs1b 0.4mM n=3 wfs1b 
0.4mM n=6. Two way ANOVA was performed and compared to the control using Bonferroni 
multiple comparisons. No significant differences were seen. 
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3.5.2 Conformation with CRISPR  
 
Figure 3.11 CRISPANT wfs1b mosaic knockout zebrafish at 48hpf. A: Control wildtype 
zebrafish at 48hpf. B: Tyrosinase CRISPANT with mosaic pigment knockout. C: wfs1b 
CRISPANTS. Zebrafish were injected with 3000ng of appropriate gRNA and Cas9 protein at 
the 1 cell stage. Zebrafish showing equivalent phenotypes were imaged at 48hpf. 
Cas9 protein was co-injected with two wfs1b guide RNAs to create mosaic CRISPANT wfs1b 
knockouts. As a control a tyrosinase (Tyr) CRISPANT was also made to knockdown pigment 
formation (Figure 3.11B). Pigment loss can be seen in the eyes and on the top of the head. 
This highlights the mosaic nature of CRISPANTs with some pigment still developing. A 
selection of wfs1b mosaic knockouts are seen in Figure 3.10c which have similar brain eye 
and tail phenotypes to the wfs1b morpholino knockdowns.  
3.6 Discussion 
The aim of this chapter was to model WS in zebrafish using morpholinos to transiently 
knockdown wfs1 expression. This was a proof of principle experiment to determine if using a 
transgenic model of WS could accurately model WS.   
Attempts to transiently knockdown the wfs1 gene in zebrafish had mixed results. Splice 
blocking morpholinos were used in both the wfs1a and wfs1b knockout models.  Although 
both splice blocking morpholinos showed abnormal phenotypes the wfs1b morpholino 
appeared to give a higher percentage of zebrafish with adverse effects. When the two 
morpholinos were combined the in the majority of embryos died. This could be explained by 
a double knockout being lethal or toxic off target effects of being injected with too much 
morpholino (Robu et al., 2007).   
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In the wfs1a knockdown there were very few changes in the morphology of the zebrafish 
with no significant differences in categories from the controls. The wfs1b splice blocking 
morpholino had more significant changes with a large number of morphant zebrafish with 
mild or abnormal phenotypes. The phenotypes seen appear consistent with a number of 
symptoms observed in the WS patient population: eye, ear and brain abnormalities (Barrett 
and Bundey, 1997). However, when looking at the changes of splicing from the wfs1b 
morpholino in the changes in splicing are not as clear as the wfs1a morpholino. One option 
why this may happen could be the levels of expression. If wfs1b is more highly expressed 
compared to wfs1a there would be more transcript to be altered resulting in a lower number 
of differentially spliced transcripts. It may also be that off target effects of the morpholino 
are the reason for seeing such phenotypes due to (Robu et al., 2007; Kok et al., 2015). In 
order to determine if this may be the case a number of controls were performed.  
The first control was to use an ATG translation blocking morpholino, this morpholino acts in 
a different manner to the splice blocking (Bill et al., 2009) so if it provided similar results 
would help to suggest this is not a splice morpholino specific phenotype. Although, a number 
of zebrafish appeared to have similar phenotypes to Figure 3.1 the translation blocking 
morpholino did suggest any changes with increasing doses. There is currently no zebrafish 
wfs1 antibody and therefore any reduced wfs1 protein expression could not be confirmed 
this way. As a result of this we decided to try a p53 knockdown in an attempt to offset the 
p53 mediated off target effects. The experiment replicated very similar results when co-
injected with a wfs1b splice blocking morpholino suggesting p53 mediated off target effects 
may not be responsible for the changes seen in wfs1b knockdowns.  
The final control that was used was a CRISPANT knockdown which uses mosaic F0 
generations to determine if any phenotypes can be seen. The wfs1b CRISPANT knockouts 
had a number of similar phenotypes such as small eyes and tail deformities. This combined 
with the p53 morpholino data suggests wfs1b knockouts are providing a real phenotype and 
not off target effects. The “Guidelines for morpholino use in zebrafish” recommend rescue 
experiments as one of the key controls for morpholino experiments (Stainier et al., 2017). 
This was not completed due to problems with cloning of the wfs1b gene into an expression 
vector. However, data presented here shows the wfs1 morpholinos confirming proof of 
principle and the two controls demonstrate that the effects of the morpholinos are specific. 
Wfs1a controls were not performed due to the lack of phenotypes seen in the morphants 
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and the total splicing seen in the PCRs suggested wfs1a may not be as important as wfs1b in 
the development of a zebrafish model of WS. 
Although there are a number of controversies surrounding morpholinos, they still provide an 
inexpensive quick tool to determine, as a first step, if gene knockouts are worth pursuing. 
The aim was to use morpholinos to transiently knockdown the two orthologues of WFS1 in 
zebrafish (wfs1a/wfs1b) to determine if transgenic mutant lines would be a project worth 
pursuing. With promising data from the wfs1b morpholino transgenic models were used to 
determine if WS could be accurately modelled in zebrafish.  
3.7 Conclusions 
Two transient wfs1 knockdown models in zebrafish were developed using a morpholinos 
(wfs1a and wfs1b). The phenotypes seen appear consistent with a number of symptoms 
observed in patients with WS. Controls for the morpholinos were not consistent, leading to 
the use of a genetic knockout for all future experiments.  
To fully confirm the morpholino models a rescue experiment would have to be carried out. 
This would require the co-injection of functioning mRNA with the morpholino to determine 
any phenotypes are non-specific. This model could then be compared to the genetic 
knockout to determine possible explanations for the difference in severity between the two 
models, which may possibly involve compensatory mechanisms not upregulated in 
morpholino experiments.   
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Chapter 4:  Characterisation of Transgenic wfs1 Mutant Zebrafish Lines  
4.1 Introduction 
Due to the promising data seen in the morpholino knockdown zebrafish (Chapter 3), a 
genomic knockout model of WS was investigated in zebrafish. Morpholinos work to 
transiently affect expression are only effective for the first few days of development (Eisen 
and Smith, 2008). As WS is mainly a degenerative disease and in order to look at zebrafish at 
older timepoints. Knockdowns will also have some functional transcript remaining, in order 
to counter these limitations found in a morpholino model a genetic knockout was used.   
Zebrafish genomes can be modified in a number of methods, more recently zebrafish 
genomes have been modified with high specificity using CRISPR Cas-9, TALENS and Zinc 
finger nucleases (Doyon et al., 2008; Sander et al., 2011; Jao et al., 2013). These methods 
use specifically targeted nucleases to edit the genome. However, more traditionally N-ethyl-
N-nitrosourea (ENU) screens were used to create large numbers of random mutations in 
spermatogonia. These developed spermatozoa were used to out cross to wild type fish, and 
future generations in crossed to develop phenotypes and mutations worked out in reverse 
(Patton and Zon, 2001). More recently this has become more specific using targeting 
induced local lesions in genomes (TILLING), this involved sequencing F1 sperm from ENU 
mutated zebrafish and outcrossing for specifically targeted genes (Kettleborough et al., 
2013). This has resulted in a large repository of zebrafish containing mutations in specific 
genes which are available to purchase. This includes lines containing nonsense mutations in 
the orthologues of WFS1, the gene responsible for WS.  
The zebrafish genome contains a number of duplicated genes with an average of 2.28 
zebrafish genes for every human orthologue (Howe et al., 2013). This was due to a genome 
duplication specific to the ray fin fish species approximately 340 million years ago (Meyer 
and Schartl, 1999; Howe et al., 2013). It has been observed that these duplications have 
diverged in expression and when a number of gene functions were tested a quarter had 
diverged in function, through changes in protein domains or subcellular localisation (Kassahn 
et al., 2009). Duplicates were also more likely to be involved in the following pathways: 
signalling, transcription, calcium ion transport, and metabolism; which WFS1 is known to be 
involved in (Kassahn et al., 2009). It is possible that a divergence in function has occurred in 
wfs1.  
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In order to determine if wfs1a or wfs1b may be a truer representation of the disease, their 
expression and role in the unfolded protein response were determined by assessing a range 
of WS-like phenotypes. 
4.2 Confirmation of Knockout Sequences  
The transgenic lines purchased from the EZRC were sent as a heterozygote outcross of F3 
outcrossed mutants. The F4 generation were in crossed to create a stable line of mutants; 
these fish were further in crossed and outcrossed to produce further generations. Knockout 
zebrafish were fin clipped and sequenced to confirm they carried the mutation, for both 
wfs1a and wfs1b knockouts.  
In wfs1a knockouts the mutation is in exon 9 and the 692nd amino acid where a G>A 
mutation causes a premature stop codon: TAG. An example of wild type and homozygote 
knockout sequences can be seen in Figure 4.1.  
 
Figure 4.1. The wfs1a gene with wfs1a knockout mutation. A schematic of the wfs1a gene 
was designed showing coding (red) and non-coding exons (white), the size of the gene and 
location of nonsense mutation. Electropherogram of wild type and knockout mutations. 
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In wfs1b knockouts the mutation is in the final exon (exon 8) and the 493rd amino acid 
where a G>A mutation causes a premature stop codon: TGA. An example of wild type and 
homozygote knockout sequences can be seen in Figure 4.2.  
 
 
Figure 4.2 The wfs1b gene with wfs1b knockout mutation. A schematic of the wfs1b gene 
was designed showing coding (blue) and non-coding exons (white), the size of the gene and 
location of nonsense mutation. Electropherogram of wild type and knockout mutations. 
With confirmation of the knockout sequences in zebrafish it was important to look at the 
expression and molecular mechanism of both wfs1 homologues in zebrafish. 
4.3 Expression of wfs1a/b 
The expression was determined in embryos and a number of adult tissues by RT and qRT-
PCR. The wfs1b expression in embryos appears at the 1 cell stage suggesting possible 
maternal expression and is constitutively expressed. wfs1a expression begins at a later time 
point and expression seems to be altered through development. In adults cDNA was 
analysed from the eyes, brains, spines and muscle of control zebrafish (Figure 4.3B). wfs1a 
expression appeared higher in muscle compared to the other tissues as quantified by qRT-
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PCR in Figure 4.8C. This finding was confirmed to show that expression of wfs1a in muscles 
was far higher than other tissues and wfs1b slightly lower. This suggests a specific tissue 
localisation of wfs1 homologues in wfs1 that may explain some differences noted between 
the two knockout models.  
 
Figure 4.3 Expression of wfs1 in embryonic and adult zebrafish. A: Embryonic expression of 
wfs1. B: Adult tissue expression of wfs1. Zebrafish cDNA generated from RNA isolated by 
TRIzol and RNeasy kit. PCR primers wfs1aq, wfs1bq1 and β-actin from Table 2.5-2.6. 1% 
agarose gel and run against hypperladder IV (bioline) and run at 100V for 30 minutes and 
visualised using UV imaging on a GelDoc-IT Imaging system (UVP). C: qPCR of wfs1 adult 
tissue expression. cDNA expression quantified by analysed on Bio-Rad CFX Manager and 
plotted mean +SEM using Graphpad Prism performed in triplicate. Significance determined 
by unpaired t-test ****p<0.0001 
4.4 UPR  
In WS the UPR is upregulated through the lack of regulation of ATF6. If the UPR is 
upregulated with wolframin to regulate ATF6 the pathway is left “on” causing an increased 
response to ER stress. To determine if this pathway may be upregulated in the zebrafish, the 
UPR was increased by heat shocking the zebrafish at 37°C. 
When zebrafish were heat shocked a number of the zebrafish appeared abnormal, (Figure 
4.4A) the wfs1a and wfs1b knockouts had more severe phenotypes than the equivalent 
controls. Figure 4.4B shows the percentage of zebrafish that died within 24hours after heat 
shock at 6hpf. No significant differences were seen between deaths in the control and the 
heat shock control. As significant differences were seen between the heat shock wfs1a and 
wfs1b and their untreated equivalents (wfs1a p<0.01 and wfs1b p<0.001) In order to 
measure ER stress, the expression of BiP, the master regulator of ER stress, was quantified 
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by western blot. (Figure 4.4C). This showed an increase in BiP expression when heat shocked 
but also interestingly wfs1a BiP basal expression appeared higher than the control and 
wfs1b. 
 
Figure 4.4 The unfolded protein response in wfs1 knockout zebrafish. A: Representative 
images of abnormal zebrafish after heat shock compared to untreated. B: The Percentage of 
dead embryos at 24hpf heat shocked vs controls. 50 embryos treated or untreated were 
incubated in E3 overnight and dead determined at 24hpf. Data plotted mean +SEM using 
Graphpad Prism n=5. Significance determined by Two-Way ANOVA with Bonferroni multiple 
comparisons **p<0.01 ****p<0.0001.  
4.5 Expression of key UPR transcripts 
To determine if other UPR proteins were increased at basal levels four UPR markers ATF6, 
BiP, CHOP, and the spliced form of XBP (XBPs) expression was measured by qRT-PCR.  These 
represent the master regulator and parts of all 3 pathways of the UPR. All four UPR markers 
were slightly upregulated. However, only CHOP was significantly upregulated (p<0.01) in the 
wfs1a knockouts.  
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Figure 4.5 Expression of UPR markers in wfs1 knockouts relative to control. Expression of 
ATF6, BiP, CHOP and XBPs normalised to ef1α and β-actin (Primers in Table 2.5-2.6). 
Normalised relative expression values taken from Bio-Rad CFX Manager and plotted mean 
+SEM using Graphpad Prism n=3. Significance determined by Two-Way ANOVA with 
Bonferroni multiple comparisons **p<0.01. 
4.6 Developmental Delay  
The transgenic knockouts did not share the obvious phenotypes observed in the morpholino 
model, such as the curly tails and smaller eyes. wfs1 knockout zebrafish were imaged at time 
points within the first 3 days of development to determine if any gross abnormalities could 
be seen. Development at 30hpf in the wfs1b knockouts appeared to be delayed. This 
development seems to be much less prevalent at 50hpf with a slight change in head tail 
angle; this change disappeared by 80hpf, suggesting an initial delay in development which is 
rectified overtime. 
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Figure 4.6 Representative images of developing embryos over the first 80 hours of life. 
Control and wfs1 knockout fish imaged at 30, 50 and 80hpf on a Leica MZ16F 
stereomicroscope with a Leica DFC420 C camera attachment. 
4.7 Size difference in wfs1 knockouts 
As the knockout zebrafish appeared slightly shorter in length (Figure 4.6), this was also 
quantified at each timepoint (Figure 4.7). For both knockouts the zebrafish were significantly 
smaller at all 3 time points. At 30hpf wfs1a knockouts are significantly shorter than controls 
and wfs1b knockouts are significantly shorter than both p<0.001. At the 50hpf time point the 
wfs1b knockouts have caught up with wfs1a but the significant difference remains when 
comparing the knockouts and controls for the remaining timepoints. 
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Figure 4.7 Zebrafish length during embryonic development. A: Zebrafish length at 30hpf. B: 
Zebrafish length at 50hpf. C: Zebrafish length at 80hpf. Images from Leica MZ16F 
stereomicroscope with a Leica DFC420 C camera attachment measured using ImageJ and 
plotted mean ±SEM using Graphpad Prism n=10. Significance determined by One-Way 
ANOVA with Bonferroni multiple comparisons **p<0.01, ***p<0.001. 
4.8 Ears 
On closer inspection at 72hpf the zebrafish otoliths in the zebrafish ear appeared to be 
slightly smaller with a few otoliths not developing in the wfs1b population (Figure 4.8A). This 
was quantified by measuring the size of the otoliths (Figure 4.8B). The quantification showed 
significantly smaller otoliths were found in both wfs1a and wfs1b knockouts. However, this 
was found in the minority of knockout zebrafish, when images were screened for 
abnormalities, 40.74% of wfs1a and 37.04% of wfs1b zebrafish ears could be easily identified 
as “abnormal” (Figure 4.8C).   
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Figure 4.8 Abnormalities in wfs1 knockout zebrafish otoliths. A: Images of abnormal 
otoliths in wfs1 knockouts compared to controls at 72hpf. Images from Leica MZ16F 
stereomicroscope with a Leica DFC420 C camera attachment. B: Otolith Area measurements. 
On Imagej circles were drawn round each otolith and the area measured. Bar graph plotted 
mean +SEM using Graphpad Prism n=25. Significance determined by One-Way ANOVA with 
Bonferroni multiple comparisons *p<0.05. C: Percentage of zebrafish that had abnormal 
otoliths by eye. Zebrafish images were assessed by eye for normal and abnormal otoliths this 
was plotted on a stacked bar graph using Graphpad Prism n=25. 
 
4.9 Weights of Adult Fish 
The adult wfs1 knockout fish had no obvious distinct phenotypes. At 4 month and 12 month 
endpoints, zebrafish were euthanized and weighed prior to dissection. At 4 months of age 
both the wfs1a and wfs1b knockouts had no significant differences from the control fish. 
However, at 12 months wfs1b zebrafish were significantly heavier than control (p<0.001) 
and wfs1a fish (p<0.05). Zebrafish weights were not controlled for population density but it 
was decided to observe movement in adult zebrafish to determine if activity levels were 
resulting in heavier zebrafish. 
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Figure 4.9 Weights of zebrafish at 4 and 12 months of age. A: Weight of zebrafish at 4 
months of age. Control n=5 wfs1a n=14 wfs1b n=14. B: Weight of zebrafish at 12 months of 
age. Control n=9 wfs1a n=12 wfs1b n=9. Significance determined by One-Way ANOVA with 
Bonferroni multiple comparisons *p<0.05 ***p<0.001. Data plotted mean ±SEM using 
Graphpad Prism 
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4.10 Adult Movement 
 
Figure 4.10 Movement tracking of adult zebrafish. A: Representative 1 minute traces of 
zebrafish swimming made in ImageJ using the trackmate plugin. B: Distance travelled by 
zebrafish. Displacement values per frame from Trackmate were added together to 
determine the total distance travelled. Data plotted mean ±SEM using Graphpad Prism. 
Significance determined by One-Way ANOVA with Bonferroni multiple comparisons 
***p>0.001, ****p>0.001. Example video can be found in Supplementary evidence 1 
Adult zebrafish were moved to a tank underneath a video camera and movements recorded 
after 3 minutes of acclimatisation for a period of 1 minute. This showed significant 
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reductions in movement for wfs1b knockouts compared to controls p<0.001 with a 4000mm 
change in total movement. The wfs1b knockouts were stationary for the majority of the time 
period. Freezing bouts can be considered a marker for anxiety in zebrafish, leaving the 
possibility that lower mobility could be due to stress rather than immobility. 
4.11 Embryonic Lethality/ Fertility 
An observation was made that a number of embryos were not surviving to 24hpf. Further 
investigation revealed the number of unfertilised embryos increased in wfs1b knockout 
zebrafish. As reduced fertility has been shown in WS, the fertility of the knockout models 
was assessed. In order to quantify this, 50 random embryos were collected and the number 
of embryos that did not survive 24 hours were recorded (Figure 4.11A). This showed a 
significant increase of unfertilised embryos in wfs1b knockouts, suggesting a fertility 
problem. It may be possible that this could have been due to fertilised embryos dying within 
the first 24 hours. To determine if this was the case, eggs were collected at 8hpf and 
embryos that were likely unfertilised were removed. The number of embryos dying in the 
first 24hpf could then be quantified. Although this was slightly increased with a difference of 
5.8% between fertilised control and fertilised wfs1, this was not significant. The difference in 
the randomly selected embryos was higher at 24.34%. The difference in fertilised embryo 
death does not account for the full difference suggesting wfs1b knockouts are less fertile.  
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Figure 4.11 Fertility of wfs1 knockout zebrafish. A: Percentage of randomly selected 
embryos at 24hpf (n=9). B: Percentage of selected fertilised embryos dead at 24hpf (n=5). 50 
random or fertilised embryos were place in E3 medium, left overnight and the dead 
determined in the morning. Data plotted mean ±SEM using Graphpad Prism. Significance 
determined by One-Way ANOVA with Bonferroni multiple comparisons **p<0.01.   
As the wfs1b knockout zebrafish reach 9 months the fertility drops further. A Significantly 
increased number of wfs1b embryos are infertile (control p<0.001 wfs1a p<0.01). wfs1b 
males and wfs1b females were outcrossed to control lines and the fertility of these embryos 
measured. The wfs1b males had a significantly increased number of dead embryos at 24hpf 
(control p<0.0001 wfs1a p<0.001).  
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Figure 4.12 Fertility of wfs1 knockout zebrafish. A: Percentage of randomly selected 
embryos at 24hpf  produced by adults over 9 months (n=9). B: Percentage of randomly 
selected embryos at 24hpf  produced by adults over 9 months with wfs1b knockouts 
outcrossed to controls (control n=9, wfs1b heterozygotes n=7). 50 random or fertilised 
embryos were place in E3 medium, left overnight and the dead determined in the morning. 
Data plotted mean ±SEM using Graphpad Prism. Significance determined by One-Way 
ANOVA with Bonferroni multiple comparisons **p<0.01, ***p<0.001 and ****p<0.0001.   
A knockout model carrying both wfs1a and wfs1b mutations were bred. This would create a 
line of double knockout fish that could be used for future experiments. When wfs1ab 
heterozygotes were crossed one double knockout mutant survived to adulthood which was 
completely infertile. 
 
Figure 4.13 Double Knockout Mutant Sequencing. Chromatogram of reverse primer 
sequencing of wfs1a and wfs1b mutations. Sequencing of PCR product by Eurofins. 
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4.12 Blood Glucose 
Blood glucose regulation is tightly controlled under normal conditions. Blood glucose of 
zebrafish at 10 months of age was determined from control and wfs1b knockout zebrafish. 
The blood glucose in overnight fasted zebrafish was significantly lower in wfs1b knockout 
zebrafish (p=0.0354). 
 
Figure 4.14 Blood Glucose Measurements. Control and wfs1b mutants were decapitated 
and the blood glucose measurements taken from heart using a Onetouch ultra glucose 
monitor. Data plotted mean ±SEM using Graphpad Prism. Significance determined by 
unpaired t-test p=0.0354. 
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4.8 Discussion 
Mutations in the zebrafish wfs1 genes were confirmed and a number of gross phenotypic 
abnormalities were assessed alongside the underlying expression and mechanism of wfs1 in 
zebrafish.  
Mutations in the wfs1 genes were confirmed by Sanger sequencing and nonsense mutations 
were described. Expression of wfs1a and wfs1b were quantified in wild type fish to 
determine if any differences could be seen between the two homologues. The wfs1a 
expression was variable in the first few days of zebrafish development, with a higher 
expression observed in the adult muscle tissue when compared to other tissues. Although 
expression of wolframin is found in the muscle of humans, there are a number of other 
tissues more relevant to the disease phenotype such as in the brain and retina (Schmidt-
Kastner et al., 2009; Uhlen et al., 2010; De Falco et al., 2012). In these tissues wfs1b 
expression is predominant which may account for many differences seen between the two 
gene knockouts. Wfs1b was also more constantly expressed at embryonic stages and also 
present at the 1 cell stage suggesting there is maternally translated transcript from wfs1b 
(Pelegri, 2003). This may be why a delay in development is observed in transgenic models, 
which was not observed in the morpholino model. Due to the divergence in expression, 
determining the subcellular localisation of wfs1a and wfs1b to see if they were localised to 
the ER would have helped determine the roles of wfs1 in comparison to humans. This was 
not possible due to the lack of specific wfs1 zebrafish antibody. However it was possible to 
determine functional changes by investigating UPR and ER stress pathways in WS. 
It was important to determine if wfs1 knockout fish were exhibiting similar molecular 
pathways to humans with WS. This would provide evidence to determine the accuracy of the 
model. The UPR is an important well characterised pathway in WS (Fonseca et al., 2005); to 
determine if the UPR was also affected in the zebrafish the fish were heat shocked to induce 
ER stress (Lam et al., 2013). The results observed were an increased death in the wfs1a and 
wfs1b knockouts suggesting increased apoptosis due to an increased ER stress response. In 
order to demonstrate the ER stress response had been upregulated, protein expression of 
the master regulator of the ER stress response (BiP) was measured and showed an increased 
expression upon heat shock. Interestingly BiP also appeared to be upregulated in wfs1a 
knockouts in untreated fish, which could suggest an increase in the wfs1a UPR proteins 
under unstressed conditions.  
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In order to monitor this, a number of proteins from the UPR were assessed in the knockout 
models by qRT-PCR. Although all 4 genes (ATF6, BiP, CHOP, and XBPs) showed slight 
increases in expression only CHOP was significantly upregulated (p<0.01) in the wfs1a 
knockouts. WFS1 regulates ATF6 at a protein level by targeting it for degradation (Fonseca et 
al., 2010), therefore looking at the protein expression of ATF6 would be a much more 
appropriate method for measuring ATF6 expression in wfs1 knockouts. However, when an 
ATF6 antibody was tested on zebrafish lysates no signal was detected as it was not zebrafish 
specific and zebrafish specific antibodies are limited.  
With the zebrafish knockouts showing changes in one of the major pathways of WS, the 
UPR, the gross morphology of the fish was checked for any phenotypic markers of WS. The 
zebrafish were imaged for each of the first three days of development, this showed changes 
in the wfs1b knockouts showing a delay in development at 30hpf. This seemed to be less 
obvious at 50hpf with no differences observed at 80hpf. A delay in growth of neurons in 
Wfs1 knockout rats has been described previously and may be a reason developmental delay 
is being observed (Cagalinec et al., 2016). These differences were quantified by measuring 
the size of the fish at each time point, which showed wfs1a, and wfs1b knockouts to be 
significantly smaller than the controls at all time points. An additional observation at 30hpf 
was a much smaller wfs1b fish, significantly smaller than the wfs1a knockouts. These fish 
caught up to the wfs1a knockouts by 50hpf but stayed smaller than control zebrafish. This 
suggests that there was an initial developmental delay. However, at the 50hpf time point the 
zebrafish are no longer behind in terms of staging but are slightly smaller. As impaired cell 
cycle progression has been observed in WFS1 knockout cells (Yamada et al., 2006; Gharanei 
et al., 2013), this can explain the molecular mechanism seen in the initial delay in 
development. As no antibody exists for the p21 protein implicated in this process for 
zebrafish this was not tested for. 
The zebrafish ears also appeared to show a difference in wfs1 knockouts. The zebrafish ear is 
comparable to other vertebrate inner ears (Whitfield, 2002). As patients in WS suffer 
sensorineural deafness, the inner ear is all that is needed to model sensorineural deafness in 
WS. A number of smaller or missing otoliths were seen in the wfs1 knockouts which were 
shown to be significantly smaller than the controls. As the otoliths are formed by cilia 
moving Ca2+ together there may be a neuronal issue causing this, which may overlap with 
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the developmental delay. As WS is a progressive disease it was also important to determine 
if the adults showed any WS phenotypes.  
The wfs1 knockouts were grown to end points at 4 and 12 months; at these time points, 
prior to dissection, fish were weighed to determine if there was any weight difference 
between controls and knockouts. At 4 months no difference in size was seen, at 12 months 
wfs1b zebrafish were significantly heavier than both controls and wfs1a knockouts. This may 
have been due to non-population matched tanks resulting in a higher amount of food thus 
bigger fish in the wfs1b zebrafish. It could also be due to inactivity of the wfs1b fish. To test 
this, zebrafish movement was recorded over a one-minute period. wfs1b knockouts were 
observed moving significantly less than the controls and wfs1a knockouts, suggesting the 
possibility that wfs1b fish were less active and therefore larger at 12 months. It was however 
noted that wfs1b knockouts during this experiment did not move at all for large periods of 
time, this was not obvious when observed in their own tanks. Freezing bouts have been 
linked to increased anxiety (Egan et al., 2009). As anxiety is observed in patients with WS 
(Urano, 2016) a number of zebrafish were placed  in a tank together (supplementary video 
2), as zebrafish are more comfortable as a group. The zebrafish showed no freezing bouts 
suggesting wfs1b zebrafish were more anxious than controls and wfs1a knockouts when 
isolated.  
The fertility of adult fish also seemed to be affected in wfs1b knockouts, with the number of 
unfertilised embryos significantly increased. This is another feature seen in knockout mice 
and patients with WS (Noormets et al., 2009; Haghighi et al., 2013), confirming a number of 
phenotypes observed in the zebrafish match a number of patient conditions (Urano, 2016). 
When the older >9month adults were outcrossed with controls they were able to produce 
viable offspring. However, the wfs1b males had a significantly higher percentage of 
unfertilised offspring. This suggests that although the fertility is affected in both genders, the 
male infertility may be more severe. In mouse knockout models, sperm morphology and 
reduced number of spermatogenic cells was hypothesised to be the cause of infertility 
(Noormets et al., 2009). However, infertility is reported in both male and female patients 
(Urano, 2016). It could be possible that something more general is affecting the fertility such 
as Ca2+ dynamics or mitochondrial dysfunction: two processes implicated in WS that are 
important in the process of fertilisation (Osman et al., 2003; Zatyka et al., 2015; Cagalinec et 
al., 2016).     
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Although a number of patient symptoms have been replicated in the zebrafish, the majority 
were seen in wfs1b zebrafish and not wfs1a. This may be partially due to the expression of 
wfs1a being less prevalent in the eyes and neural tissue, which would be more histologically 
relevant in WS. It may also be due to differences in affected pathways. Although the UPR is 
the best characterised pathway in WS, proinsulin modification and Ca2+ flux has also been 
shown to be implicated, although the underlying role of Ca2+ is much less well understood 
(Osman et al., 2003; Gharanei et al., 2013), it is possible these roles may differ between the 
two knockouts.  
Overnight fasted blood glucose was significantly lower in wfs1b knockouts. Blood glucose 
homeostasis is disrupted in diabetes mellitus due to the inability to synthesise insulin and 
correctly store glycogen (Eames et al., 2010). Zebrafish had to be culled for the reading of 
blood glucose which resulted in low number of replicates. The knockout zebrafish had a 
significantly lower blood glucose suggesting problems with homeostasis. wfs1b morpholino 
injected fish had a reduction in β-islet cells, which would suggest insulin production is the 
cause of this blood glucose reduction (O'Hare et al., 2016). However, in diabetes mellitus we 
would expect an increase in fasted blood glucose which is not observed in wfs1 zebrafish.  
The wfs1 knockout models had a number of markers that shared similarities to WS in 
humans, such as infertility and features of anxiety. However, Optic  Atrophy remains a 
significant issue for patients with WS as it currently has no available therapeutic 
management options Therefore in the following Chapter, this phenotype is discussed in 
detail in the zebrafish to determine whether the fish are a good model for all DIDMOAD 
characteristics.  
4.9 Conclusions 
The genetic knockout model of wfs1a and wfs1b was confirmed by Sanger sequencing. The 
models expression and tissue specificity was confirmed for the two genes. The models were 
compared to known functions in patients and other models with an increased response to 
heat shock and a number of phenotypic markers of WS. Fertility, anxiety and length were all 
affected in the zebrafish models, mirroring a number of phenotypes observed in patients. 
The wfs1b knockout act as a better representation of the phenotypes expressed in WS and 
had a more representative expression pattern.   
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Further work would be required to fully examine the anxiety by examining the shoaling, 
stress hormones or other markers of anxiety in the fish (Stewart et al., 2012). Determining if 
the zebrafish have diabetes mellitus could be attempted with glucose tolerance test or 
histology of the liver to examine the pancreatic islet cells. p21 or cell cycle expression 
markers could be examined in greater detail to determine the difference in cell cycle 
regulation in the development of WS. 
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Chapter 5: Assessment of Retinal Structure and Function in wfs1 Mutant 
Zebrafish Models  
5.1 Introduction 
In human retinal cells, expression of wolfram is observed in retinal ganglion cells (RGCs), 
optic axons and the proximal optic nerve and also expressed in retinal pigment epithelial 
(RPE) when detected in culture (Schmidt-Kastner et al., 2009). In the mouse retina wolframin 
was localised to amacrine, Müller cells, photoreceptors and horizontal cells (Kawano et al., 
2008), the authors were unable to conclude if the differences observed were due to tissue 
preparation or interspecies variation (Schmidt-Kastner et al., 2009).  
Optic atrophy (OA) is the second most common symptom in WS occurring in 82.14% of 
patients (de Heredia et al., 2013). OA is the end point of any condition that leads to the 
death of retinal ganglion cells (RGCs) or the optic nerve, also referred to as optic neuropathy.  
Patients with WS who develop OA presented with decreasing visual acuity and loss of colour 
vision, this progressed to a visual acuity of 6/60 in the majority of patients at varied rates of 
progression (Range 1-25 years median 8 years) (Barrett et al., 1997). 58% of patients will 
develop OA as the second clinical symptom, which begins to develop in the early second 
decade. The probability of having developed OA before 26 years is 90% (de Heredia et al., 
2013). Alongside the reduced colour vision and visual acuity optic nerve atrophy, cataracts 
abnormal pupillary light reflexes, nystagmus, and visual fields defects have all been observed 
in WS patients (Hoekel et al., 2014). Although some patients have been observed with 
diabetic retinopathy, the majority will not have these symptoms suggesting this is an 
independent mechanism from the diabetes (Barrett et al., 1997).  
RGC loss is seen in patients with WS with loss of myelination in the optic nerve (Ross-
Cisneros et al., 2013). The loss of myelination in WS is predominantly seen in the 
papillomacular bundle which is also seen in LHON (Ross-Cisneros et al., 2013). The loss of 
these smaller axons is thought, in LHON, to be due to the large energetic demand in these 
axons, paired with a relatively low energetic potential (Pan et al., 2012). As WS optic nerves 
follow a similar pattern it is hypothesised that energy production may be a key feature of OA 
in WS (Ross-Cisneros et al., 2013). 
95 
 
One marker that appears to correlate with disease severity is retinal nerve fibre layer (RNFL) 
thickness, which demonstrates the importance the loss of RGCs has in the pathology of the 
disease (Hoekel et al., 2014). Alongside this they also described patients with no ocular 
phenotypes and a thinning of RNFL suggesting a possible developmental condition 
worsening later in life. This compliments the theory of brain developmental problems in WS 
discussed in Chapter 6 (Hershey et al., 2012; Hoekel et al., 2014).  
The wfs1 knockout zebrafish will be assessed histologically and functionally to determine if 
they show signs of OA, a key hallmark of WS. 
5.2 Embryo histology 
At 5dpf zebrafish were fixed, processed, paraffin embedded and sectioned at 4µm. H&E 
stained sections were assessed for any abnormalities. As no significant changes could be 
seen in the wfs1 knockouts and WS being a degenerative disease, aged zebrafish were also 
examined.  
 
Figure 5.1 5dpf retinal sections. Control, wfs1a and wfs1b knockout larvae at 5 days were 
paraffin embedded and sectioned a 4µm. Sections were stained using H&E and imaged on 
Axio Imager Z1 fluorescence microscope (Zeiss). Scale bar 50µm.  
5.3. Retinal Ganglionic Cell Count/Retinal Thickness 
Wfs1 knockout zebrafish were aged to 4 and 12 months and the number of RGCs were 
assessed. The images seen in Figure 5.2A are representative images of 4 month zebrafish 
retinas. At 4 months of age both wfs1a and wfs1b knockouts had a significantly lower 
number of RGCs per 100μm (p<0.005 One way ANOVA with Bonferroni's Multiple 
Comparison Test). At 12 months of age the numbers of RGCs were also assessed. As the 
control values were not normally distributed Mann Whitney tests were performed between 
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controls and knockouts. There were significantly less RGCs in the knockouts (wfs1a p=0.0104 
and wfs1b p<0.0001) as seen at 4 months. The RGC count in the wfs1b (18.99 RGCs) 
knockouts was also significantly lower than the wfs1a (21.67 RGCs, p=0.0036 unpaired t-
test). As the RGC number was affected the effect of this on the optic nerve was assessed to 
determine if this was also impacted. 
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Figure 5.2 Adult Zebrafish Retinas and RGC counts. A: Representative sections of control 
and knockout retinas. Fixed and decalcified zebrafish heads were paraffin embedded and 
sectioned a 4µm. Sectioned were stained using H&E and imaged on Axio Imager Z1 
fluorescence microscope (Zeiss). Scale bar 100µm. Six 100μm2 areas along the retina were 
selected and the RGCs counted. B: RGC count per 100μm at 4 months of age control n=8 
wfs1a n=10 wfs1b n=9. C: RGC count per 100μm at 12 months of age, n=9. Graphs plotted ± 
SEM, significance was calculated by One-way ANOVA with Bonferroni’s multiple comparison 
tests. As control results were not normally distributed in Figure 6.3C Mann Whitney test 
were used vs control unpaired t-test wfs1a/b  *p<0.05 **p<0.01, ***p<0.005 and 
****p<0.001. 
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5.4 Optic Nerve Width 
The optic nerve measurements were taken from sections of 4 month zebrafish retinas when 
the optic head was visible. No significant differences were seen (One-way ANOVA with 
Dunnett's Multiple Comparison Test) although the wfs1a and wfs1b knockouts had higher 
means (control 129.7μm, wfs1a 139.8μm and wfs1b 148.7μm). Due to the variability in data 
generated using this method, a different approach to measuring optic nerves was employed. 
 
Figure 5.3 Optic Nerve Measurments at 4 months. Fixed and decalcified zebrafish heads 
were paraffin embedded and sectioned a 4µm. Sectioned were stained using H&E and 
imaged on Axio Imager Z1 fluorescence microscope (Zeiss). Retinal sections containing the 
optic head had the optic nerve width measured at the RPE layer (Figure 6.1). Graphs plotted 
± SEM, significance was calculated by One-way ANOVA with One way ANOVA with 
Bonferroni’s multiple comparison tests. Control n=4, wfs1a n=11 and wfs1b n=9. 
5.4.1 Optical Coherence Tomography (OCT) 
In order to get a more accurate representation of optic nerves in wfs1 knockout zebrafish 
OCT was used (Figure 5.4). This was performed at 12 months and creates a cross section of 
live zebrafish retinas. The area in the middle with no layers represents the optic nerve; in 
wfs1b knockouts it was visibly smaller.  
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Figure 5.4 OCT representative images of 12 month zebrafish. OCT B-scan images showing 
Retinal cross sections of live 12 month zebrafish. Images taken on a Bioptigen Envisu R2200 
SDOIS. 
It was important to ensure the loss of RGCs and optic nerve had a functional effect on 
zebrafish vision.   
5.5 Optokinetic Response (OKR) 
To determine potential functional defects in the vision of knockout fish, the OKR was 
measured. This counts the number of zebrafish eye movements in response to a moving 
black and white grate. One eye movement can be seen in Figure 5.5 with a video in 
supplementary evidence 3.  
 
Figure 5.5 Eye movement during OKR experiment.  
Videos were recorded at 4 (Figure 6.6) and 12 (Figure 6.7) months and at a slower and faster 
speed. At 4 months there were significantly less eye movements in the wfs1b knockouts at 
both 8 (p>0.05) and 16rpm (p>0.01). The wfs1a knockouts at 8rpm had significantly less eye 
movements per minute but no change at 16rpm. This is not the expected outcome as the 
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quicker revolutions should be the first to demonstrate a difference, the data points are 
widely spread in the wfs1a knockouts compared to the control and wfs1b groups.  
 
 
Figure 5.6 OKR Results of 4 Month Zebrafish. Videos were recorded of fish eye tracking and 
movements manually counted. Graphs plotted as mean ± SEM, significance was calculated 
One way ANOVA with Bonferroni’s multiple comparison tests *p<0.05 and**p<0.01. 
At 12 months the wfs1a zebrafish have no significant difference from the controls at 8 or 
16rpm suggesting the 4 month results may have been an anomaly. However, the wfs1b 
knockout zebrafish have significantly less eye movements with a mean of 50 under both 
circumstances. One wfs1b zebrafish did not move at all suggesting it may be completely 
blind.   
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Figure 5.7 OKR Results of 12 Month Zebrafish. Videos were recorded of fish eye tracking 
and movements manually counted. Graphs plotted as mean ± SEM, significance was 
calculated One way ANOVA with Bonferroni’s multiple comparison tests *p<0.05. 
5.6 Electron Microscopy 
The 12 month adult optic nerves were analysed for transmission electron microscopy (TEM) 
to look at myelination of the nerves and to look at mitochondrial structure and ER contacts 
(Newcastle University Electron Microscopy Research Services). When looking at the optic 
nerves under the electron microscope the fixation was not of an appropriate standard to 
look at in detail due to mitochondrial ultrastructure and ER contacts. This meant that no 
useful information could be taken from these experiments.  
 
Figure 5.8 TEM images of 12 month zebrafish Optic Nerves. TEM imaging performed by 
Newcastle University Electron Microscopy Research Services. Optic nerves fixed in 3% 
glutaraldehyde. Scale bar 100nm. 
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5.7 Discussion  
To determine the zebrafish models suitability as a model of WS, optic atrophy (OA) was 
assessed. As WS is multifaceted with severities and phenotypes varying with mutations, one 
of the more common phenotypes was chosen to look at in greater detail. 82.14% of patients 
develop OA within the disease course (de Heredia et al., 2013). Although diabetes mellitus is 
more common with 98.21% of patients developing it (de Heredia et al., 2013), with 
therapeutic screening in mind, OA cannot be managed in the same manner as diabetes so it 
was important the model matched this phenotypically. The zebrafish eye development, 
structure and function are comparable to the human eye making zebrafish an excellent 
model for OA (Richardson et al., 2017).  
Characterisation of optic atrophy in the wfs1 zebrafish was carried out by: histological and 
functional assessments of the zebrafish retinas. As OA is a progressive disorder, a number of 
time points, embryonic, 4 months and 12 months, were analysed. At the embryonic stage 
histological sections were taken at 5dpf however, these were not quantified as orientation 
of larvae was not consistent.  
In the adult fish loss of RGCs was observed in both wfs1a and wfs1b knockouts at both 4 and 
12 months. At 4 months the RGC count was wfs1a-25.51 and wfs1b-26.27RGCs which was 
significantly lower than the controls 33.59RGCs. At 12 months however the wfs1b count had 
also dropped to be significantly lower than the wfs1a knockouts. This suggests a more 
severe retinal degeneration in the wfs1b knockout zebrafish at 12 months. As there was a 
loss of RGCs it was expected that a thinning of the optic nerve would be seen. When 
measuring the optic nerve width in retinal slices we looked to find the optic head and 
measure from there (Pei et al., 2010). The measurements of the optic nerve were variable, 
mainly due to the orientation of the fish, which, if slightly different, would change the 
cutting angle of the retina; this could lead to varying sizes of the optic nerve at the optic 
head. As the zebrafish contains no macular this should not have affected the RGC counts. 
OCT was used to create cross sections of live zebrafish retinas (Toms et al., 2017) Where the 
size of the optic nerve was visible. The size had visually decreased in the wfs1b knockouts at 
12 months which would correlate with the loss of RGCs. Retinal nerve fibre layer (RNFL) 
thinning is a hallmark characteristic of OA in WS (Hoekel et al., 2014) and the localisation of 
wolframin in human retinas is in the RGCs and optic nerve, and some expression seen in the 
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RPE (Schmidt-Kastner et al., 2009). The zebrafish, especially wfs1b, models the thinning optic 
nerve and loss of RGCs, which is promising for a model of OA for WS.  
To see if the histological changes were having any effect on the vision of the zebrafish, OKR 
experiments were performed. The OKR tests the zebrafish eye movements in response to a 
moving black and white grate (Cameron et al., 2013). Eye movements for wfs1b knockouts 
were consistently, at both time points and speeds, significantly lower than the controls. The 
fact that at 12 months some of the wfs1b zebrafish made no eye movements suggests that 
some may even be completely blind at 12 months. The wfs1a knockout zebrafish only had a 
significantly lower number of eye movements at 4 months at 8rpm (p>0.05). It would be 
expected for the zebrafish to show a more severe phenotype at with the zebrafish, unable to 
distinguish between the separate bands of the grating. It would also be expected that since 
the wfs1a and wfs1b knockouts had similar reductions in RGCs they would have a similar loss 
in vision. The wfs1a results at 4 months had a much higher variation compared to the 
controls and wfs1b knockouts which highlights the possibility that some experimental error 
may have played a role in the wfs1a results. There could also be downstream complications 
as wolframin is expressed in the optic nerve (Schmidt-Kastner et al., 2009) so complications 
in the neurons such as Ca2+ dysfunction, implicated in WS (Takei et al., 2006), may play a role 
in signalling.  
Expression may also play a role in the difference between the two knockout models. It was 
described in Chapter V that wfs1a expression is lower in the eyes compared to wfs1b. There 
may even be differences in expression between retinal cell types, as interspecies variation of 
expression in other retinal tissue, such as the Müller glial cells and neurons of the INL have 
been reported in the mouse that was not in the human retina (Kawano et al., 2008; Schmidt-
Kastner et al., 2009). This could not be detected by PCR of the whole tissue. There is no 
antibody available for expression studies therefore it may be possible to perform in situ 
hybridisation to determine cell specific expression. It is also possible that the initial changes 
in RGC counts are caused by a neuronal developmental condition which progresses to a 
neurodegenerative phenotype, accounting for differences seen between the models. 
Neuronal development has been described as being affected in WS so may possibly explain 
differences in the early models (Hershey et al., 2012; Cagalinec et al., 2016). RNFL thickness 
has also been described as thinner even in patients with mild or no visual symptoms (Hoekel 
et al., 2014). This can explain why we see 4 months wfs1a knockout zebrafish with a loss of 
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RGCs but no loss of visual acuity. The difference may come later which we see in wfs1b 
knockouts as they become more degenerative by 12 months. 
Patients with OA tend to develop this within the first or second decade of life (de Heredia et 
al., 2013). OA progress to a visual acuity of 6/60 or less in 35/45 patients (with a median 
time  of 8 years) (Barrett et al., 1997). Although the wfs1b zebrafish appear to lose a 
significant ability to distinguish a moving grate at 12 months, this is significantly longer in 
comparison for a zebrafish lifespan, in the wild zebrafish tend to live for 1 year and in 
captivity approximately 2 years. One explanation for this delay in onset may be the 
regenerative capacity of zebrafish RGCs (Sherpa et al., 2008), this regeneration could be why 
we do not see a complete loss of vision in the wfs1b zebrafish. Another explanation for this 
could be the tissue differences between humans and zebrafish. It was hypothesised that the 
unmyelinated axons of the RGCs prior to the lamina cribrosa  with the high energy demand 
and high mitochondria concentration may be playing a key role in OA in WS (Schmidt-
Kastner et al., 2009). As zebrafish RGC optic fibres are fully myelinated this might explain 
why we see a less obvious phenotype in the wfs1 knockouts (Chhetri et al., 2014a).  
As myelination and mitochondrial dysfunction are thought to be affected in WS (Ross-
Cisneros et al., 2013; Cagalinec et al., 2016; Lugar et al., 2016) electron microscopy was 
performed on the 12 month zebrafish optic nerves to look at myelination and mitochondria 
ultrastructure and ER connections. This experiment did not work due to poor tissue 
preservation as the fixation was poor quality possibly due to the myelin providing a barrier 
to the fixative. This should be performed again but using a perfusion fixation to deliver the 
fixative to ensure higher quality fixation. Unfortunately due to time constraints this was not 
possible during this PhD. 
Of the two zebrafish models the wfs1b knockout better resembled the OA phenotype seen 
in WS patients. The wfs1b knockout demonstrated a significant loss of RGCs and loss of 
visual function overtime. This again follows a recurring theme that wfs1b knockouts may 
slightly better model WS than wfs1a. The embryos also had slight changes in function which 
highlighted a possible developmental phenotype even if a change in structure was not 
obvious. Neuronal function and development alongside mitochondrial dysfunction are key 
elements that require further investigation from these results.  
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5.8 Conclusions 
The wfs1b knockout model was a better representative model of OA in WS. A progressive 
loss of RGCs, thinning of the optic nerve and a functional loss of visual acuity was observed 
in this model by 12 months of age.  The wfs1a knockout model developed a milder OA 
phenotype with a lower RGC loss and smaller changes in visual acuity. 
Future work should examine the role of myelin and the mitochondrial function in the optic 
nerve. The mitochondrial connection to the endoplasmic reticulum could be examined using 
3d-SEM with improved fixation of the zebrafish eyes. This would allow for a detailed picture 
of the optic nerve which myelination could also be measured. Expression profiles between 
the wfs1a and wfs1b knockouts would also be interesting to determine why wfs1a 
knockouts show a milder phenotype. 
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Chapter 6: Assessment of Early Neuronal Development in wfs1 Mutant 
Zebrafish Models 
 
6.1 Introduction 
WS is known to be a neurodegenerative disease (Grosse Aldenhovel et al., 1991; Barrett et 
al., 1995; Kinsley et al., 1995), this tends to be the cause of death in patients due to brain-
stem atrophy leading to central respiratory failure (Barrett et al., 1995). A number of other 
neurological abnormalities have been described in patients with WS such as cerebellar ataxia 
and myoclonus (Barrett et al., 1995) and alongside this patients are more likely to suffer 
from psychiatric disorders (Swift et al., 1991).  
The underlying mechanism of neurodegeneration in WS is not fully understood. A recent fly 
knockdown suggested wolframin may be having a protective role against stresses involved 
with aging in neurons (Sakakibara et al., 2018). It has also been suggested that mitochondrial 
dysfunction may be important in neuronal degeneration. Whole transcriptome expression 
profiling of WFS1 siRNAs HEK cells showed a number of changes in genes related to 
mitochondrial dysfunction (Koks et al., 2013). Mitochondrial dysfunction and energy 
production is also thought to be disturbed in the optic nerve causing the degeneration of the 
smaller neurons in the optic nerve (Ross-Cisneros et al., 2013). Mitochondrial dysfunction 
was also observed in cultured mouse neurons with trafficking and mitophagy changes which 
was hypothesised to be caused by changes in Ca2+ homeostasis (Cagalinec et al., 2016). 
These neurons had a slight delay in growth suggesting wolframin may have a role in 
neuronal development. 
Atrophy of the optic nerves, chiasm, cerebellum and brainstem were described in 
postmortum patients of WS (Barrett et al., 1997). However, as another factor neuronal 
development has more recently been implicated in WS. The brain stem and cerebellum due 
to the nature of their development are thought to be more susceptible to changes in general 
neurodevelopment (Barkovich et al., 2009). The brainstem and cerebellum volume were 
both observed as significantly smaller in WS patients, independent of disease progression 
(Hershey et al., 2012).  This alongside the reduced growth in isolated neurons suggests WS 
has both a developmental and a degenerative component to consider. 
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Although a number of changes in size can be observed in the zebrafish brain, the overall 
organization of major components of the zebrafish brain are comparable to human brains 
(Tropepe and Sive, 2003). Although the behaviours may not be as complex as rodent models 
there are a number of integrated neurological functions that affect behaviour (Lieschke and 
Currie, 2007). This allows for basic functional tests alongside histological to determine if 
altered neurogenesis or degradation are affecting animal behaviour.  
Development of motor neurons in the zebrafish tail stems from three cell bodies in the 
spinal cord: Caudal, Middle and Rostral Primary motor neurons (CaP, MoP and RoP)(Myers et 
al., 1986). These three bodies develop as described in Figure 6.1 to form functional motor 
neurons and neuromuscular junctions along the tail of the zebrafish. These neurons project 
from the spinal cord towards acetylcholine clusters (Panzer et al., 2005). 
 
Figure 6.1 Caudal, Middle and Rostral Primary motor neurons development over the first 
72 hours of zebrafish development. Neurons grow from neuronal body towards 
acetylcholine receptors (red circles) forming neuromuscular junctions.   
Neurogenesis is suspected to be affected in patients with WS. Using a zebrafish model of WS 
we can monitor the development of the brain and motor neurons to determine if there is a 
developmental aspect to this neurodegenerative disease.  
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6.2 Neuronal Development Delay 
24hpf zebrafish were immunostained using SV2 to visualise motor neurons and alpha 
bungarotoxin to visualise the acetylcholine receptors at the neuromuscular junctions. The 
motor neuron staining demonstrated differences in the wfs1b knockouts with a shortening 
of motor axons. This was quantified in Figure 6.2B, no difference was determined between 
control and wfs1a knockouts. Between the controls (79.86μm) and wfs1b (48.23µm) a 
significant difference was detected (p<0.001). A change was also observed between wfs1a 
and wfs1b knockouts (p<0.01).The alpha bungarotoxin staining although slightly fainter in 
the wfs1b knockouts clustered in the expected positions in all groups.  
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Figure 6.2 Motor neuron development at 24hpf. A: immunofluorescence of motor neurons 
and acetylcholine receptors. Motor neurons stained with SV2 in green, shorter axons are 
highlighted by white arrows; Acetylcholine receptors stained for alpha bungarotoxin in red. 
Max intensity projections imaged on Nikon confocal. B: Quantification of motor axon length 
at 24hpf. Data plotted mean ±SEM using Graphpad Prism n=9. Significance determined by 
One-Way ANOVA with Bonferroni multiple comparisons **p>0.01 ****p>0.0001.  
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To determine if this continued on through development motor neurons were stained again 
at 48hpf in Figure 6.3. At 48hpf the development of the motor neurons in wfs1b descended 
in the ventral direction to a similar position as the controls and wfs1a knockouts. When the 
length was quantified, no significant differences were measured. The next stage of 
development of the zebrafish motor neurons involves growth along the myoseptum this was 
imaged in Figure 6.4 to monitor any differences.      
 
Figure 6.3 Lateral motor neuron development at 48hpf. A: immunofluorescence of motor 
neurons. Motor neurons stained with SV2 in green. B: Quantification of motor neuron length 
at 48hpf. Data plotted mean ±SEM using Graphpad Prism n=3. Significance determined by 
Kruskal-Wallis test with Dunns multiple comparisons due to unequal variances. Max intensity 
projections imaged on Nikon confocal. 
The growth along the myoseptum is the next phase of growth as described in Figure 6.1. The 
axon growth along the myoseptum at 48hpf dobserved in Figure 6.4, appeared to be 
affected in both wfs1a and wfs1b knockouts. Although the majority of neurons have tracked 
into the correct positions there are gaps in the knockouts where there should be motor 
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neurons Figure 6.4 (marked by white arrows). Some staining can still be observed it may be a 
problem with axon branching in the development of the neurons being slightly delayed  
 
Figure 6.4 Motor neuron growth along the myoseptum at 48hpf. Immunofluorescence of 
motor neurons. Motor neurons stained with SV2 in green. White arrows indicate missing 
neurons. Max intensity projections imaged on Nikon confocal. 
Acetylcholine receptors were also stained at 48hpf. Neurons grow towards acetylcholine 
receptors clusters. At the position of the missing neurons there is no obvious bungarotoxin 
staining as seen in the other myosepta.   
 
Figure 6.5 Acetylcholine receptors along the myoseptum at 48hpf. Immunofluorescence of 
acetylcholine receptors. acetylcholine receptors stained with alpha bungarotoxin in red. 
White arrows indicate missing neurons. Max intensity projections imaged on Nikon confocal. 
Motor neuron development was observed at later timepoints to determine if this difference 
was corrected. 4dpf zebrafish were stained for motor neurons. At 4dpf the loss of axons 
along the myosepta had disappeared.  
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Figure 6.6 Motor neuron growth along the myoseptum at 4dpf. Motor neurons stained 
with SV2 in green. Max intensity projections imaged on Nikon confocal. 
 
Although staining of motor neurons showed no changes at 4 days, an acetylcholinesterase 
(AChE) assay was performed to determine if an overall change in neuronal population could 
be determined.  AChE is expressed in the CNS and has been observed in primary neurons of 
the zebrafish embryo (Bertrand et al., 2001; Behra et al., 2002). Measuring activity in 
homogenates of zebrafish embryos is an indirect way of measuring neural tissue. The 
knockout zebrafish both showed reductions in the amount of AChE activity at 3 and 5dpf 
(p<0.01 and p<0.0001 respectively). Only the wfs1b zebrafish had significantly reduced AChE 
activity at 4dpf.    
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Figure 6.7 Acetylcholine esterase assay of developing zebrafish larvae 2-5dpf. Protein 
quantified using BCA assay and the acetylcholine esterase activity measured from 10μg of 
protein using a Varioskan LUX plate reader. Repeat data normalised to control of 1st plate. 
Data plotted mean ±SEM using Graphpad Prism, n=6. Significance determined by One-Way 
ANOVA with Bonferroni multiple comparisons **p>0.01 ****p>0.0001. 
6.3 Zebrafish Brain Development and Degeneration 
To look at the brain development, zebrafish were grown in 1-Phenyl-2-thiourea (PTU), to 
stop pigment formation. As the zebrafish heads are transparent the brain can be viewed. 
Part of the cerebellum can be easily measured, highlighted by the white arrow in Figure 
6.8A. The area of the cerebellum was quantified by manually measuring on ImageJ. This 
showed a significant smaller area of cerebellum in wfs1b knockout zebrafish (p>0.05 against 
controls).  
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Figure 6.8 Brain development in wfs1 knockout zebrafish at 72hpf. A: Representative 
images of control and knockout brains viewed from overhead. Images from Leica MZ16F 
stereomicroscope with a Leica DFC420 C camera attachment. White arrow highlights the 
cerebellum in the control zebrafish. B: Quantification of zebrafish cerebellum area. Data 
plotted mean ±SEM using Graphpad Prism. Control n=5, wfs1a n=9 and wfs1b n=5. 
Significance determined by One-Way ANOVA with Bonferroni multiple comparisons *p>0.05 
and **p>0.01. 
The zebrafish brain also expresses AChE. Changes in brain AChE levels could provide an 
indirect measure of neurodegeneration in adult zebrafish as described in Figure 6.9. The two 
time points: 4 months and 12 months, showed a significant reduction of wfs1a and wfs1b 
AChE activity compared to controls (p<0.001 and p<0.0001). At 12 months wfs1a is no longer 
reduced in comparison to controls while wfs1b is significantly downregulated compared to 
controls (p<0.0001) and wfs1a (p<0.001). 
115 
 
 
Figure 6.9 Acetylcholine esterase assay on brains of 4 and 12 month zebrafish. Protein 
quantified using BCA assay and the acetylcholine esterase activity measured from 10μg of 
protein using a Varioskan LUX plate reader. Data plotted mean ±SEM using Graphpad Prism 
n=3. Significance determined by One-Way ANOVA with Bonferroni multiple comparisons 
***p>0.001 ****p>0.0001. 
 
6.4 Functional Neuronal Impairment 
To determine if the changes observed in neuronal development had a functional effect, two 
tests, spontaneous movement at 24hpf, and touch response at 48hpf, were carried out. The 
spontaneous movements of the wfs1b zebrafish were significantly higher compared to the 
controls and wfs1a knockouts (p<0.01). To determine if the wfs1b knockout embryos were 
moving due to delayed development, videos were recorded at 27hpf when the movement 
should stop. wfs1b knockouts continue to perform spontaneous movements when controls 
and wfs1a’s have ceased. 
At 48hpf the touch response showed a significant decrease in the distance moved by the 
wfs1b zebrafish as compared to the controls (p<0.01), with the majority of wfs1b knockouts 
hardly moving at all.  
116 
 
 
Figure 6.10 Functional assessment of neuronal development in developing zebrafish. A: 
Twitch response of zebrafish embryos at 24hpf, 15 embryos were recorded and the average 
movement per fish per minute calculated, control n=8 wfs1a n=6 wfs1b n=7. B: Image of a 
zebrafish moving within the chorion. C: Distance travelled following tactile stimulation: 
n=10. D: representative image of control vs wfs1b knockout zebrafish, red line represents 
distance travelled. Graphs plotted as mean ± SEM, significance was calculated by One way 
ANOVA with Bonferroni’s multiple comparison tests *p<0.05 **p<0.01. Videos of twitch and 
touch response in supplementary evidence 5 and 6. 
6.5 Muscle Structure 
Muscle structure was observed to determine that differences in movement were neuronal 
and not caused by defects of muscle function. At 48hpf zebrafish were subjected to 
phalloidin staining for F-Actin, this shows the muscle fibres in the zebrafish tail. No 
differences in gross muscle fibre architecture could be distinguished between the controls 
and the knockouts. 
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Figure 6.11 Muscle Fibre Immunostaining. F-actin stained using phalloidin to detect muscle 
fibres. Max intensity projections imaged on Nikon confocal. 
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6.6 Discussion 
Neuronal development has become a new area of interest for the function of wolframin. The 
zebrafish offers a unique opportunity to model neuronal development in WS. As the 
zebrafish develop externally and are transparent it allowed for whole mount 
immunostaining of neuronal development and functional testing on the earliest time points 
of development.  The wfs1 knockouts particularly the wfs1b knockouts showed significant 
reductions in neuronal development. 
At 24hpf there is a significant difference in length of the motor axons in wfs1b knockout 
zebrafish (p>0.001). The acetylcholine receptors develop in a similar pattern in all three 
conditions suggesting this is an axonal outgrowth defect rather than abnormal muscle 
development. The differences of length in the lateral growth of the motor neurons appear to 
be corrected at 48hpf.  The dorsal growth along the myoseptum is affected in both wfs1 
knockouts, with motor neurons not growing along a number of myosepta. The expression 
patterns of the mutated genes may be accounting for a difference between the two models, 
as described in Figure 5.3. This showed wfs1b was expressed from the 1 cell stage while 
wfs1a expression increased later; the expression was also lower in neural tissue in adults. 
This explains the obvious differences at 24hpf and why only slight changes were observed at 
48hpf. 
To determine if these changes were carried into later developmental time points; at 4dpf 
missing axons could no longer be observed. This mirrors what was found in Wfs1 shRNA-
transfected mouse neurons with a delay of growth at early stages which evened out in 
mature neurons (Cagalinec et al., 2016). A very slight loss in the number of neurons was also 
observed in the knockout mouse neurons; this may be too subtle for detection with whole 
mount immunostaining. In order to determine if changes in neuronal development could be 
quantified, an acetylcholinesterase assay was performed. AChE breaks down acetylcholine 
and is expressed in the CNS cholinergic and noncholinergic fibers (Bertrand et al., 2001; 
Behra et al., 2002). This assay was used as its activity can be interpretted as an indirect 
measure of neuronal tissues. Differences were observed at  and 3dpf, 4dpf (p<0.01) and 5dpf 
(p<0.0001) in wfs1b but only 3dpf and 5dpf in wfs1a knockouts. This is most likely due to the 
large SEM observed in wfs1a knockouts at 3dpf. The development was not progressing as 
fast in both wfs1 knockouts. As the AChE assay took the whole zebrafish into account the 
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difference in AChE activity may be due to reduced brain development as this has been 
described patients with WS (Hershey et al., 2012).  
The wfs1 embryos were grown in PTU which blocks pigment formation so they remain 
transparent for longer. Pictures of the brain could be taken in live zebrafish to determine if 
any gross morphological changes were occurring in knockout zebrafish. The zebrafish 
cerebellums were significantly smaller at 72hpf. This is in concurrence with the results found 
in patients that the cerebellum is reduced in volume, independent of disease progression 
(Hershey et al., 2012). Cerebellum development is linked with general neurodevelopment 
disorders (Barkovich et al., 2009).  
The AChE activity was also measured in adult brains at 4 and 12 months. At 4 months 
reductions in AChE activity was reduced in both wfs1a and wfs1b knockouts. However, at 12 
months the wfs1a knockouts showed no significant differences with controls while wfs1b 
knockouts were significantly lower than both. This could suggest a neurodevelopmental 
effect at the early time point and degeneration at the 12 month stage with a further 
reduction in AChE activity in wfs1b knockouts. Adults zebrafish brains undergo constant 
neurogenesis and neural regeneration (Schmidt et al., 2013). This can explain why the brain 
AChE activity of wfs1a knockouts becomes similar to the controls overtime. The wfs1b 
knockouts never catch up which could either suggest problems in neurogenesis or 
neurodegeneration of the brain. To determine if degeneration is happening in the brain 
apoptotic markers could be monitored in zebrafish brains such as caspase 3.   
To determine if the changes in zebrafish neuronal development had functional effects on the 
knockout zebrafish, behavioural tests were carried out. The spontaneous movement of 
zebrafish begins at 17hpf and gradually decreases in frequency until stopping at 27hpf 
(Saint-Amant and Drapeau, 1998; Menelaou et al., 2008). As wfs1b knockout zebrafish were 
observed performing more movement at 24hpf it is likely the wfs1b knockouts are behind in 
development. Further evidence for this was provided when the zebrafish were recorded at 
27hpf and wfs1b zebrafish were moving while controls and wfs1a fish had stopped 
spontaneously moving. At 48hpf the majority of wfs1b zebrafish moved very little, this was 
significantly lower than the controls and wfs1a knockouts (p<0.01 and p<0.05). In order to 
determine if this lack of movement was due to problems with muscle morphology, F-actin 
was stained for to look at muscle fibre structure. As no differences were detected in the 
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muscle fibre structure it shows a problem with neuronal signalling in response to the tactile 
stimulation. 
Deficiencies in neuronal development have been detected in wfs1 knockouts. This is 
observed in the immunostaining, the functional assays and the brain development. Although 
the when observing the immunostaining the deficiencies appear to be corrected by later 
developmental time points, the AChE assay determined that the deficiency in development 
continues past the 5 day point. This suggests that WS has a neuronal development condition 
that is compounded later in life by the neurodegeneration.  
The wfs1b model appears to be more severely affected than wfs1a knockouts. Significant 
changes were observed in the early immunostaining and functional tests and brain 
development which suggested this knockout was affected more. This was not entirely 
surprising when looking at the localisation in Figure 5.3 where higher wfs1b expression was 
observed in the brain of the adult zebrafish. The AChE assay showed equal reductions in 
activity which was unexpected. As the AChE assay is an indirect measurement it may be 
possible that AChE itself has been affected by wfs1 knockout or that other non-imaged 
neurons had a more severe phenotype in wfs1a knockout zebrafish.    
As WFS1’s function in the neuron is not as well characterised as in pancreatic cells there are 
a number of theories of what WFS1’s function in neurons is. In cultured mouse and rat cells 
it is suggested that it plays a role in Ca2+ regulation and mitochondrial dynamics, while in the 
fly model these two things were not observed. However, the authors of the study 
hypothesise a neuroprotective role of wolframin against oxidative stress and ageing 
(Cagalinec et al., 2016; Sakakibara et al., 2018). As mitochondria play an important role in 
neurons and their history in the involvement of WS, mitochondrial function was looked at in 
more detail in the zebrafish model.   
6.7 Conclusion 
Early neuronal development in is impaired in the wfs1 knockout models. Differences in 
motor neuron staining can be detected in the first 48 hours of development. Functional 
neuronal impairment is also detected in wfs1b knockout zebrafish, while no muscular 
changes could be observed by immunofluorescence. Changes in the AChE activity can be 
detected in 3-5dpf suggesting less neuronal tissue in larvae as they develop, which could also 
be observed in the knockout adult brains. This suggests a reduction in neuronal tissue 
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throughout the life of the zebrafish which may be comparable to patients with WS (Hershey 
et al., 2012). 
Future work could involve electrophysiological recording of muscles, nerves or in the brain 
to determine in detail if/where the nerve conduction fault occurs (Baraban, 2013). 
Mitochondrial co-localisation may also be useful in determining the involvement of energy 
production in the affected nerves, while Ca2+ homeostasis could also be studied in the nerve 
to determine if it is a factor in the changes in neurodevelopment.       
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Chapter 7: Mitochondrial Dysfunction in wfs1 Mutant Zebrafish Models 
7.1 Introduction 
WS historically was thought of as a mitochondrial disease, due to the phenotypes being 
similar to other ATP supply defect disorders such as LHON (Bu and Rotter, 1993). This was 
compounded by the discovery of a number of patients containing mtDNA deletions (Zeviani 
et al., 1989; Rotig et al., 1993). After the discovery of mutations in the WFS1 gene describing 
an autosomal mutation and not mtDNA the role of mitochondria in WS became less clear 
(Inoue et al., 1998; Strom et al., 1998). Further evidence against mitochondrial involvement 
came with a study of 40 patients where no evidence supporting a role for mtDNA in WS was 
found and concluded that patients with mtDNA deletions were not typical of WS (Barrett et 
al., 2000). In this study lack of changes in mitochondrial function in patient muscle biopsies 
were also described (Barrett et al., 2000). Wolframin is also localised to the ER rather than 
mitochondria and the role in the ER stress response was suggested to be a key feature of WS 
(Takeda et al., 2001; Yamaguchi et al., 2004).  
More recently the role of mitochondrial dysfunction in WS has been brought into question 
again. Silencing of WFS1 in HEK cells upregulated pathways of mitochondrial damage (Koks 
et al., 2013). Alongside this, dysfunctional mitochondrial trafficking was observed in 
developing cultured mouse neurons (Cagalinec et al., 2016). More evidence for the role of 
mitochondrial dysfunction is seen in WS type 2. WS type 2 is caused by mutations in CISD2 
and has a similar phenotype to WS. Similar to WFS1, CISD2 has roles in Ca2+ regulation, 
however no direct interactions between the two proteins has been discovered (Wiley et al., 
2013). CISD2 has been shown to be directly involved in Ca2+ dynamics of the mitochondria 
(Wiley et al., 2013; Rouzier et al., 2017b). Knockout patient fibroblasts of CISD2 had a 
number of other mitochondrial abnormalities including increased ER-mitochondria contact 
and a hyperfused mitochondrial network (Rouzier et al., 2017b).  A patient in 2012 was 
diagnosed with WS initially suspected to be mitochondrial disease due to biochemical data 
suggesting a complex I defect and multiple mtDNA deletions (Lieber et al., 2012). The 
authors hypothesise that wolframin is affecting mitochondrial function and mtDNA 
maintenance.  
The zebrafish mtDNA is comparable to humans, it contains all 44 genes that have this same 
gene order and is approximately 70% similar to the human mtDNA (Broughton et al., 2001; 
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Steele et al., 2014b). This makes zebrafish a useful model for the study of mitochondrial 
diseases. The external and rapid early development allows for a number of mitochondrial 
techniques to be performed that would be very difficult in more complex models. This 
includes assessing live in vivo mitochondrial dynamics, whole system OXHOPS 
measurements and neuronal development/degeneration (Stackley et al., 2011; Steele et al., 
2014a; Dukes et al., 2016).  Zebrafish do have differences in the OXPHOS pathway, 
alternative pathways for complex III feeding have been suggested meaning to some extent 
zebrafish can bypass complex I and II (Pinho et al., 2013).  A Parkin knockout zebrafish with 
reduced complex I expression demonstrated no significant changes in swimming behaviour 
suggesting these alternative pathways may be able to alleviate some of the stress involved in 
complex I disorders (Flinn et al., 2009). 
The aim of this chapter was to observe the mitochondrial function of wfs1 knockout 
zebrafish in order to better understand the mitochondrial role in the development of WS. 
 
7.2 Mitochondrial Axonal Transport 
As mitochondrial dynamics was affected in a culture model of WS, the effect of wfs1 
knockout on zebrafish dynamics was assessed in live embryos at 48hpf. To identify the 
correct neuron, GFP was expressed under the neuro-d promotor and the lateral line located. 
A mito-tagged RFP expressed under a neuro-d promotor was also expressed and 
mitochondria in the lateral line of the developing zebrafish were observed (Figure 7.1A). 
Analysis was performed using kymographs (Figure 7.1B) to track movement, velocity, 
distance and directional changes of mitochondria.  
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Figure 7.1 Mitochondrial Transport. A: A 60x confocal image of the mito-RFP in the zebrafish 
lateral line (video in supplementary evidence 7). B: A representative kymograph of 
movement in the lateral line. The white lines represent mitochondria and the movements 
can be measured and converted into velocity (distance/time).  
The wfs1 knockouts both had a reduction in the distance travelled by mitochondria. Wfs1a 
knockout mitochondria travelled 7.269μm less distance per movement (p<0.01) and wfs1b 
travelled 4.66µm less per movement (p<0.001). When the velocity of these mitochondrial 
movements was measured only the wfs1a knockouts were significantly different with a 
reduction of 0.2μm/s (p<0.01).   
 
Figure 7.2 Quantification of Speed and Distance Travelled. A: Average distance travelled of 
moving mitochondria in the lateral line B: Average velocity of moving mitochondria in the 
lateral line. Control n=119 wfs1a n=73 wfs1b n=162. Statistics: Kruskal-Wallis test with 
Dunn's Multiple Comparison Test *p<0.05 **p<0.01, ***p<0.001 Graphs plotted mean 
+SEM. 
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The distance and velocity can also be separated into anterograde and retrograde 
movements. The only changes from the combined grouping were in the velocity where 
wfs1b knockouts move significantly slower than the control p<0.05. A result that was 
previously masked in Figure 7.2B. 
 
Figure 7.3 Quantification of Speed and Distance Travelled in Anterograde and Retrograde 
Directions. A: Average velocity of moving mitochondria in the lateral line B: Average distance 
travelled of moving mitochondria Anterograde Control n=63, Reterograde Control n= 56,  
Anterograde wfs1a n=22, Reterograde wfs1a n=51, Anterograde wfs1b n=67 and 
Reterograde wfs1b n=95. Statistics: Kruskal-Wallis test with Dunn's Multiple Comparison 
Test *p<0.05 and **p<0.01 Graphs plotted mean +SEM. 
It also appeared the mitochondria were moving differently when the kymographs were 
analysed so to determine if this was the case the number of changes of movement of each 
mitochondria, and the percentage of time spent moving were measured.  The wfs1b 
knockout zebrafish mitochondria had an increased number of changes in movement 
(p<0.05), such as moving to stationary or changes in anterograde or retrograde travel. The 
wfs1b knockouts also spent 60.85% of their time moving 20% more than controls (p<0.01).  
 
 
126 
 
 
Figure 7.4 Changes in Phases of Mitochondrial Movement and Percentage of Time Moving. 
A: Number of changes in movement of mitochondria during 5 minute timelapse 
(anterogradestationaryretrograde) Percentage of time mitochondria spend moving. 
Control n=129 wfs1a n=62 wfs1b n=85. Statistics: Kruskal-Wallis test with Dunn's Multiple 
Comparison Test *p<0.05 and **p<0.01 Graphs plotted +SEM. 
7.3 Seahorse XF Mito Stress Test 
In order to determine if zebrafish mitochondrial function was affected in knockout zebrafish 
a Seahorse XF Mito Stress Test was optimised and used on a Seahorse XFe96 on whole 
zebrafish larvae at 48hpf (Figure 7.5). The knockout wfs1b had severely affected 
mitochondrial respiratory function   compared to controls. Oligomycin (blocks ATP 
production), FCCP (transports H+ ions through inner membrane) and a combination of 
rotenone and antimycin A (blocks complex I+IV) were sequentially added to the zebrafish. 
These drugs allowed affect respiration in specific manners allowing the calculation of a 
number parameters: non-mitochondrial respiration, basal respiration, proton leak, max 
respiration, ATP production and spare respiratory capacity (Figure 7.5).   
Basal Respiration was lower (p<0.0001) without a reduction in non-mitochondrial 
respiration, max respiration (p<0.0001), ATP production (p<0.001) and spare respiratory 
capacity (p<0.001) were all also significantly lower in wfs1b knockouts. The wfs1a knockouts 
had no significant differences from controls even though the majority had a lower mean OCR 
this fell within the range of standard error. 
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Figure 7.5 Seahorse XF Cell Mito Stress Test. A) Oxygen Consumption Rate vs Minutes, OCR 
was measured and plotted as mean ± SEM under the following conditions: basal conditions 
and following the sequential addition of oligomycin (injection 1), FCCP (injection 2/3) and 
rotenone with antimycin A (injection 4). B)The following parameters were calculated and 
plotted as mean ± SEM: Non-mitochondrial respiration, Basal respiration, Maximal 
respiration, Proton leak, ATP-prodiction and Spare respiratory capacity. Significance 
calculated using Two-way ANOVA with Bonferroni multiple comparisons. ***=p<0.001 
****=p<0.0001 ab n=60, wfs1a n=64 and wfs1b n=60.  
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7.4 mtDNA Levels 
mtDNA was examined to determine if changes in mitochondrial function were due to 
mitochondrial biogenesis changes. The levels of mtDNA were measured using qPCR of nd1 
compared to the number of genomic copies of ef1α. If the ratio of nd1 increases it suggests 
an increase in mtDNA. No significant differences were determined between the controls and 
wfs1 knockouts, although wfs1b knockout means were slightly higher (0.475 ΔCT higher). 
 
Figure 7.6 mtDNA Levels of 48hpf Zebrafish. ΔCT of nd1 subtracted by ΔCT of ef1α of 
nuclear extracted DNA (Hot shot). Graphs plotted as mean ± SEM, significance was 
calculated by One way ANOVA with Bonferroni’s multiple comparison tests no differences 
determined between groups, n=23 
7.5 Mitochondrial Complexes 
As no significant changes in mtDNA were observed, protein levels of the components of the 
OXPHOS system were examined. The OXPHOS complexes I-IV creates the proton gradient 
and V uses this to produce ATP. Complex I levels were examined to find the cause of 
respiratory changes.  
At 48hpf complex I subunit NDUF9A levels was observed by Western blot. The wfs1 
knockouts had a reduced complex I amounts compared to controls with wfs1b being more 
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severely affected. Complex I densities were normalised to VDAC expression as a marker of 
mitochondrial loading.  
 
Figure 7.7 Complex I protein levels in 48hpf whole zebrafish lysates. A: NDUF9A and VDAC 
Western blots of control wfs1a and wfs1b knockout whole zebrafish lysates. B: 
Quantification of density normalised to VDAC as a mitochondrial loading control. Embryos at 
48hpf taken for each genotype. Statistics: Paired t-test *p<0.05 and **p<0.01 Graphs plotted 
mean ± SEM 
Heat shock show changes to BiP expression and zebrafish mortality in Chapter 5. To 
determine if heat shock was having any effect on mitochondrial proteins, zebrafish were 
heat shocked at 6hpf for one hour.  The VDAC expression was very faint at 7hpf so a 
Coomassie staining was also performed to determine equal loading. The wfs1a knockout 
NDUF9A expression was higher than the control at 7hpf, while the wfs1b was lower which is 
consistent with the results at 48hpf. In heat shocked zebrafish there is a difference in 
NDUF9A expression in wfs1a knockouts. 
No differences could be determined in ATP5A (complex V subunit) expression throughout.  
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Figure 7.8 Complex I protein levels in 7hpf whole zebrafish lysates. VDAC, NDUF9A and 
ATP5A Western blots of control, wfs1a and wfs1b knockout and heat shocked equivalents, 
whole zebrafish lysates, Coomassie gel image to confirm equal loading. Embryos collected at 
7hpf or after 1 hour of heat shock at 37⁰C taken for each genotype.  
 
In order to determine is tissue specificity may be a a factor in the complex I changes 
observed in Figure 7.6-7 adults zebrafish where disected and the brain eyes and muscle were 
used for protein analysis. Changes in the brain showed a higher protein level of NDUF9A in 
wfs1a knockouts and a reduction in wfs1b knockouts. The eye had reductions in NDUF9A in 
both knockouts with wfs1b being more severe. Muscle tissue had a large reduction in 
NDUF9A in wfs1a knockouts and a less severe reduction in wfs1b.   
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Figure 7.9 Complex I protein levels in adult tissue specific zebrafish lysates. NDUF9A and 
VDAC Western blots of control wfs1a and wfs1b knockout tissue zebrafish lysates from 
dissected brains, eyes and muscles.  
The densities were quantified in imagej and normalised to VDAC for a mitochondrial loading 
control. When quantified, changes in the eye and the increase NDUF9A levels in the wfs1a 
knockout brain were not significant.   
 
Figure 7.10  Quantification of density normalised to VDAC as a mitochondrial loading 
control. A: Brain Complex I/VDAC density. B: Eye Complex I/VDAC density. C: Muscle 
Complex I/VDAC density. Statistics: Paired t-test *p<0.05 and **p<0.01 Graphs plotted ± 
SEM 
The other OXPHOS complexes were looked at to determine if this change was specific only to 
complex I, or if in general mitochondrial complexes were affected. In the brain and muscle it 
appeared this was only specific to complex 1. In wfs1 knockouts NDUF9A was increased in 
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the brain and reduced in the muscle, while wfs1b was reduced in both. In the eye it appears 
VDAC expression may be effected causing a reduction in the other complexes in both wfs1 
knockouts.  
 
Figure 7.11 Western Blots of Adult Tissue Mitochondrial Complexes I, II, IV, V and VDAC. 
Coomassie for equal loading, SDHA (complex II), MTCO1 (complex IV), ATP5A (complex V) 
VDAC (mitochondrial loading control) and NDUF9A (complex I).  Brain muscle and eye tissue 
dissected from adult zebrafish. 
 
7.6 Native Page Gels 
Native page gels were used to assess the integrity of the complex I structure. As observed 
from the previous blots less NDUF9A could be observed in the isolated mitochondria of wfs1 
knockouts. Mitochondria were isolated from zebrafish embryos by differential centrifugation 
and digitonin solubilisation. 
The knockout wfs1 isolated mitochondria had lower levels of NDUF9A detected in the higher 
molecular weight bands. This was observed at both 24 and 48hpf in the developing embryo. 
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Figure 7.12 Blue Native PAGE Complex I Western Blots. A: BN-PAGE Western Blot of 
isolated mitochondria were isolated from zebrafish at 24hpf an 48hpf. Isolated mitochondria 
were run on a BN-PAGE. Complex I detected using NDUF9A antibody. B: Ratio of lower 
band/higher bands at 24hpf. C:Ratio of lower band/higher bands at 48hpf. Density 
determined on imagej for each band and ratios calculated n=1. 
7.7 Mitochondrial Ca2+ 
To determine if any changes in mitochondrial Ca2+ homeostasis could be observed, 
mitochondria were isolated from adult muscle tissue and Ca2+ uptake measured. 
Mitochondria Ca2+ uptake was measured in isolated mitochondria. 20μM CaCl2 was added to 
50μg of isolated mitochondria in an Oregon green dye which fluoresces when bound to Ca2+. 
Oregon Green is cell impermeable so cannot enter the mitochondria therefore changes in 
this fluorescence originates from a loss of available Ca2+. The results were plotted on the 
graph in Figure 7.14 
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Figure 7.13 Isolated Mitochondria Ca2+ Uptake. 20μM CaCl2 was added to 50μg isolated 
muscle tissue mitochondria and the reduction of flourescence over 5 minutes represents 
uptake of Ca2+. 
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The difference in fluorescent units from CaCl2 injection to the end of recording was plotted 
and the rate of change calculated and plotted. Although both wfs1a and wfs1b knockouts 
had increased levels of Ca2+ uptake these were both non-significant.  
 
Figure 7.14 Quantification of Isolated Mitochondria Ca2+ Uptake. A: Differences in 
Flourescence of Oregon Green when 20μM CaCl2 is added to the end of 5 minute period. B: 
Rate of change (Change over time). Graphs plotted mean ± SEM. 
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7.8 Discussion 
The role of mitochondria in WS is not well understood. Using the zebrafish knockouts of 
wfs1, mitochondrial function was assessed to determine if it was involved in development of 
WS.  
Mitochondrial trafficking was affected in wfs1 knockouts. This is something that has been 
observed in cultured rat neurons before but not in vivo (Cagalinec et al., 2016). The results 
confirmed mitochondrial dynamics were altered with distance of runs being lower in both 
knockouts and the cultured neurons described in Cagalinec et al.. Velocity was also 
decreased in culture which was observed in wfs1a knockouts. An increase in changes of 
direction was another change in culture which was replicated in the wfs1b knockouts. There 
is a difference between the zebrafish and the isolated cells, in the percentage of time the 
mitochondria spend moving. In culture ~40% mitochondria are motile for both control cells, 
control zebrafish and knockdown cells but, in wfs1b knockout zebrafish we see a significant 
increase in movement with wfs1b knockout mitochondria moving 20% more than controls. 
Changes in mitochondrial transport could be caused by changes in the cytosolic Ca2+ binding 
to the Miro/Milton complex. 
Although slight changes in the difference between the results, the zebrafish and the shRNA 
silenced mouse neurons systems appear comparable (Cagalinec et al., 2016). This was 
further demonstrated by the loss of ATP production which was downregulated in cultured 
neurons (by ATP assay) was also observed in the oxygen consumption measurement of the 
knockout zebrafish. However, by using the mitochondrial stress test we were also able to 
determine the wfs1b knockout zebrafish had significantly lower basal respiration without a 
change in the non-mitochondrial respiration. This suggests that the defect is in fact 
mitochondrial rather than glycolytic. A significant reduction in max respiration and spare 
respiratory capacity were also observed. Spare respiratory capacity changes are able to 
suggest if the fish are close to a bioenergetic limit (Brand and Nicholls, 2011). As spare 
respiratory capacity is lower in wfs1b knockout fish it is likely the variable high energy tissue 
such as neurons would be more severely affected (Brand and Nicholls, 2011).  The smaller 
neurons in the optic nerve are the first to die off in WS. This is due to the large energetic 
demand in these axons paired with a relatively low energetic potential (Pan et al., 2012; 
Ross-Cisneros et al., 2013). A reduction in spare respiratory capacity would explain the 
predominant loss of these neurons during OA. This change in spare respiratory capacity 
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helps to explain the changes in early neuronal development. At early time points of neuronal 
development mitochondria operate very close to their max respiration with hardly any spare 
respiratory capacity (Agostini et al., 2016). This could explain why neuronal development is 
delayed in the wfs1b model at early time points. In order to understand what was driving the 
respiratory changes in wfs1b knockouts the change in mtDNA was examined. 
This was to determine if any changes in mitochondrial biogenesis could be found in wfs1 
knockouts. No significant differences were detected in wfs1 knockout zebrafish; a very minor 
non-significant rise in copy number was detected in wfs1b knockouts. In LHON significantly 
higher numbers of mtDNA have been detected to act as a compensatory mechanism for 
changes in complex I (Giordano et al., 2014). To determine if complex I changes could be 
observed, Western blots for the NDUF9A subunit of complex I levels were performed at 
48hpf. When adjusted to account for VDAC expression complex I is downregulated in both 
wfs1 knockouts and more severely in wfs1b. Finding a reduction in wfs1a knockouts was 
unexpected as it did not appear to affect the results from the oxygen consumption 
measurement, although the wfs1a results had a higher SEM than control zebrafish so a 
possible difference may be detected with higher n numbers. It is also possible that complex I 
is not the rate limiting step in this reaction meaning a slight reduction may not affect the 
max respiration.   
As heat shocking the zebrafish showed changes in the death rate of wfs1 knockout zebrafish 
the OXPHOS subunits were observed to determine if mitochondrial dysfunction had a role in 
this. After heat shocking wfs1a complex I levels appeared to fall although no changes were 
determined in controls and wfs1b knockouts. VDAC was also hard to detect so equal 
mitochondrial loading was not confirmed, even if the Coomassie staining determined equal 
protein loading. ATP5A for complex V had no changes between knockouts or heat shocked 
embryos. The UPR and mitochondrial function are closely linked with PERK playing an 
important role in mitochondrial function and ER-mitochondria interactions (Verfaillie et al., 
2012). ATF6 is also associated with changes in mitochondrial ultrastructure suggesting a 
possible link between the ER stress response and mitochondrial function (Wang et al., 2018).  
As the VDAC expression was difficult to detect it is hard to determine the overall effect heat 
shock had on the mitochondria. Electron Microscopy would be able to determine changes in 
ER-mitochondria contacts and ultrastructure changes. However, an interesting change was 
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complex I levels in wfs1a knockouts at 7hpf being higher than controls, when at 48hpf it was 
lower. It may be due to tissue specificity described in Chapter V that highlighted the 
muscular expression of wfs1a. The first post mitotic cells that will go on to develop axial 
somite-derived muscles can be defined at the 90%-epiboly stage (9hpf) (Kimmel et al., 1995) 
which would explain why we do not observed this knockdown of NDUF9A at the earlier time 
point. This was further tested in isolated adult tissues. 
Adult zebrafish were euthanized and their tissues dissected. Using lysates from the brain, 
the eyes and muscle NDUF9A and VDAC expression were observed. wfs1b knockouts had 
reductions in all three tissues, although not significant in the eye. wfs1a had a non-
significant increase of expression in the brain, slightly non-significant reduced expression in 
the eyes and was almost undetectable in the muscles. This was unexpected as the largest 
differences between the disease models and controls have been in the wfs1b knockout 
models. The differences in expression may also explain why there are no significant changes 
in the oxygen consumption analysis, if one tissue type is masking a defect in another. A 
possible way to examine this would be to perform an oxygen consumption analysis on some 
dissociated cells of different tissue types or their isolated mitochondria. This upregulation of 
complex I may be a compensatory mechanism which would be interesting to determine if 
this is also the case in double knockout fish. Complex I reductions in the wfs1b explain why a 
reduced max respiration and spare respiratory capacity are observed in this knockout model. 
This, alongside changes in mitochondrial dynamics, would explain changes in neuronal 
development and degeneration seen in OA.  
As quite severe reductions in complex I are described in wfs1b knockouts and certain tissues 
in wfs1a knockouts, it would be expected to see rather severe phenotypes. As mentioned 
previously a complex III feeding, suggests zebrafish can bypass complex I and II could be the 
reason especially in wfs1a why the phenotypes are more mild than expected (Pinho et al., 
2013). As with the embryos it was important to determine if other mitochondrial complexes 
were affected. There was less VDAC in the eyes of both knockouts so all changes in the eye 
could be linked to a reduction in the number of mitochondria rather than specific 
complexes. As we have observed in both wfs1a and wfs1b knockouts a reduction in RGCs 
may account for a reduction in mitochondria as a relatively high energy tissue, mitochondria 
are important in the optic nerve and RGCs. In the brain and muscle the only obvious changes 
were in complex I suggesting this change is specific. 
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To determine if this was having any effect on super complex formation Native gels were 
looked at in isolated mitochondria. Ratios of the lower weight NDUF9A bands were 
compared to the intensity of the higher weight bands. At 24hpf the changes were more 
subtle but at 48hpf the difference in higher molecular weight complexes was more striking 
with both wfs1 knockouts. 48hpf had a lower ratio of higher weight complexes. This is an 
interesting observation as supercomplexes are important in energy production making 
electron transfer more efficient but also playing an important role in the stability of the 
complexes (Vempati et al., 2009; Lapuente-Brun et al., 2013; Maranzana et al., 2013). 
However it is not certain if supercomplexes are not forming due to the reduction in complex 
I, or the lack of supercomplexes causing a reduction in complex I. 
The composition of lipids in the IMM is important in the stability of these super complexes 
(Pfeiffer et al., 2003). The mitochondrial connection at the ER is a vital for phospholipid 
production (Vance, 2015). If like in CISD2 the connection at the MAM is not as tight (Rouzier 
et al., 2017b), this process is likely effected. To determine if this is the case EM could 
demonstrate if connections between two organelles are effected. Lipidomics of isolated 
mitochondria or a phospholipid transfer assay would allow the determination of lipid 
concentrations (Kojima et al., 2016). This could explain a reduction in supercomplex stability 
which could be responsible for the complex I reduction. It could also be possible that due to 
the subunits of complex I assembly factors having shorter half-lives (Kim et al., 2012; 
Karunadharma et al., 2015), are more susceptible to the possible effects of ER stress such as 
reduced transcription. RNAseq may be able to provide answers to this. 
Mitochondrial Ca2+ uptake was observed in isolated mitochondria. There were no significant 
changes in wfs1 knockouts. However, this is consistent with what has been reported in 
HEK293 WFS1 knockdown cells were mitochondrial Ca2+ was essentially unaltered (Takei et 
al., 2006). Cytosolic Ca2+ and ER flux have been reported to be altered in other cell types 
(Takei et al., 2006; Cagalinec et al., 2016). Cytosolic Ca2+ is being monitored by collaborators 
in live zebrafish and may provide answers to the role Ca2+ is playing in wfs1 knockout 
zebrafish (Bakayan et al., 2015). 
Mitochondrial transport, respiration and complex I expression are all affected in wfs1 
knockout zebrafish. wfs1b knockouts again have a stronger phenotype apart from in the 
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muscle where the expression of wfs1a appears more important in the expression of complex 
I.  
7.9 Conclusions 
wfs1 knockout in the zebrafish has significant effects on the function and complex I 
expression. Changes in trafficking of mitochondria could be observed in both wfs1 knockouts 
in the lateral line of the zebrafish. Mitochondrial respiration was reduced in wfs1b knockouts 
and reductions could be seen in complex I protein in the whole larvae, the brain and the 
muscle. Complex I protein concentration was also reduced in the whole larvae and the 
muscle in wfs1a knockouts. The formation of supercomplexes was reduced in both wfs1 
knockouts while Ca2+ uptake and mtDNA levels remained unchanged. 
Further experiments could involve in gel activity of the complexes in native gels or 
spectrophotometric assays of respiratory complex activity to further determine the effect of 
wfs1 knockout on respiratory function. Electron microscopy could help determine any 
morphological differences and also determine the role of the ER and mitochondrial 
connection in WS. Although no changes were determined in isolated mitochondrial Ca2+ 
uptake there may still be issues with ER Ca2+ leak through the IP3R or problems with ER Ca
2+ 
uptake through SERCA. To begin with cytosolic Ca2+ levels could be examined in live zebrafish 
using a red-emitting aequorin variant (Bakayan et al., 2015). Cytosolic changes indicate any 
overall homeostasis dysfunctions that could be observed in greater detail. 
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Chapter 8: General Discussion 
The aim of this project was to characterise zebrafish models of WS to further our 
understanding of the role of wolframin in WS. Specifically, the zebrafish model can provide 
insights into mitochondrial function regulation and neuronal development; something which 
is difficult to achieve in other animal models. 
Both morpholino mediated knockdown and transgenic genomic knockouts were used to 
model WS. These models of wfs1 knockdowns/kockouts acted as useful models of WS. A 
morpholino screen was utilised initially to determine the effectiveness of wfs1a and wfs1b 
knockouts. This demonstrated early on that wfs1b knockouts had a more significant effect 
on the zebrafish in the early development. However, significant problems with the 
morpholino model such as possible off target effects have made researchers wary of 
morpholino models (Kok et al., 2015). Although a number of controls were carried out 
including p53 rescues and CRISPANT models a number of other controls needed for 
validation prior to publication including RNA rescue and multiple types of morpholino 
(Stainier et al., 2017). With the purchase of mutant knockout zebrafish lines it was 
determined this would not be a worthwhile route to pursue to model WS.  
In comparison to the knockout models a number of the morpholino phenotypes proved to 
be exaggerated such as the loss of eyes, tail abnormalities and obvious cranial shape 
changes. This could be explained by the upregulation of compensatory mechanisms seen in 
mutants, which are not affected by transcript altering morpholinos (Rossi et al., 2015). The 
wfs1a splice blocking morpholinos only had a small increase in severity of phenotypes with 
the changes from normal zebrafish being non-significant. When expression of the wfs1a 
cDNA was observed at very early stages it was not expressed and the expression was much 
higher in the muscles when adult tissue transcripts were observed. This explains why a 
wfs1a morpholino was less effective as morpholinos are more effective in the first few days 
of development. The combination of the two morpholinos was lethal. A similar pattern was 
also seen in wfs1 mutant crosses where one double knockout mutant was produced which 
was completely infertile. The wfs1ab knockout as a model was not pursued further due to 
breeding difficulties. The single knockout models were perused further.  
The single knockouts were characterised in Chapter 5 and shared a number of characteristics 
with WS. Changes in the unfolded protein response were observed. This is a fundamental 
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pathway that has been shown to be affected in WS (Fonseca et al., 2005). Unfortunately 
another important pathway, Ca2+ homeostasis, was not fully characterised. Although 
mitochondrial Ca2+ was examined, cytosolic Ca2+ which has been shown to be affected in a 
number of cell types has not yet been determined (Takei et al., 2006; Zatyka et al., 2015). 
Zebrafish from the study described here have been given to collaborators to determine if 
cytosolic Ca2+  is affected but the experiments had not been completed at the time of writing 
(Bakayan et al., 2015).  
The wfs1 zebrafish did develop a number of phenotypes similar to humans. Zebrafish were 
smaller and patients have also been reported to be shorter (Lugar et al., 2016). Problems 
were seen in the ears of the zebrafish with reductions in otolith size. Anxiety and fertility 
were also affected with zebrafish with them moving less in isolation and producing 
unfertilised embryos. These are all changes that can be linked with changes seen in WS 
patients (Urano, 2016). The two most common symptoms of WS in patients are diabetes 
mellitus and optic atrophy. Diabetes mellitus was studied in less detail in this project 
partially due to the large focus of other models on this particular facet and the previously 
published morpholino model also showed a loss of β-islet cells (O'Hare et al., 2016). 
However, fasted blood glucose was significantly lower in wfs1b knockout zebrafish. Diabetes 
mellitus can also be managed by insulin treatment while optic atrophy has no treatment at 
all. OA was characterised in detail in the zebrafish knockouts in Chapter 4.  
The zebrafish eyes early on in development did not show any obvious changes histologically. 
At 4 and 12 months changes were seen histologically in the quantification of RGCs showing 
reductions in both wfs1a and wfs1b knockouts. Alongside this functional data from OKR 
showed that wfs1b knockout fish had a reduction of visual acuity. OCT images were also 
taken of the optic nerve and wfs1b zebrafish at 12 months had a thinner optic nerve. This is 
comparable to the human condition suggesting we have an accurate model of OA in wfs1b 
knockouts. Unfortunately this comes around 4 to 12 months which removes one of the 
major benefits of zebrafish models which is the ability to use large numbers at early time 
points. However, this is a better fit in retinal degeneration than the mouse model and 
comparable in timescale of OA onset to the rat model (Bonnet Wersinger et al., 2014; Plaas 
et al., 2017). 
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The development of neurons in the wfs1 knockout fish were also affected. Neuronal 
outgrowth was impeded in a similar to manner as to what has been previously observed in 
cultured mouse neurons (Cagalinec et al., 2016). Functional tests also showed impaired 
neuronal signalling from the touch response experiments. The changes in neuronal growth 
and structure could be linked to the changes in ER stress, which may be reducing 
transcription. This could possibly be limiting growth. Another possibility is mitochondrial 
dysfunction causing a delay in growth. Developing neurons function close to the 
bioenergetics limit, while mature neurons have a larger spare respiratory capacity (Agostini 
et al., 2016). In wfs1b knockouts the spare respiratory capacity is reduced and so is the size 
of the neurons observed at 24hpf. This reduction in energy availability may be delaying 
growth.  
Reductions in acetylcholine esterase activity were observed in wfs1a knockouts at time 
points 3dpf and 5dpf this was also observed in wfs1b knockouts (3, 4 and 5dpf). This 
suggests that both knockouts either have less neuronal tissue or at least a reduction of AChE 
activity which has a vital role in regulating neuronal signalling. This was surprising as wfs1a 
knockout zebrafish showed no functional test differences from the controls. It could be 
possible that wfs1a zebrafish begin to show symptoms later in development due to the later 
onset of expression of wfs1a while wfs1b is expressed from the 1 cell stage. Functional tests 
like the touch response are much harder to carry out at later larvae time points as they begin 
moving independently at 4dpf. The AChE activity in the brains of wfs1 knockouts were also 
altered. The results mirrored the data from the RGC counts where reductions were initially 
seen in wfs1a at 4 months with wfs1b knockouts becoming more severe at 12 months. It is 
possible we are observing an initial developmental deficit which is either corrected at later 
time points or degeneration in the adult wfs1b tissue or a combination of the two. Zebrafish 
neuronal tissue is capable of regenerating (Schmidt et al., 2013). As neuronal generation is a 
high energy process this may play a key role in the differences in any 
regeneration/degeneration of the two zebrafish models (Agostini et al., 2016).  
Mitochondrial function was altered in both wfs1 knockout models. In wfs1a knockouts 
transport, protein expression and supercomplex formation were all significantly altered 
while wfs1b knockouts also showed respiration deficiencies. The wfs1a knockout zebrafish 
muscles show quite large changes in complex I protein levels in adult tissue while the 
embryos and other tissues had less drastic reductions in NDUF9A compared to wfs1b 
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knockouts. Mitochondrial respiratory chain activities were shown to be within normal ranges 
in patient muscle biopsies (Barrett and Bundey, 1997). However, ATP production was 
reduced in isolated mouse neurons which may suggest tissue specificity to these 
mitochondrial dysfunctions (Cagalinec et al., 2016). Future work on mitochondrial 
dysfunction should be performed on neurons derived from Induced pluripotent stem cells 
derived from patient cell lines to determine if an ATP reduction is also observed. 
Unpublished work from our group suggests in patient fibroblasts complex I activity is 
decreased when measured by Oxygraph (Dr David Moore, PhD Thesis  2016). These changes 
could be due to the changes in supercomplex formation observed in the zebrafish embryos, 
determining if this is true for WFS1 patient fibroblasts would be an interesting observation. 
The majority of results throughout this study shared a common theme: the wfs1b knockouts 
appear to have more severe phenotype than the wfs1a knockouts. This may be due to the 
expression of wfs1a which was shown to be expressed at a later time point and 
predominantly in the muscle. As muscle is not one of the main types of tissue affected in WS 
it is no surprise this model is a milder representation of WS. It would also be interesting to 
see proteins or transcripts that differ between the two models to determine why the wfs1a 
model is less severe. There may be compensatory mechanisms that are causing a protective 
effect. RNA-Seq or proteomics may provide large unbiased comparative studies to 
determine this while also providing comparisons to control tissue. For future experiments it 
would be beneficial to focus on the wfs1b knockout model only.  
Knockout zebrafish could also be crossed to multiple fluorescent lines GAP43:GFP zebrafish 
have GFP in the RGCs (Diekmann et al., 2015), ptf1a:eGFP;insa:mCherry have fluorescent 
pancreatic islet cells (O'Hare et al., 2016) , fluorescent neurons could provide a live time 
lapse of development rather than fixed time points. The mitochondrial network could be 
assessed in more detail in transgenic lines (Kim et al., 2008). A completely pigment free 
zebrafish line has also been developed which would allow for in detail Ca2+ imaging in the 
zebrafish retina (Antinucci and Hindges, 2016). Crossing to transgenic lines would require 
significant time ~8months to produce homozygotes and a further 3-4 months for those to 
begin breeding.  
Electron microscopy should be an avenue that is explored further, 3d EM could have 
provided answers to important factors such as the ER and mitochondrial contacts that have 
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not been explored in this project (Wu et al., 2017). This is an important factor in knockout 
CISD2 fibroblasts which should be explored further in WS (Rouzier et al., 2017b). The ER and 
mitochondrial connection is essential for ER flux, fission and lipid metabolism (Rowland and 
Voeltz, 2012). Unfortunately fixation of the optic nerves was not adequate for this in adult 
zebrafish, this can be attempted again in perfusion fixed adults, different tissue or possibly 
larvae.  
Other possible future directions from this project include drug screening. The wfs1b model 
has a number of rapidly observable differences from controls at the larval stages. 
Mitochondrial respiration, neuronal development/function, size and response to heat shock 
could all be rapidly tested. This could be tested against various drug libraries due to the high 
number of zebrafish embryos. Promising candidates could be trialed for longer periods on 
adult zebrafish to determine the response to retinal degeneration. Dantrolene and sodium 
valproate could be tested due to their promising results in other models (Gharanei et al., 
2013; Lu et al., 2014). Idebenone is another candidate that has shown promising results in 
LHON treatment (Carelli et al., 2011). It is reported that Idebenone increases the ATP 
production in LHON fibroblasts, as maximum respiration of wfs1b zebrafish was reduced this 
could be a promising therapy (Yu-Wai-Man et al., 2017).  
In summary two models of WS have been characterised in this thesis. The model of wfs1b 
appears more severe than the wfs1a knockout. The wfs1b model more accurately models 
the important OA phenotype seen in WS. Overall the wfs1b model appears to be a better 
phenocopy of WS and testing of therapeutic compounds could be trialed on this line. 
Mitochondrial dysfunction was observed in this model including trafficking, complex I 
dysfunction and reductions in respiratory function. The insight gained into the function of 
mitochondria in WS can help further our understanding of the mechanisms of the disease in 
patients.  
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Neuronal Development and Mitochondrial Dysfunction Caused by wfs1 Mutations in a 
Zebrafish Model 
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Wolfram syndrome (WS) is a neurodegenerative disorder defined historically by the 
combination of diabetes insipidus, diabetes mellitus, optic atrophy and sensorineural 
deafness. It is now increasingly apparent that a significant proportion of patients (30-40%) 
will develop additional neurological impairment, in particular ataxia, epilepsy and 
dysfunction of the long corticospinal tract neurons. The majority of patients with WS 
harbour recessive mutations within the WFS1 gene (4p16.1), which encodes for the 
Wolframin protein. Wolframin is an endoplasmic reticulum (ER) transmembrane protein and 
the depletion in protein level contributes to the neuropathology of WS. Wolframin is 
implicated in a number of critical cellular pathways, including the ER stress response, 
calcium homeostasis, and mitochondrial biogenesis. Assays were designed and optimised to 
investigate neuronal development and mitochondrial dysfunction in zebrafish harbouring 
wfs1 mutations: spontaneous movement at 24 hours post fertilization (hpf) and touch 
response at 48hpf, which is an indicator of spinal cord and peripheral nervous system 
function. Immunostaining of the primary motor neurons were also performed to track their 
development in the tail. Mitochondrial axonal transport was quantified in vivo in wfs1 
knockout zebrafish by tracking mitochondria along the lateral line at 48hpf with high-
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resolution confocal microscopy. Abnormalities in spontaneous movement, touch response 
and primary motor neuron staining were all consistent with impaired neuronal development 
and maturation in our wfs1 Zebrafish models Depletion of the wolframin protein had a 
major impact on mitochondrial axonal transport with a significant impairment in trafficking. 
The wolframin protein plays an important role in neuronal development in early 
development and our data supports a role for mitochondrial dysfunction in the progressive 
neurodegenerative process seen in patients with WS. 
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Early Career Mitoscientist Meeting 2017, Newcastle (Oral Presentation) 
Mr George Cairns, Wellcome Centre for Mitochondrial Research, Newcastle University 
Wolfram syndrome (WS) is a neurodegenerative disorder defined historically by the 
combination of diabetes insipidus, diabetes mellitus, optic atrophy and sensorineural 
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deafness. It is now increasingly apparent that a significant proportion of patients (30-40%) 
will develop additional neurological impairment, in particular ataxia, epilepsy and 
dysfunction of the long corticospinal tract neurons. The majority of patients with WS 
harbour recessive mutations within the WFS1 gene (4p16.1), which encodes for the 
Wolframin protein. Wolframin is an endoplasmic reticulum (ER) transmembrane protein and 
the depletion in protein level contributes to the neuropathology of WS. Wolframin is 
implicated in a number of critical cellular pathways, including the ER stress response, 
calcium homeostasis, and mitochondrial biogenesis. Assays were designed and optimised to 
investigate neuronal development and mitochondrial dysfunction in zebrafish harbouring 
wfs1 mutations: spontaneous movement at 24 hours post fertilization (hpf) and touch 
response at 48hpf. Immunostaining of the primary motor neurons were performed to track 
their development in the tail. Mitochondrial axonal transport and mitochondrial function 
was also tested using the: Seahorse XF Cell Mito Stress and axonal transport assay. 
Abnormalities in spontaneous movement, touch response and primary motor neuron 
staining were all consistent with impaired neuronal development and maturation in our wfs1 
Zebrafish models Depletion of the wolframin protein had a major impact on mitochondrial 
function and the respiratory capacity of the mitochondria. Wolframin plays an important 
role in neuronal development in early development and our data supports a role for 
mitochondrial dysfunction in the progressive neurodegenerative process seen in patients 
with WS. 
Fishmed 2018, Warsaw (Poster Presentation) 
Neuronal Development and Mitochondrial Dysfunction caused by WFS1 Mutations in a 
Zebrafish model. 
George Cairns1 , Florence Burte1 , John Sayer2 & Patrick Yu-Wai-Man3  
1 Wellcome Trust Centre for Mitochondrial Research Institute of Genetic Medicine, 
Newcastle University, Newcastle Upon Tyne, UK  
2 Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK  
3 Department of Clinical Neurosciences, School of Clinical Medicine, University of 
Cambridge, Cambridge, UK 
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Wolfram syndrome (WS) is a neurodegenerative disorder defined historically by the 
combination of diabetes insipidus, diabetes mellitus, optic atrophy and sensorineural 
deafness. It is now increasingly apparent that a significant proportion of patients (30- 40%) 
will develop additional neurological impairment, in particular ataxia, epilepsy and 
dysfunction of the long corticospinal tract neurons. The majority of patients with WS 
harbour recessive mutations within the WFS1 gene (4p16.1), which encodes for the 
Wolframin protein. Wolframin is an endoplasmic reticulum (ER) transmembrane protein and 
the depletion in protein level contributes to the neuropathology of WS. Wolframin is 
implicated in a number of critical cellular pathways, including the ER stress response, 
calcium homeostasis, and mitochondrial biogenesis. Assays were designed and optimised to 
investigate neuronal development and mitochondrial dysfunction in zebrafish harbouring 
wfs1 mutations: spontaneous movement at 24 hours post fertilization (hpf) and touch 
response at 48hpf. Immunostaining of the primary motor neurons were performed to track 
their development in the tail. Mitochondrial axonal transport and mitochondrial function 
was also tested using the: Seahorse XF Cell Mito Stress and axonal transport assay. 
Abnormalities in spontaneous movement, touch response and primary motor neuron 
staining were all consistent with impaired neuronal development and maturation in our wfs1 
Zebrafish models Depletion of the wolframin protein had a major impact on mitochondrial 
function and the respiratory capacity of the mitochondria. Wolframin plays an important 
role in neuronal development in early development and our data supports a role for 
mitochondrial dysfunction in the progressive neurodegenerative process seen in patients 
with WS. 
Mitochondrial Medicine 2018, Cambridge (Poster Presentation/Lightning Talk) 
Evidence of mitochondrial and visual dysfunction in a zebrafish wfs1 model of Wolfram 
syndrome 
George Cairns1, Florence Burte, Juliane Mueller1, Angela Pyle1, Maria Toms5, Mariya 
Moosajee5, John Sayer2, Patrick Yu-Wai-Man3,4,5 
1. Welcome Trust Centre for Mitochondrial Research, Newcastle University, Newcastle Upon 
Tyne, UK. 2. Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK. 
3. Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of 
Cambridge, Cambridge, UK. 4. MRC Mitochondrial Biology Unit, University of Cambridge, 
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Cambridge, UK. 5. NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL 
Institute of Ophthalmology, London, UK. 
Wolfram syndrome (WS) is a neurodegenerative disorder defined historically by the 
combination of diabetes insipidus, diabetes mellitus, optic atrophy and sensorineural 
deafness. It is now increasingly apparent that a significant proportion of patients (30-40%) 
will develop additional neurological complications, in particular ataxia, epilepsy and 
degeneration of the long corticospinal tract neurones. The majority of patients with WS 
harbour recessive mutations within the WFS1 gene (4p16.1, OMIM 606201), which encodes 
for the Wolframin protein. Wolframin is an endoplasmic reticulum (ER) transmembrane 
protein and the depletion in protein level contributes to the neuropathology of WS. 
Wolframin is implicated in a number of critical cellular pathways, in particular the ER stress 
response and calcium homeostasis. Mitochondrial dysfunction is suspected to play a key role 
in the pathology of the disease. This link is highlighted by mutations in the CISD2 (4q24, 
OMIM 611507) gene, which also result in WS through a deleterious effect on mitochondrial 
calcium flux and disturbed ER-mitochondrial interactions. Changes in mitochondrial function 
were assessed in a wfs1 zebrafish model using a broad range of experimental methods in 
both larvae and adult fish. Mitochondrial axonal transport was quantified in vivo in wfs1 
knockout zebrafish by tracking mitochondria along the lateral line at 48hpf with high-
resolution confocal microscopy. Mitochondrial function was tested using a Seahorse XF Cell 
Mito Stress test. The mitochondrial respiratory chain complexes were assessed by SDS-PAGE 
and BN-PAGE. The functional consequences of wfs1 depletion in retinal ganglion cells were 
investigated with standardised visual function tests and our findings were corroborated with 
the histopathological findings in zebrafish retinas. We have characterised a wfs1 zebrafish 
model that faithfully recapitulates the clinical phenotype in patients with WS. Our results 
indicated that disturbed mitochondrial axonal transport and a reduction in mitochondrial 
complex I activity contribute to the loss of retinal ganglion cells and loss of visual function. 
Our disease model provides a versatile tool for further investigation the development and 
progression of WS and importantly, therapeutic drug screening. 
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